|3-甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺|CsnPharm

CAS No.: 85622-93-1

替莫唑胺 Catalog No. CSN12046

Synonyms: NSC 362856;CCRG 81045;TMZ

Temozolomide is a DNA-methylating agent and an alkylating cytostatic drug used in the treatment of some brain cancers, astrocytoma and glioblastoma multiforme.

规格	价格	促销价格	库存	数量

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

加入购物车大规格询价

加入收藏

产品咨询

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

纯度 & 质量文件批次:

靶点选择性

生物活性

实验方案

技术信息

生物活性

描述DNA damage is an abnormal chemical structure in DNA, while a mutation is a change in the sequence of standard base pairs. DNA damages cause changes in the structure of the genetic material and prevent the replication mechanism from functioning and performing properly. Temozolomide is converted to the active metabolite 5-(3-methyltriazen-1-yl) imidazole-4-carboxamide (MTIC) by non-enzymatic chemical conversion that produces DNA damage^[3]. In vitro, temozolomide exhibited anti-proliferation to human malignant glioma cell lines U373MG, U87MG, and T98G with IC₅₀ values of 40, 30 and 350 μM, respectively. Temozolomide induced apoptosis in the MGMT expressing cells occurred through AKT-Glycogen-Synthase-Kinase-3β signaling and is mediated by myelocytomatosis oncoprotein^[4]. Temozolomide treatment at concentration of 100 mM for 72h increased the population at the G2/M phase and decreased the population at the G1 phase in all malignant glioma cells. In addition, temozolomide induced autophagy in U373-MG cells^[5]. In vivo, administration of 40 mg/kg temozolomide significantly increased survival times in a B16F10 mouse metastatic melanoma model^[6]. Treatment with temozolomide at dose of 2.5 mg/kg daily for 4 weeks resulted in a 78.30% tumor suppression, and reduced microvessel density in the glioblastoma orthotopic xenograft model^[7].
细胞研究

Cell Data

Cell Lines	Concentration	Assay Type	Time	Activity Description	Data Sources
A172	200 μM	Function Assay	48 h	increases BRCC3 mRNA expression	25337721
A172	200 μM	Function Assay	48 h	increases the expression of BRCA1, BRCA2, RAD51 and FANCD2	25337721
A172	200 μM	Function Assay	24/72/120 h	increases γH2AX foci formation time-dependently	25337721

动物研究

剂量

Nude Mice: 0.9 mg/kg - 266 mg/kg^[1] (p.o.) Mice: 50 mg/kg^[2] (i.v.)

给药途径

p.o., i.v.

动物药代数据

Animal	Mice^[2]
Dose	50 mg/kg
Administration	i.v.
T_1/2	0.689 ± 0.019 h (plasma)
AUC_0→7h	36.81 ± 1.11 μg/g·h (brain) 65.40 ± 2.00 μg/ml·h (plasma)

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT00611247	Leukemia, Myeloid	Phase 2	Completed	-	United States, California ... more >> Stanford University School of Medicine Stanford, California, United States, 94305 Collapse <<
NCT00611247	-	-	Completed	-	-
NCT00869050	Neuroendocrine Tumors	Phase 2	Completed	-	United States, New York ... more >> Columbia University Medical Center New York, New York, United States, 10032 Collapse <<

更多
参考文献

实验方案

计算器摩尔计算器总药量计算器工作液计算器
储存液制备
- 1 mg
- 5 mg
- 10 mg
- 1 mM
- 5.1507 mL
- 25.7533 mL
- 51.5066 mL
- 5 mM
- 1.0301 mL
- 5.1507 mL
- 10.3013 mL
- 10 mM
- 0.5151 mL
- 2.5753 mL
- 5.1507 mL

技术信息

CAS号

85622-93-1

储存条件

粉末: Sealed in dry,2-8°C

液体: -20°C:3-6 月 -80°C:12月

分子式

C6H6N6O2

运输

蓝冰

分子量

194.15

别名

NSC 362856;CCRG 81045;TMZ;TZM;Methazolastone;Temodal;SCH-52365;MB-39831;R-P46161;TMZ. US brand names: Methazolastone;Temodar. Foreign brand name: Temodal;替莫唑胺

溶解度

DMSO	36.0 mg/mL (185.4 mM)
Water	Insoluble
Ethanol	Insoluble

动物实验配方

5% DMSO+30% PEG 300+water

2 mg/mL

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

Cell Lines	Concentration	Assay Type	Time	Activity Description	Data Sources

A172	200 μM	Function Assay	48 h	increases BRCC3 mRNA expression	25337721
A172	200 μM	Function Assay	48 h	increases the expression of BRCA1, BRCA2, RAD51 and FANCD2	25337721
A172	200 μM	Function Assay	24/72/120 h	increases γH2AX foci formation time-dependently	25337721
A2058	-	Growth Inhibition Assay	48 h	IC50=12 μM	25524552
A375	-	Growth Inhibition Assay	48 h	IC50=265 μM	25524552
CHP-212	-	Growth Inhibition Assay	48 h	IC50=7.97 ± 0.69 μM	25960282
CHP-212Cis100	-	Growth Inhibition Assay	48 h	IC50=9.55 ± 0.88 μM	25960282
D54-MG	0-800 μM	Growth Inhibition Assay	72 h	inhibits cell viability in a dose dependent manner	24093630
DLD1	-	Growth Inhibition Assay	7 d	GI50=501.4±93 μM	25277441
GB-SCC010	-	Growth Inhibition Assay	4 d	IC50=226 μM	23612755
GB-SCC026	-	Growth Inhibition Assay	4 d	IC50=53.1 μM	23612755
GB-SCC028	-	Growth Inhibition Assay	4 d	IC50=167 μM	23612755
HCC-1937	0-300 μM	Growth Inhibition Assay	48 h	inhibits cell growth in a dose-dependent manner	24623736
HCT116	-	Growth Inhibition Assay	7 d	GI50=579.9±32 μM	25277441
HCT116	100 µM	Function Assay	3 h	induces the Chk1 Phosphorylation	23667469
HCT3-6	100 µM	Function Assay	3 h	induces the Chk1 Phosphorylation	23667469
Hs683	0-1000 μM	Growth Inhibition Assay	96 h	IC50=128.9 μM	24495907
HT-29	500 μM	Function Assay	24/48 h	enhances the levels of γ-H2AX	24038068
Kelly	-	Growth Inhibition Assay	48 h	IC50=139.20 ± 5.95 μM	25960282
KellyCis83	-	Growth Inhibition Assay	48 h	IC50=251.00 ± 15.75 μM	25960282
LN229	0-50 μM	Growth Inhibition Assay	-	IC50=16 μM	25750273
LN229	20 μM	Cytotoxity Assay	48 h	reduceds the percentages of colonies formed	25434381
LNT-229	3-100 μM	Growth Inhibition Assay	24 h	inhibits clonogenic survival in a dose-dependent manner	23667632
LNZ308	0-1000 μM	Growth Inhibition Assay	96 h	IC50=326.7 μM	24495907
M21	-	Growth Inhibition Assay	48 h	IC50=221 μM	25524552
M238	-	Growth Inhibition Assay	48 h	IC50=40 μM	25524552
M249	-	Growth Inhibition Assay	48 h	IC50=254 μM	25524552
MCF7	0-1000 μM	Growth Inhibition Assay	48 h	inhibits cell growth in a dose-dependent manner	24623736
MDA-MB-231	0-40 μM	Growth Inhibition Assay	48 h	inhibits cell growth in a dose-dependent manner	24623736
MDA-MB-231-br	0-10 μM	Growth Inhibition Assay	48 h	inhibits cell growth in a dose-dependent manner	24623736
MDA-MB-468	0-500 μM	Growth Inhibition Assay	48 h	inhibits cell growth in a dose-dependent manner	24623736
MRC5	-	Growth Inhibition Assay	7 d	GI50=449.4±8 μM	25277441
PC-3	0-25 μM	Growth Inhibition Assay	48 h	inhibits cell growth which can be potentiated by lycopene	23746934
PC-3	25 μM	Apoptosis Assay	48 h	induces apoptosis which can be potentiated by lycopene	23746934
SHG-44	10-200 μM	Growth Inhibition Assay	96 h	IC50=9.73 ± 2.12 μM	24065569
SK-N-AS	-	Growth Inhibition Assay	48 h	IC50=227.70 ± 22.15 μM	25960282
SK-N-ASCis24	-	Growth Inhibition Assay	48 h	IC50=480.60 ± 101.15 μM	25960282
SNB19M	-	Growth Inhibition Assay	7 d	GI50=469.9±88 μM	25277441
SNB19V	-	Growth Inhibition Assay	7 d	GI50=35.7±12 μM	25277441
SNB19V	100 μM TMZ	Function Assay	0-72 h	increases γH2AX expression between 16 and 72 h	25277441
SNB19VR	-	Growth Inhibition Assay	7 d	GI50=280.2±18 μM	25277441
T47D	0-100 μM	Growth Inhibition Assay	48 h	inhibits cell growth in a dose-dependent manner	24623736
T98G	5/10/15 μM	Growth Inhibition Assay	24 h	induces cell death dose-dependently after concomitant-temozolomide with NPe6-PDT	25262961
T98G	15 μM	Function Assay	24 h	increases DNA-fragmentation in NPe6-PDT treated glioma cells	25262961
T98G	0-750 μM	Growth Inhibition Assay	72/96 h	inhibits cell viability in a dose dependent manner	24324080
T98G	50-400 μM	Growth Inhibition Assay	144 h	inhibits cell viability in a dose dependent manner	23715499
T98G	10-700 μM	Growth Inhibition Assay	24 h	inhibits clonogenic survival in a dose-dependent manner	23667632
TR-LN229	0-50 μM	Growth Inhibition Assay	-	IC50=77 μM	25750273
U118	50-350 μM	Growth Inhibition Assay	48 h	inhibits cell growth slightly	25554223
U118	250/350 μM	Function Assay	48 h	enhances TMX-induced p-PKC-pan decrease	25554223
U-118 MG	-	Growth Inhibition Assay	72 h	IC50=1.05 mM	25245332
U251	20 μM	Cytotoxity Assay	48 h	reduceds the percentages of colonies formed	25434381
U251	25-200 μM	Growth Inhibition Assay	48 h	inhibits cell growth in a dose-dependent manner	25400745
U251	100-400 μM	Growth Inhibition Assay	72/96 h	the anti-proliferative effect can be enhanced by gossypol enhanced	25375271
U251	200 μM	Function Assay	48 h	increases BRCC3 mRNA expression	25337721
U251	200 μM	Function Assay	48 h	increases the expression of BRCA1, BRCA2, RAD51 and FANCD2	25337721
U251	200 μM	Function Assay	24/72/120 h	increases γH2AX foci formation time-dependently	25337721
U251	5/10/15 μM	Growth Inhibition Assay	24 h	induces cell death dose-dependently after concomitant-temozolomide with NPe6-PDT	25262961
U251	15 μM	Function Assay	24 h	increases DNA-fragmentation in NPe6-PDT treated glioma cells	25262961
U251	100-400 μM	Growth Inhibition Assay	48 h	inhibits cell growth in a dose-dependent manner	24623736
U251	100 μM	Apoptosis Assay	48 h	increases the caspase-3/7 activity	24481586
U251	-	Growth Inhibition Assay	24 h	IC50=86.29 ± 1.58 μM	24326954
U251	-	Growth Inhibition Assay	48 h	IC50=75.34 ± 1.02 μM	24326954
U251	-	Growth Inhibition Assay	72 h	IC50=72.42 ± 1.45 μM	24326954
U251	-	Growth Inhibition Assay	96 h	IC50=69.82 ± 3.04 μM	24326954
U251MG	100 μM	Apoptosis Assay	48 h	induces apoptosis	25680464
U251-MG	0-800 μM	Growth Inhibition Assay	72 h	inhibits cell viability in a dose dependent manner	24093630
U251-MG	100 µM	Growth Inhibition Assay	72 h	inhibits cell growth which can be enhanced by GTB	23696788
U343	100-400 μM	Growth Inhibition Assay	72/96 h	the anti-proliferative effect can be enhanced by gossypol enhanced	25375271
U373	100-400 μM	Growth Inhibition Assay	72/96 h	the anti-proliferative effect can be enhanced by gossypol enhanced	25375271
U373	10-200 μM	Growth Inhibition Assay	96 h	IC50=10.13 ± 1.02 μM	24065569
U373M	-	Growth Inhibition Assay	7 d	GI50=368.7±86 μM	25277441
U373MG-LUC	-	Growth Inhibition Assay	72 h	IC50>600 μM	25431953
U373V	-	Growth Inhibition Assay	7 d	GI50=68.0±32 μM	25277441
U373VR	-	Growth Inhibition Assay	7 d	GI50=288.8±33 μM	25277441
U87	100 μM	Function Assay	24-72 h	induces DcR1 expression	25808868
U87	0–200 µM	Apoptosis Assay	24 h	enhances CQ induced apoptosis	25681668
U87	50-350 μM	Growth Inhibition Assay	48 h	inhibits cell growth slightly	25554223
U87	250/350 μM	Function Assay	48 h	enhances TMX-induced p-PKC-pan decrease	25554223
U87	250/350 μM	Growth Inhibition Assay	48 h	increases the percentage of cells in S and G2/M cotreated with TMX	25554223
U87	25-200 μM	Growth Inhibition Assay	48 h	inhibits cell growth in a dose-dependent manner	25400745
U87	200 μM	Function Assay	48 h	increases BRCC3 mRNA expression	25337721
U87	200 μM	Function Assay	24/72/120 h	increases γH2AX foci formation time-dependently	25337721
U87	-	Growth Inhibition Assay	24 h	IC50=260.34 μM	25173233
U87	100-400 μM	Growth Inhibition Assay	48 h	inhibits cell growth in a dose-dependent manner	24623736
U87	0-1000 μM	Growth Inhibition Assay	96 h	IC50=18.45 μM	24495907
U87	100 μM	Apoptosis Assay	48 h	increases the caspase-3/7 activity	24481586
U87	100 µM	Function Assay	3 h	elevates the levels of pChk1 and pChk2	23667469
U87	-	Growth Inhibition Assay	4 d	IC50=45.2 μM	23612755
U-87	0-40 μM	Growth Inhibition Assay	12 d	inhibits cell growth in a dose-dependent manner	23645729
U-87	0-40 μM	Apoptosis Assay	3/6 d	induces apoptosis in both dose- and time-dependent manner	23645729
U-87	0-40 μM	Function Assay	3/6 d	induces autophagy in both dose- and time-dependent manner	23645729
U87 GSLCs	-	Growth Inhibition Assay	24 h	IC50=766.11 μM	25173233
U-87 MG	-	Growth Inhibition Assay	72 h	IC50=0.93 mM	25245332
U87 stem cell	-	Growth Inhibition Assay	4 d	IC50=66.7 μM	23612755
U87MG	100 μM	Apoptosis Assay	48 h	induces apoptosis	25680464
U87MG	-	Growth Inhibition Assay	7 d	GI50=38.3±20 μM	25277441
U87MG	-	Growth Inhibition Assay	72 h	IC50=15.625 μM	25050915
U87-MG	100 µM	Growth Inhibition Assay	72 h	inhibits cell growth which can be enhanced by GTB	23696788
U87MG-luc2	100-400 μM	Growth Inhibition Assay	72/96 h	the anti-proliferative effect can be enhanced by gossypol enhanced	25375271

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00611247	Leukemia, Myeloid	Phase 2	Completed	-	United States, California ... more >> Stanford University School of Medicine Stanford, California, United States, 94305 Collapse <<
NCT00611247	-	-	Completed	-	-
NCT00869050	Neuroendocrine Tumors	Phase 2	Completed	-	United States, New York ... more >> Columbia University Medical Center New York, New York, United States, 10032 Collapse <<
NCT00869050	-	-	Completed	-	-
NCT00389090	Glioma Astroc... more >>ytoma Oligodendroglioma Oligoastrocytoma Collapse <<	Phase 2	Terminated(AOI Pharma terminat... more >>ed the license agreement. IND Transferred to NCI) Collapse <<	-	United States, California ... more >> AOI Pharmaceuticals Investigative Site Los Angeles, California, United States, 90033 United States, Florida AOI Pharmaceuticals Investigative Site Orlando, Florida, United States, 32804 United States, Illinois AOI Pharmaceuticals Investigative Site Chicago, Illinois, United States, 60611 AOI Pharmaceuticals Investigative Site Evanston, Illinois, United States, 60201 United States, Kentucky AOI Pharmaceuticals Investigative Site Lexington, Kentucky, United States, 40536 AOI Pharmaceuticals Investigative Site Louisville, Kentucky, United States, 40202 United States, Minnesota AOI Pharmaceuticals Investigative Site Minneapolis, Minnesota, United States, 54407 United States, North Carolina AOI Pharmaceuticals Investigative Site Durham, North Carolina, United States, 27710 United States, South Carolina AOI Pharmaceuticals Investigative Site Greenville, South Carolina, United States, 29605 United States, Texas AOI Pharmaceuticals Investigative Site Dallas, Texas, United States, 75246 AOI Pharmaceuticals Investigative Site Houston, Texas, United States, 77024 United States, Utah AOI Pharmaceuticals Investigative Site Salt Lake City, Utah, United States, 84132 Collapse <<
NCT00704080	Mixed Gliomas ... more >> Malignant Gliomas Glioblastoma Multiforme Collapse <<	Phase 1	Completed	-	United States, Alabama ... more >> Investigational Site Number Birmingham, Alabama, United States, 35205 United States, California Investigational Site Number Los Angeles, California, United States, 90024 United States, Massachusetts Investigational Site Number Boston, Massachusetts, United States, 02115 United States, New York Investigational Site Number New York, New York, United States, 10021 Investigational Site Number Rochester, New York, United States, 14642 United States, Ohio Investigational Site Number Cleveland, Ohio, United States, 44195 Collapse <<
NCT00098865	Central Nervous System Tumor, ... more >>Pediatric Neuroblastoma Collapse <<	Phase 2	Completed	-	United States, Massachusetts ... more >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Collapse <<
NCT02477813	Small Cell Lung Cancer Recurre... more >>nt Collapse <<	Phase 2	Terminated(Lack of eligible pa... more >>tient recruitment) Collapse <<	-	Italy ... more >> Ircc Irst Meldola, FC, Italy, 47014 Oncologia Medica, Azienda ospedaliera universitaria di Ferrara Ferrara, FE, Italy, 44124 Oncologia Medica AOU Policlinico di Modena Modena, MO, Italy, 41100 U.O. Oncologia Medica Faenza, RA, Italy, 48018 U.O Oncologia medica Lugo, RA, Italy, 48022 UO Oncologia Medica, Ospedale S.Maria delle Croci Ravenna, RA, Italy, 48121 U.O Oncologia medica Rimini, RN, Italy, 47923 Oncologia Medica Ospedale Guglielmo da Saliceto Piacenza, Italy, 29121 Collapse <<
NCT00098865	-	-	Completed	-	-
NCT00883298	Recurrent Glioblastoma Multifo... more >>rme Recurrent Gliosarcoma Collapse <<	Phase 2	Completed	-	United States, Arizona ... more >> Center for Neurosciences Tucson, Arizona, United States, 85718 Collapse <<
NCT00632203	-	-	Terminated	-	-
NCT01550224	Acute Myeloid Leukemia With 11... more >>q23-abnormality in Relapse Collapse <<	Phase 2	Completed	-	United States, California ... more >> Stanford University Medical Center Stanford, California, United States, 94305 Collapse <<
NCT02928575	Glioblastoma Multiforme	Phase 2	Unknown	June 2017	Canada, Alberta ... more >> Tom Baker Cancer Center and University of Calgary Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Jacob Easaw, MD PhD FRCPC 403-521-3446 Jay.Easaw@albertahealthservices.ca Canada, Quebec McGill University Health Centre Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Bassam Abdulkarim, MD PhD FRCPC 514-934-1934 ext 43915 bassam.abdulkarim@mcgill.ca Collapse <<
NCT00501891	Glioblastoma Multiforme	Phase 2	Completed	-	United States, North Carolina ... more >> Duke University Medical Center (Brain Tumor Center) Durham, North Carolina, United States, 27710 Collapse <<
NCT01550224	-	-	Completed	-	-
NCT03749187	Glioblastoma ... more >>IDH1 Gene Mutation IDH2 Gene Mutation Low Grade Glioma Malignant Glioma Recurrent Glioblastoma Recurrent WHO Grade II Glioma Recurrent WHO Grade III Glioma WHO Grade II Glioma WHO Grade III Glioma Collapse <<	Phase 1	Not yet recruiting	July 2027	-
NCT00501891	-	-	Completed	-	-
NCT03156036	Advanced Rectal Cancer	Phase 2	Recruiting	February 2021	Korea, Republic of ... more >> Asan Medical Center Recruiting Seoul, Songpa, Korea, Republic of, 05505 Contact: Yong Sang Hong, M.D., Ph.D. +82-2-3010-3227 yshong@amc.seoul.kr Contact: Tae Won Kim, M.D., Ph.D. +82-2-3010-3910 twkimmd@amc.seoul.kr Collapse <<
NCT02337426	Adult Brain Glioblastoma ... more >> Adult Giant Cell Glioblastoma Adult Gliosarcoma Collapse <<	Phase 1	Completed	-	United States, Virginia ... more >> Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Collapse <<
NCT00990652	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, Illinois ... more >> Northwestern University Chicago, Illinois, United States, 60611 Collapse <<
NCT00632203	Carcinoma, Non-Small-Cell Lung... more >> Adenocarcinoma Carcinoma, Large Cell Carcinoma, Squamous Cell Collapse <<	Phase 2	Terminated	-	-
NCT00990652	-	-	Completed	-	-
NCT02395692	Adult Brain Glioblastoma	Phase 2	Active, not recruiting	-	United States, Alabama ... more >> University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States, 35233 United States, California UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 UCSF Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Maryland Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Michigan Henry Ford Cancer Institute¿Downriver Brownstown, Michigan, United States, 48183 Henry Ford Hospital Detroit, Michigan, United States, 48202 Henry Ford West Bloomfield Hospital West Bloomfield, Michigan, United States, 48322 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 Collapse <<
NCT01189643	Sarcoma Desmo... more >>plastic Small Round Cell Tumor (DSRCT) Collapse <<	Early Phase 1	Active, not recruiting	August 2019	United States, New York ... more >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Collapse <<
NCT01180816	Glioblastoma Multiforme ... more >> Anaplastic Astrocytoma Collapse <<	Phase 1	Active, not recruiting	December 2018	United States, New York ... more >> Lenox Hill Brain Tumor Center New York, New York, United States, 10065 Collapse <<
NCT00362817	-	-	Completed	-	-
NCT01009788	Breast Cancer ... more >> Metastatic Breast Cancer BRCA1 Gene Mutation brca2 Gene Mutation Collapse <<	Phase 2	Active, not recruiting	June 2020	United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Collapse <<
NCT00266812	Carcinoma, Non-Small-Cell Lung	Phase 2	Terminated(Patient target coul... more >>d not be reached within the planned timeframe.) Collapse <<	-	-
NCT03672773	Recurrent Extensive Stage Smal... more >>l Cell Lung Carcinoma Refractory Extensive Stage Small Cell Lung Carcinoma Collapse <<	Phase 2	Not yet recruiting	November 1, 2020	United States, California ... more >> UCLA / Jonsson Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90095 Contact: Jonathan W. Goldman 310-633-8400 jwgoldman@mednet.ucla.edu Principal Investigator: Jonathan W. Goldman Collapse <<
NCT02530502	Adult Glioblastoma	Phase 1 Phase 2	Active, not recruiting	November 2020	United States, Illinois ... more >> Northwestern University Chicago, Illinois, United States, 60611 Collapse <<
NCT03204019	Pancreatic Neuroendocrine Tumo... more >>r Collapse <<	Phase 2	Recruiting	September 2018	China, Beijing ... more >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Yihebali Chi yihebalichi@yahoo.com.cn Collapse <<
NCT00313729	CNS Tumor, Adult	Phase 2	Completed	-	United States, California ... more >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Collapse <<
NCT00362817	Brain Tumor B... more >>rain Metastases Collapse <<	Phase 1 Phase 2	Completed	-	United States, Ohio ... more >> Ohio State University Columbus, Ohio, United States, 43210 Collapse <<
NCT00590681	Glioblastoma Multiforme	Phase 2	Completed	-	United States, Illinois ... more >> The University of Chicago Chicago, Illinois, United States, 60637 NorthShore University health system Evanston, Illinois, United States, 60201 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48103 United States, Wisconsin Medical college of Wisconsin Milwaukee, Wisconsin, United States, 53226 Waukesha health care Waukesha, Wisconsin, United States, 53188 Collapse <<
NCT03011671	Malignant Glioma of Brain	Phase 1	Not yet recruiting	March 2020	United States, Illinois ... more >> University of Chicago Medical Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Bakhtiar Yamini, MD byamini@surgery.bsd.uchicago.edu Collapse <<
NCT00266812	-	-	Terminated(Patient target coul... more >>d not be reached within the planned timeframe.) Collapse <<	-	-
NCT03363659	Glioblastoma ... more >>Glioblastoma Multiforme Collapse <<	Phase 2	Recruiting	January 21, 2027	United States, Wisconsin ... more >> Aurora Health Care, Aurora St. Luke's Medical Center Recruiting Milwaukee, Wisconsin, United States, 53215 Contact: Lynda Yanny 414-649-6685 lynda.yanny@aurora.org Principal Investigator: George Bobustuc, MD Sub-Investigator: Richard A Rovin, MD Sub-Investigator: Asad Khan, MD Sub-Investigator: Amin Kassam, MD Sub-Investigator: Santhi Konduri, PhD Collapse <<
NCT00576680	Pancreatic Neuroendocrine Tumo... more >>r Collapse <<	Phase 1 Phase 2	Active, not recruiting	December 2019	United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Collapse <<
NCT00792012	Glioblastoma Multiforme	Phase 1	Completed	-	United States, Colorado ... more >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Collapse <<
NCT02689336	Glioma Rhabdo... more >>myosarcoma Osteosarcoma Medulloblastoma Neuroectodermal Tumor Ependymoma Ewing's Sarcoma Wilms Tumor Collapse <<	Phase 2	Recruiting	May 31, 2020	United States, Missouri ... more >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Alok Kothari, M.D. 314-454-6018 alok@wustl.edu Principal Investigator: Alok Kothari, M.D. Collapse <<
NCT03535350	Glioblastoma	Phase 1	Recruiting	April 1, 2019	United States, Ohio ... more >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Manmeet S. Ahluwalia, MD, FACP 216-444-6145 ahluwam@ccf.org Collapse <<
NCT00012116	Metastatic Cancer	Phase 2	Completed	-	United States, California ... more >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Collapse <<
NCT00687323	Leukemia, Acute Myeloid ... more >> Myelodysplastic Syndrome Collapse <<	Phase 2	Completed	-	-
NCT00687323	-	-	Completed	-	-
NCT00841555	Glioblastoma Multiforme/Anapla... more >>stic Astrocytoma Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Collapse <<
NCT00597493	-	-	Completed	-	-
NCT03466450	Glioblastoma	Phase 1 Phase 2	Recruiting	March 2021	Spain ... more >> Institut Catalá de Oncología Badalona/Hospital Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Contact: Carmen Balañá, M.D. +34 972 22 58 34 cbalana@iconcologia.net Principal Investigator: Carmen Balañá, M.D. Institut Catalá de Oncología Girona/Hospital Universitari Dr. Josep Trueta Recruiting Girona, Spain, 17007 Contact: Sonia del Barco, M.D. +34 972 22 58 34 ext 7977 sdelbarco@iconcologia.net Principal Investigator: Sonia del Barco, M.D. Hospital Universitario Ramón y Cajal Recruiting Madrid, Spain Contact: Mª Ángeles Vaz 91 336 80 00 ext 7977 mavaz4@gmail.com Principal Investigator: Mª Ángeles Vaz, M.D. Hospital Universitario y Politécnico La Fe Recruiting Valencia, Spain, 46009 Contact: José Muñoz Langa, M.D. +34 934344412 munyoz_joslan@gva.es Principal Investigator: José Muñoz Langa, M.D. Collapse <<
NCT00597493	Recurrent Glioblastoma Multifo... more >>rme Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> Duke University Health System Durham, North Carolina, United States, 27710 Collapse <<
NCT01110876	Brain Cancer ... more >>Glioblastoma Multiforme Collapse <<	Phase 1 Phase 2	Terminated(Unanticipated Toxic... more >>ities) Collapse <<	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00492141	Ewing's Sarcoma	Phase 1 Phase 2	Completed	-	United States, Texas ... more >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02934204	Primary CNS Lymphoma	Phase 2	Recruiting	February 2019	China, Guangdong ... more >> Guangdong general hospital Recruiting Guangzhou, Guangdong, China, 510080 Contact: Sichu Liu, MD PhD +86 20 81884713 ext 80411 sisi.lau@foxmail.com Collapse <<
NCT00515788	Neoplastic Meningitis	Phase 1	Terminated(Study terminated du... more >>e to slow accrual with no expansion to additional phase.) Collapse <<	-	United States, Texas ... more >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01765088	Anaplastic Oligoastrocytoma ... more >> Anaplastic Astrocytoma Glioblastoma Collapse <<	Phase 3	Recruiting	December 2019	China, Guangdong ... more >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhong-ping Chen, MD,PhD +86-20-87343310 chenzhp@sysucc.org.cn Contact: Cheng-cheng Guo, MD,PhD +86-20-87343656 guochch@sysucc.org.cn Principal Investigator: Zhong-ping Chen, MD,PhD Collapse <<
NCT00841555	-	-	Completed	-	-
NCT00392171	Glioma Astroc... more >>ytoma Oligodendroglioma Glioblastoma Collapse <<	Phase 2	Completed	-	-
NCT01235793	-	-	Terminated(The clinical trial ... more >>was terminated due to poor enrollment) Collapse <<	-	-
NCT00614978	Metastatic Breast Cancer ... more >> Brain Metastases HER2 Positive Collapse <<	Phase 1	Completed	-	Belgium ... more >> Jules Bordet Institute Brussels, Belgium, 1000 Collapse <<
NCT02761070	Glioblastoma ... more >>Recurrence Progression Collapse <<	Phase 3	Recruiting	July 2023	Japan ... more >> Hirosaki University School of Medicine Recruiting Hirosaki, Aomori, Japan, 036-8563 Contact: Kenichiro Asano, M.D. +81-172-39-5111 asanoken@hirosaki-u.ac.jp Ehime University Graduate School of Medicine Recruiting Shizukawa, Ehime, Japan, 791-0295 Contact: Shohei Kouno, M.D. +81-89-960-5338 kouno1220@gmail.com Iwate Medical University Recruiting Morioka, Iwate, Japan, 020-8505 Contact: Takaaki Beppu, M.D. +81-19-651-5111 tbeppu@iwate-med.ac.jp Tohoku University Graduate School of Medicine Recruiting Sendai, Miyagi, Japan, 980-8574 Contact: Masayuki Kanamori, M.D. +81-22-717-7000 mkanamori@med.tohoku.ac.jp Kansai Medical University Recruiting Hirakata, Osaka, Japan, 573-1191 Contact: Akio Asai, M.D. +81-72-804-0101 aasaikun@hirakata.kmu.ac.jp Contact: Masahiro Nonaka, M.D. +81-72-804-0101 nonakamasa65@gmail.com Osaka University Graduate School of Medicine Recruiting Suita, Osaka, Japan, 565-0871 Contact: Naoki Kagawa, M.D. +81-6-6879-3652 nkagawa@nsurg.med.osaka-u.ac.jp Saitama Medical University International Medical Center Recruiting Hidaka, Saitama, Japan, 350-1298 Contact: Ryo Nishikawa, M.D., Ph.D. +81-42-984-4111 rnishika@saitama-med.ac.jp Contact: Kazuhiko Misima, M.D., Ph.D. +81-42-984-4111 kmishima@saitama-med.ac.jp Kusyu University Graduate School of Medical Sciences Recruiting Fukuoka, Japan, 812-8582 Contact: Koji Yoshimoto, M.D., Ph.D. +81-92-642-5524 kyoshimo@ns.med.kyushu-u.ac.jp Hiroshima University Hospital Recruiting Hiroshima, Japan, 734-8551 Contact: Kazuhiko Sugiyama, M.D. +81-82-257-5227 sugiyama-hma@umin.ac.jp Kagoshima University Graduate School of Medical and Dental Sciences Recruiting Kagoshima, Japan, 890-8520 Contact: Hirofumi Hirano, M.D. +81-99-275-5111 hirahira@m2.kufm.kagoshima-u.ac.jp Kitasato University School of Medicine Recruiting Kanagawa, Japan, 252-0374 Contact: Toshihiro Kumabe, M.D., Ph.D. +81-3-3972-8111 kuma@kitasato-u.ac.jp Kyoto University Graduate School of Medicine Recruiting Kyoto, Japan, 606-8507 Contact: Yoshiki Arakawa, M.D. +81-75-366-7776 yarakawa@kuhp.kyoto-u.ac.jp Osaka International Cancer Institute Recruiting Osaka, Japan, 541-8567 Contact: Manabu Kinoshita, M.D. +81-6-6945-1181 mail@manabukinoshita.com Nakamura Memorial Hospital Recruiting Sapporo, Japan, 060-8570 Contact: Kenichi Sato, M.D. +81-11-231-8555 satoken@med.nmh.or.jp Hokkaido University Graduate School of Medicine Recruiting Sapporo, Japan, 060-8648 Contact: Hiroyuki Kobayashi, M.D. +81-11-716-1161 hiro-ko@med.hokudai.ac.jp Shizuoka Canser Center Hospital Recruiting Shizuoka, Japan, 411-8777 Contact: Yoko Nakasu, M.D. +81-55-989-5222 y.nakasu@scchr.jp Contact: Kouichi Mitsuya, M.D. +81-55-989-5222 k.mitsuya@scchr.jp National Cancer Center Hospital Recruiting Tokyo, Japan, 104-0045 Contact: Yoshitaka Narita, M.D., Ph.D. +81-3-542-2511 yonarita@ncc.go.jp The University of Tokyo Hospital Recruiting Tokyo, Japan, 113-8655 Contact: Shota Tanaka, M.D. +81-3-5800-8853 tanakas-tky@umin.ac.jp Keio University Hospital Recruiting Tokyo, Japan, 160-8582 Contact: Hikaru Sasaki, M.D. +81-3-3353-1211 hsasaki@a5.keio.jp Nihon University School of Medicine Itabashi Hospital Recruiting Tokyo, Japan, 173-0032 Contact: Atsuo Yoshino, M.D. +81-3-3972-8111 yoshino.atsuo@nihon-u.ac.jp Contact: Shun Yamamuro, M.D. +81-3-3972-8111 yamamuro.shun@nihon-u.ac.jp Kyorin University Faculty of Medicine, Department of Neurosurgery Recruiting Tokyo, Japan, 181-8611 Contact: Keiichi Kobayashi, M.D., Ph.D. +81-422-47-5511 kekobayashi@kki.biglobe.ne.jp Contact: Motoo Nagane, M.D., Ph.D. +81-422-47-5511 mnagane@ks.kyorin-u.ac.jp Collapse <<
NCT02168270	Anaplastic Astrocytoma ... more >> Anaplastic Oligodendroglioma Anaplastic Oligoastrocytoma Glioblastoma Gliosarcoma Collapse <<	Phase 1	Terminated	-	United States, Nebraska ... more >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Collapse <<
NCT01235793	B-Cell Lymphoma Originating in... more >> the CNS Collapse <<	Phase 2	Terminated(The clinical trial ... more >>was terminated due to poor enrollment) Collapse <<	-	United States, California ... more >> Cedars Sinai Medical Center Los Angeles, California, United States, 90048 Collapse <<
NCT02168270	-	-	Terminated	-	-
NCT00400816	Central Nervous System Tumors ... more >> Brain Tumor Collapse <<	Phase 2	Completed	-	United States, Ohio ... more >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Collapse <<
NCT00392171	-	-	Completed	-	-
NCT02340156	RECURRENT GLIOBLASTOMA	Phase 2	Recruiting	December 2019	United States, Texas ... more >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Kathy Hunter 713-745-5769 kuhunter@mdanderson.org Taiwan China Medical University Hospital Recruiting Taichung, Taiwan, 40447 Contact: Sophia Lin 886-937-722118 tinghsun3@gmail.com Contact: Ya-Hui Lin 886-978-523673 yahuilin02@gmail.com Principal Investigator: Der-Yang Cho, MD Collapse <<
NCT00643825	Glioblastoma	Phase 2	Unknown	January 2012	Belgium ... more >> Cliniques Universitaires Saint-Luc Recruiting Brussels, Europe, Belgium, 1200 Contact: Jean-Francois BAURAIN, MD, PhD +32 2 764 54 71 jean-francois.baurain@@uclouvain.be Collapse <<
NCT01124734	Malignant Melanoma	Phase 2	Unknown	August 2017	United States, Pennsylvania ... more >> Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Collapse <<
NCT00612339	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> Duke University Health System Durham, North Carolina, United States, 27710 Collapse <<
NCT00740636	Lung Cancer	Phase 2	Completed	-	United States, New Jersey ... more >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Collapse <<
NCT00612339	-	-	Completed	-	-
NCT01985451	Central Nervous System Tumors	Phase 2	Unknown	March 2015	-
NCT00629187	Central Nervous System Neoplas... more >>ms Neoplasm Metastasis Collapse <<	Phase 1	Terminated(The study was stopp... more >>ed due to lack of adequate enrollment.) Collapse <<	-	United States, Massachusetts ... more >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Collapse <<
NCT03243851	Glioblastoma	Phase 2	Recruiting	December 31, 2018	Korea, Republic of ... more >> National Cancer Center Korea Recruiting Ilsan, Gyeonggi-Do, Korea, Republic of, 10408 Contact: Heon Yoo, MD., PhD. +82-31-920-1249 heonyoo@ncc.re.kr Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-Do, Korea, Republic of, 13620 Contact: Yu Jung Kim, MD., PhD. +82-31-787-8210 cong1005@gmail.com Ajou University Hospital Recruiting Suwon-si, Gyeonggi-Do, Korea, Republic of, 16499 Contact: Se Hyuk Kim, MD., PhD. +82-31-219-3559 nsksh@ajou.ac.kr Chonnam National University Hwasun Hospital Recruiting Hwasun, Jeollanam-Do, Korea, Republic of, 58128 Contact: Shin Jung, MD., PhD. +82-2-379-8954 sjung@chonnam.ac.kr Incheon St. Mary's Hospital Recruiting Incheon, Korea, Republic of, 21431 Contact: Dong Sup Chung, MD., PhD. +82-32-280-5876 dschung@catholic.ac.kr Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Tae Min Kim, MD., PhD. +82-2-2072-1672 gabriel9@snu.ac.kr Severance Hospital Recruiting Seoul, Korea, Republic of, 03722 Contact: Jong Hee Chang, MD., PhD. +82-2-2228-2162 changjh@yuhs.ac Konkuk University Hospital Recruiting Seoul, Korea, Republic of, 05030 Contact: Young Cho Koh, MD., PhD. +82-2-2030-7622 kohyc@kuh.ac.kr Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Contact: Jeong Hoon Kim, MD., PhD. +82-2-3010-3559 jhkim1@amc.seoul.kr Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: Do Hyun Nam, MD., PhD. +82-2-3410-3497 nsnam@skku.edu Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of, 06591 Contact: Yong-Kil Hong, MD., PhD. +82-2-2258-2101 hongyk@catholic.ac.kr Saint Vincent's Hospital, Korea Recruiting Suwon-si, Korea, Republic of, 16247 Contact: Seung Ho Yang, MD., PhD. +82-31-249-8304 72ysh@catholic.ac.kr Collapse <<
NCT02389738	Blood Brain Barrier Defect	Early Phase 1	Completed	-	United States, Maryland ... more >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Collapse <<
NCT00740636	-	-	Completed	-	-
NCT03139916	Glioblastoma	Phase 2	Active, not recruiting	July 31, 2023	United States, Massachusetts ... more >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts general Hospital Boston, Massachusetts, United States, 02115 Collapse <<
NCT01534845	Anaplastic Glioma of Brain ... more >> Loss of Chromosomes 1p/19q Collapse <<	Phase 2	Unknown	February 2017	Korea, Republic of ... more >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Collapse <<
NCT02389738	-	-	Completed	-	-
NCT01473901	Glioblastoma	Phase 1	Completed	-	United States, Arkansas ... more >> Highlands Oncology Group Highlands Oncology Fayetteville, Arkansas, United States, 72703 United States, Massachusetts Dana Farber Cancer Institute SC (1) Boston, Massachusetts, United States, 02215 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson DeGrout Houston, Texas, United States, 77030-4009 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8V 5C2 Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28040 Collapse <<
NCT01985087	Glioblastoma	Phase 1 Phase 2	Recruiting	May 2019	United States, Kentucky ... more >> James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 Contact: Clinical Trials Office 502-562-3429 ctobcc@louisville.edu Principal Investigator: Eric Burton, MD Sub-Investigator: Shiao Woo, MD Collapse <<
NCT02039778	Glioblastoma ... more >>Malignant Glioma Brain Tumors Anaplastic Astrocytoma Collapse <<	Not Applicable	Terminated(Poor Accural)	-	United States, New York ... more >> Roosevelt Hospital New York, New York, United States, 10019 Collapse <<
NCT01591577	Newly Diagnosed Glioblastoma M... more >>ultiforme Collapse <<	Phase 2	Recruiting	December 7, 2019	United States, California ... more >> UCLA Recruiting Los Angeles, California, United States, 90095 Principal Investigator: Pioanh Nghiemphu, MD Collapse <<
NCT01067066	Melanoma	Phase 1	Terminated(Phase I/II study ha... more >>lted as Phase I, Low Response Rate) Collapse <<	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01601184	Histologically Confirmed Medul... more >>loblastoma Activation of the Sonic Hedgehog (SHH) Pathway Collapse <<	Phase 1 Phase 2	Terminated(The number of succe... more >>sses is not reached at the end of first stage of the phase II. The study is stopped.) Collapse <<	-	France ... more >> CHU La Timone Marseille, Bouches Du Rhône, France, 13385 Institut Claudius Régaud (iuct-oncopole) Toulouse, Haute-Garonne, France, 31059 Hopital de La Pitié Salpétrière Paris, Ile De France, France, 75013 Institut de Cancérologie de l'Ouest - René Gauducheau St Herblain, Loire Atlantique, France, 44805 Hopital Central de Nancy Nancy, Meurthe Et Moselle, France, 54035 CHBS Hôpital du Scorff Lorient, Morbihan, France, 56322 CHRU de Lille Lille, Nord, France, 59037 Centre Léon Bérard Lyon, Rhone, France, 69373 Institut de Cancérologie de l'Ouest - Paul Papin Angers, France, 49933 Institut Bergonié Bordeaux, France, 33076 Italy BELLARIA Ospedale Bologna, Italy, 40139 University of Turin Torino, Italy, 10126 Switzerland Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland, CH-8091 University Hospital Zurich Zurich, Switzerland, CH-8091 United Kingdom University College London Hospital - Mount Vernon Cancer Centre - Mount Vernon hospital London, United Kingdom, London-NW1-2PG Collapse <<
NCT02209428	Astrocytoma O... more >>ligodendroglioma Oligoastrocytoma Collapse <<	Phase 2	Unknown	May 2016	China, Shanghai ... more >> Huashan Hospital Affiliated to Fudan University Recruiting Shanghai, Shanghai, China, 200040 Contact: Jinsong Wu, Professor 52887200 wjsongc@126.com Principal Investigator: Jinsong Wu, Professor Collapse <<
NCT01205828	Hepatocellular Carcinoma	Phase 2	Terminated(Lack of efficacy)	-	United States, District of Col... more >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Collapse <<
NCT01736800	Central Nervous System (CNS) M... more >>etastases Brain Metastases Collapse <<	Phase 2	Withdrawn(No enrollment and PI... more >> requested study termination per IRB system.) Collapse <<	-	United States, Texas ... more >> Houston Methodist Hospital Houston, Texas, United States, 77030 Methodist Neurological Institute - Department of Neurosurgery Houston, Texas, United States, 77030 Collapse <<
NCT02039778	-	-	Terminated(Poor Accural)	-	-
NCT01242566	Primary Brain Tumor ... more >> Glioblastoma Collapse <<	Phase 2	Completed	-	France ... more >> Pitie salpetriere hospital Paris, France, 75013 Collapse <<
NCT02766270	Grade II/III Glioma	Early Phase 1	Recruiting	December 2018	China, Beijing ... more >> Beijing Tiantan Hospital Recruiting Beijing, Beijing, China, 100050 Contact: Xiao-Guang Qiu, M.D. ttyy6611@126.com Principal Investigator: Tao Jiang, M.D. Collapse <<
NCT01900951	Carcinoma, Small Cell	Phase 2	Unknown	June 2016	China, Beijing ... more >> PLA general hospital BeiJing, Beijing, China, 100853 Collapse <<
NCT03529448	Glioblastoma	Phase 1 Phase 2	Not yet recruiting	June 2020	Spain ... more >> Institut Català d'Oncología L'Hospitalet Not yet recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Miguel Gil, M.D. secretaria@geino.es Principal Investigator: Miguel Gil, M.D. Hospital Universitario Son Espases Palma de Mallorca, Mallorca, Spain Consorcio Hospitalario Provincial de Castellón Not yet recruiting Castelló, Valencia, Spain, 12002 Contact: Ramón de las Peñas, M.D. secretaria@geino.es Principal Investigator: Ramón de las Peñas, M.D. Hospital del Mar Not yet recruiting Barcelona, Spain, 08003 Contact: Maria Martinez, M.D. secretaria@geino.es Principal Investigator: María Martínez, M.D. Complejo Hospitalario Regional Virgen de las Nieves Not yet recruiting Granada, Spain, 18004 Contact: Raquel Luque, MD secretaria@geino.es Principal Investigator: Raquel Luque, M.D. Hospital Universitario 12 de Octubre Not yet recruiting Madrid, Spain, 28041 Contact: Juan Sepúlveda secretaria@geino.es Principal Investigator: Juan Sepúlveda, M.D. Hospital Regional Universitario de Malaga Malaga, Spain Hospital Clínico Universitario de Salamanca Not yet recruiting Salamanca, Spain, 37007 Contact: Luis Miguel Navarro, M.D. secretaria@geino.es Principal Investigator: Luis Miguel Navarro, M.D. Collapse <<
NCT00619112	-	-	Completed	-	-
NCT01205828	-	-	Terminated(Lack of efficacy)	-	-
NCT01858168	Ewing Sarcoma	Phase 1	Recruiting	July 2020	United States, Massachusetts ... more >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Barbara Anderson, RN 617-724-4000 banderson@partners.org Contact: Sienna Durbin, BS 617-724-4000 Principal Investigator: Edwin Choy, MD, PhD Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Steven Dubois, MD 617-632-5460 Steven_Dubois@dfci.harvard.edu Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Melissa Hohos, RN 617-582-7162 mhohos@partners.org Contact: Mark Morley, RN 617-632-3989 mmorley@partners.org Principal Investigator: George Demetri, MD Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Melissa Hohos, RN 617-582-7162 mhohos@partners.org Contact: Mark Morley, RN 617-632-3989 mmorley@partners.org Principal Investigator: George Demetri, MD United States, Tennessee St. Jude's Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Sara Federico, MD 866-278-5833 sara.federico@stjude.org Collapse <<
NCT02781792	Glioma Gliobl... more >>astoma Multiforme Collapse <<	Phase 1	Recruiting	August 31, 2020	United States, Missouri ... more >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Jian Campian, M.D., Ph.D. 314-747-4241 campian.jian@wustl.edu Principal Investigator: Jian Campian, M.D., Ph.D. Sub-Investigator: Katherine Weilbaecher, M.D. Sub-Investigator: Joshua Rubin, M.D., Ph.D. Collapse <<
NCT00619112	Recurrent Central Nervous Syst... more >>em Neoplasm Collapse <<	Phase 2	Completed	-	United States, California ... more >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Collapse <<
NCT01987830	Recurrent Glioblastoma	Not Applicable	Recruiting	September 2020	United States, Massachusetts ... more >> Massachuesett General Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Tracy Batchelor, MD 617-724-8770 tbatchelor@partners.org Principal Investigator: Tracy Batchelor, MD Collapse <<
NCT01517776	Gliomas	Phase 2	Terminated(due to an altered b... more >>enefit/risk assessment.) Collapse <<	-	Germany ... more >> University Children´s Hospital Halle, Saxonia-Anhalt, Germany, 06120 Collapse <<
NCT02898012	Glioblastoma Multiforme ... more >> Primary Brain Tumor Collapse <<	Phase 2	Completed	-	France ... more >> Groupe Hospitalier Pitié-Salpêtrière Paris, France, 75013 Collapse <<
NCT02446704	Small Cell Lung Cancer	Phase 1 Phase 2	Recruiting	August 2022	United States, Massachusetts ... more >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Anna Farago, MD, PhD 617-724-4000 afarago@mgh.harvard.edu Principal Investigator: Anna Farago, MD, PhD Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: David Barbie, MD 617-632-6049 dbarbie@partners.org Principal Investigator: David Barbie, MD Beth Israel Deaconess Medical Center Active, not recruiting Boston, Massachusetts, United States, 02215 Collapse <<
NCT03633552	Glioblastoma Multiforme of Bra... more >>in Anaplastic Astrocytoma of Brain Collapse <<	Phase 3	Recruiting	April 3, 2021	Iran, Islamic Republic of ... more >> Radiation ward of Emam Reza Hospital Recruiting Mashhad, Razavi Khorasan, Iran, Islamic Republic of, 9137913316 Contact: Roham Salek, M.D. +985138426936 SalekR@mums.ac.ir Principal Investigator: Kazem Anvari, M.D. Omid Hospital Recruiting Mashhad, Razavi Khorasan, Iran, Islamic Republic of, 917661377 Contact: Seyed Amir Aledavood, M.D. +985138426936 AledavoodA@mums.ac.ir Principal Investigator: Kazem Anvari, M.D. Principal Investigator: Mahdi Silanian Toosi, M.D. Collapse <<
NCT02605811	Small Cell Lung Cancer ... more >> Metastatic Carcinoma Collapse <<	Phase 2	Enrolling by invitation	April 2021	China, Guangdong ... more >> The first affiliated hospital of Guangzhou MC Guangzhou, Guangdong, China, 510120 Collapse <<
NCT03514069	Glioma Gliobl... more >>astoma Collapse <<	Phase 1	Recruiting	December 2020	United States, Ohio ... more >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Manmeet Ahluwalia, MD 866-223-8100 CancerCenterResearch@ccf.org Principal Investigator: Manmeet Ahluwalia, MD Collapse <<
NCT01956734	Glioblastoma Multiforme ... more >> Recurrent Tumor Collapse <<	Phase 1	Completed	-	Spain ... more >> Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 Collapse <<
NCT01781403	-	-	Active, not recruiting	-	-
NCT01114555	Neuroblastoma	Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Collapse <<
NCT03422445	Advanced Melanoma	Phase 2	Recruiting	February 2019	China ... more >> Beijing Cancer Hospital Recruiting Beijing, China Contact: Jun Guo Collapse <<
NCT03495921	Ewing Sarcoma ... more >> Ewing Family of Tumors Ewing's Tumor Metastatic Ewing's Sarcoma Metastatic Collapse <<	Phase 3	Recruiting	July 1, 2022	United States, Arkansas ... more >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Catherine Redinger, RN 501-364-4290 RedingerCatherineL@uams.edu United States, Florida Mayo Clinic Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Steven Attia, DO 904-953-7292 Attia.Steven@mayo.edu Nicklaus Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Coraly Diaz-Gamboa, BS 786-624-2853 coraly.diaz@NicklausHealth.org United States, Massachusetts Dana-Farber/Boston Children's Cancer and Blood Disorders Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Steven DuBois, MD 617-632-5460 Steven_Dubois@dfci.harvard.edu United States, Missouri Washington University Siteman Cancer Center Recruiting Saint Louis, Missouri, United States, 63110 Contact: Michele Landeau 314-747-9488 landeaum@wustl.edu United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Dara Herman schwamd@mskcc.org Contact: Leonard H. Wexler, MD 212-639-7990 Principal Investigator: Leonard H. Wexler, MD United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact 513-636-2799 cancer@cchmc.org Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Peter Anderson, MD 216-445-4044 andersp@ccf.org Contact: Stacey Zahler, MD 216-445-3588 zahlers@ccf.org United States, Pennsylvania Fox Chase Cancer Center Not yet recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Sujana Movva, MD 215-728-4300 Sujana.Movva@fccc.edu United States, Texas Texas Oncology - Pediatrics Recruiting Dallas, Texas, United States, 75230 Contact: Maurizio Ghisoli, MD 972-566-6647 Maurizio.Ghisoli@usoncology.com Collapse <<
NCT03213002	Glioblastoma Multiforme (GBM) ... more >> Glioblastoma Glioma of Brain Glioblastoma, Adult Brain Tumor Brain Tumor, Primary Brain Tumor Adult Cancer Brain Cancer Collapse <<	Phase 1 Phase 2	Recruiting	June 2021	United States, New York ... more >> Lenox Hill Brain Tumor Center Recruiting New York, New York, United States, 10075 Contact: Tamika Wong, MPH 212-434-4836 twong4@northwell.edu Principal Investigator: John Boockvar, MD Sub-Investigator: David Langer, MD Sub-Investigator: Anuj Goenka, MD Sub-Investigator: Christopher Filippi, MD Sub-Investigator: Lalitha Anand, MD Sub-Investigator: Sherese Fralin, NP Sub-Investigator: Ashley Ray, NP Sub-Investigator: Tamika Wong, MPH Collapse <<
NCT02343081	-	-	Completed	-	-
NCT01781403	Rectal Cancer	Phase 1	Active, not recruiting	December 2018	Korea, Republic of ... more >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138-736 Collapse <<
NCT02113007	Primary Central Nervous System... more >> Lymphoma Collapse <<	Phase 2	Terminated(Closed early due to... more >> slow accrual.) Collapse <<	-	United States, Connecticut ... more >> Yale School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Memorial Cancer Institute Hollywood, Florida, United States, 33021 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Tennessee Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 Collapse <<
NCT01127594	Melanoma	Phase 1	Completed	-	United States, Florida ... more >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02113007	-	-	Terminated(Closed early due to... more >> slow accrual.) Collapse <<	-	-
NCT03435302	Melanoma	Phase 3	Recruiting	February 2019	China ... more >> Beijing Cancer Hospital Recruiting Beijing, China, 100142 Contact: Bin Lian, MD +86(10)88196951 lianbin0214@126.com Contact: Lu Si, MD +86(10)88196951 silu.net@hotmail.com Sub-Investigator: Bin Lian, MD Collapse <<
NCT03643549	Glioblastoma	Phase 1 Phase 2	Recruiting	August 31, 2023	Norway ... more >> Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Dorota Goplen, MD, PhD +4755974019 dgop@helse-bergen.no Contact: Jorunn Brekke, MD +4755970986 joub@helse-bergen.no Collapse <<
NCT01847235	Anaplastic Oligodendroglioma ... more >> Anaplastic Oligoastrocytoma Collapse <<	Phase 2	Completed	-	Korea, Republic of ... more >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Collapse <<
NCT02343081	Brain Neoplasms, Malignant, Pr... more >>imary Collapse <<	Phase 4	Completed	-	Argentina ... more >> FLENI Instituto Clínico-Quirúrgico de Diagnóstico y Tratamiento Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1428AQK FLENI Instituto de Rehabilitación y Educación Terapéutica Escobar, Buenos Aires, Argentina, B1625XAS Collapse <<
NCT02972320	Extensive Stage Small Cell Lun... more >>g Cancer Collapse <<	Phase 2	Unknown	December 2018	China, Liaoning ... more >> The First Affiliated Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 110001 Contact: mingfang zhao, professor 13644055129 Collapse <<
NCT03291990	Glioblastoma Multiforme	Early Phase 1	Recruiting	October 1, 2021	United States, District of Col... more >>umbia Sibley Hospital Not yet recruiting Washington, District of Columbia, United States, 20016 Contact: Victoria Croog, MD 202-537-4787 vcroog1@jhmi.edu Principal Investigator: Victoria Croog, MD Suburban Hospital Not yet recruiting Washington, District of Columbia, United States, 20818 Contact: Brandi Pge, MD 301-896-2012 bpage5@jhmi.edu Principal Investigator: Brandi Page, MD United States, Maryland SKCCC at Johns Hopkins (East Baltimore) Recruiting Baltimore, Maryland, United States, 21287 Contact: Lawrence Kleinberg, MD 410-614-2597 lkleinb1@jhmi.edu Sub-Investigator: Chetan Bettegowda, MD Sub-Investigator: Stuart Grossman, MD Sub-Investigator: Matthias Holdhoff, MD Sub-Investigator: Michael Lim, MD Sub-Investigator: Kristin Redmond, MD Collapse <<
NCT03556384	Gastrointestinal Stromal Tumor... more >>s Sdh GIST Cancer Collapse <<	Phase 2	Recruiting	September 2024	United States, California ... more >> UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Elaine Eng e1eng@ucsd.edu Principal Investigator: Adam M Burgoyne, MD, PhD Sub-Investigator: Jason K Sicklick, MD Collapse <<
NCT03463733	Glioma Gliobl... more >>astoma Collapse <<	Phase 1	Recruiting	June 2020	Netherlands ... more >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081 HV Contact: H.M.W Verheul, MD, PhD +31 (0)20 4444321 h.verheul@vumc.nl Collapse <<
NCT02507232	Glioma	Phase 2	Recruiting	April 2022	United States, California ... more >> John Wayne Cancer Institute Recruiting Santa Monica, California, United States, 90404 Collapse <<
NCT03359005	Ewing Sarcoma	Phase 2	Recruiting	February 28, 2025	China, Beijing ... more >> Peking University People's Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Jie Xu 86 15901040835 xujie_pkuph@sina.com Principal Investigator: Wei Guo, M.D., Ph.D. Collapse <<
NCT02654106	Brain Metastases	Phase 2	Completed	-	China, Beijing ... more >> Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 Collapse <<
NCT00977431	Glioblastoma	Phase 1	Completed	-	United Kingdom ... more >> Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Ninewells Hospital & Medical School Dundee, United Kingdom, DD1 9SY The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN The Christie Hospital Manchester, United Kingdom, M20 4BX The Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT Collapse <<
NCT03663725	Glioblastoma	Phase 3	Not yet recruiting	May 1, 2023	-
NCT00994071	Medulloblastoma ... more >> Pontine Glioma Ependymoma Astrocytoma PNET Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Collapse <<
NCT03139331	Sarcoma	Phase 1	Recruiting	November 30, 2019	United States, California ... more >> UCSF Benioff Children's Hospital, Oakland Recruiting Oakland, California, United States, 94609 Contact: Jennifer Michlitsch, MD 510-428-3372 jmichlitsch@mail.cho.org Principal Investigator: Jennifer Michlitsch, MD UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94158 Contact: Kieuhoa Vo, MD, MAS 415-476-3831 kieuhoa.vo@ucsf.edu Principal Investigator: Kieuhoa Vo, MD, MAS United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Steven DuBois, MD 617-632-5640 steve_dubois@dfci.harvard.edu Principal Investigator: Steven DuBois, MD Collapse <<
NCT00526617	Non-hematologic Malignancies ... more >> Metastatic Melanoma Breast Cancer Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer Hepatocellular Carcinoma Collapse <<	Phase 1	Completed	-	-
NCT01506609	Metastatic Breast Cancer	Phase 2	Active, not recruiting	May 30, 2019	-
NCT03128047	High Grade Glioma	Phase 1	Recruiting	February 2019	United States, New Jersey ... more >> Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Jeanette Haugh, APN 551-996-3457 jeanette.haugh@hackensackmeridian.org Collapse <<
NCT00482677	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 3	Completed	-	Canada, Alberta ... more >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 BCCA - Vancouver Island Cancer Centre Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Atlantic Health Sciences Corporation Saint John, New Brunswick, Canada, E2L 4L2 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Centre hospitalier regional de Trois-Rivieres Trois-Rivieres, Quebec, Canada, G8Z 3R9 Germany Klinikum Der J.W. Goethe Universitaet Frankfurt, Germany, 60590 Universitaetsklinikum Freiburg Freiburg, Germany, 79106 Universitaetsklinikum Leipzig Leipzig, Germany, 04103 Universitaetsklinikum Tuebingen Tuebingen, Germany, 72076 Japan Hiroshima University Hospital Hiroshima, Japan, 734-8551 Netherlands Maastro - Maastricht Radiation Oncology Maastricht, Netherlands, 6201 Collapse <<
NCT00943826	Glioblastoma	Phase 3	Completed	-	-
NCT02358356	Midgut Neuroendocrine Tumours ... more >> Pancreatic Neuroendocrine Tumours Collapse <<	Phase 2	Recruiting	December 2020	Australia, New South Wales ... more >> Royal North Shore Hospital Recruiting St Leonards, New South Wales, Australia, 2065 Contact: Kathryn Jenkins Kathryn.Jenkins@health.nsw.gov.au Principal Investigator: Nick Pavlakis Australia, Queensland Royal Brisbane and Women's Hospital Recruiting Herston, Queensland, Australia, 4029 Contact: Jenny Campbell Jenny.Campbell@health.qld.gov.au Australia, Victoria Peter MacCallum Cancer Centre Recruiting East Melbourne, Victoria, Australia, 8006 Contact: Elizabeth Drummond Elizabeth.Drummond@petermac.org Australia, Western Australia Fiona Stanley Hospital Recruiting Murdoch, Western Australia, Australia, 6150 Contact: Kanako Ohara kanako.ohara@health.wa.gov.au Principal Investigator: David Ransom Collapse <<
NCT02617589	Brain Cancer	Phase 3	Recruiting	October 1, 2019	-
NCT00885534	Melanoma Skin... more >> Cancer Collapse <<	Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Collapse <<
NCT00609011	Metastatic Melanoma	Phase 1 Phase 2	Completed	-	United States, California ... more >> The Angeles Clinic Los Angeles, California, United States, 90025 United States, Florida Cancer Centers of Florida Ocoee, Florida, United States, 34761 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States, 84112 Collapse <<
NCT02344355	Glioblastoma Multiforme	Phase 2	Recruiting	December 2023	United States, Iowa ... more >> Holden Comprehensive Cancer Center Recruiting Iowa City, Iowa, United States, 52242 Contact: Sandy Vollstedt, RN, BSN 319-353-7143 sandy-vollstedt@uiowa.edu Contact: Heather Brown, RN, BAN 319-384-7912 heather-brown@uiowa.edu Sub-Investigator: John M. Buatti, MD Sub-Investigator: Joseph J. Cullen, MD Sub-Investigator: Daniel Berg, MD Sub-Investigator: Matthew Howard, MD Sub-Investigator: Jeremy Greenlee, MD Sub-Investigator: David Hasan, MD Sub-Investigator: Patrick Hitchon, MD Sub-Investigator: Varun Monga, MD Sub-Investigator: Mark C. Smith, MD Sub-Investigator: Carryn M. Anderson, MD Sub-Investigator: Wenqing Sun, MD, PhD Sub-Investigator: Douglas Spitz, PhD Sub-Investigator: Mohammed Milhem, MBBA Sub-Investigator: Garry R. Buettner, PhD Collapse <<
NCT03082846	Glioma Radiot... more >>herapy, Intensity-Modulated Maximum Tolerated Dose Collapse <<	Not Applicable	Completed	-	-
NCT01141244	Unspecified Childhood Solid Tu... more >>mor, Protocol Specific Collapse <<	Phase 1	Completed	-	-
NCT00482677	-	-	Completed	-	-
NCT00895960	Glioblastoma ... more >>CNS Disease Brain Diseases Collapse <<	Phase 1	Terminated(Sponsor withdrew su... more >>pport; Study did not progress to Phase II.) Collapse <<	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00885534	-	-	Completed	-	-
NCT00039494	Adult Giant Cell Glioblastoma ... more >> Adult Glioblastoma Adult Gliosarcoma Collapse <<	Phase 2	Completed	-	-
NCT02975882	Childhood Solid Neoplasm ... more >> Recurrent Central Nervous System Neoplasm Recurrent Malignant Solid Neoplasm Refractory Central Nervous System Neoplasm Refractory Malignant Solid Neoplasm Collapse <<	Phase 1	Recruiting	June 3, 2020	-
NCT01835145	Recurrent Uveal Melanoma ... more >> Stage III Uveal Melanoma AJCC v7 Stage IIIA Uveal Melanoma AJCC v7 Stage IIIB Uveal Melanoma AJCC v7 Stage IIIC Uveal Melanoma AJCC v7 Stage IV Uveal Melanoma AJCC v7 Collapse <<	Phase 2	Completed	-	-
NCT02179086	Adult Giant Cell Glioblastoma ... more >> Adult Glioblastoma Adult Gliosarcoma Collapse <<	Phase 2	Recruiting	May 2024	-
NCT00026494	-	-	Completed	-	-
NCT02029573	Glioblastoma Multiforme	Phase 2	Completed	-	Saudi Arabia ... more >> King Fahad Medical City Riyadh, Saudi Arabia, 11525 Collapse <<
NCT02831179	Functional Pancreatic Neuroend... more >>ocrine Tumor Malignant Somatostatinoma Merkel Cell Carcinoma Metastatic Adrenal Gland Pheochromocytoma Metastatic Carcinoid Tumor Multiple Endocrine Neoplasia Type 1 Multiple Endocrine Neoplasia Type 2A Multiple Endocrine Neoplasia Type 2B Neuroendocrine Neoplasm Non-Functional Pancreatic Neuroendocrine Tumor Pancreatic Glucagonoma Pancreatic Insulinoma Recurrent Adrenal Cortex Carcinoma Recurrent Adrenal Gland Pheochromocytoma Recurrent Merkel Cell Carcinoma Somatostatin-Producing Neuroendocrine Tumor Stage III Adrenal Cortex Carcinoma Stage III Thyroid Gland Medullary Carcinoma Stage IIIA Merkel Cell Carcinoma Stage IIIB Merkel Cell Carcinoma Stage IV Adrenal Cortex Carcinoma Stage IV Merkel Cell Carcinoma Stage IVA Thyroid Gland Medullary Carcinoma Stage IVB Thyroid Gland Medullary Carcinoma Stage IVC Thyroid Gland Medullary Carcinoma Thymic Carcinoid Tumor VIP-Producing Neuroendocrine Tumor Well Differentiated Adrenal Cortex Carcinoma Zollinger Ellison Syndrome Collapse <<	Phase 1	Withdrawn(Loss of funding supp... more >>ort) Collapse <<	February 2020	-
NCT00943826	-	-	Completed	-	-
NCT00612651	Gliosarcoma G... more >>lioblastoma Anaplastic Astrocytoma Collapse <<	Phase 1	Completed	-	United States, North Carolina ... more >> Duke University Health System Durham, North Carolina, United States, 27710 Collapse <<
NCT00544284	Brain and Central Nervous Syst... more >>em Tumors Lymphoma Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Collapse <<	Phase 1	Completed	-	United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Collapse <<
NCT00026494	Metastatic Cancer	Phase 1 Phase 2	Completed	-	United States, Illinois ... more >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Collapse <<
NCT00147160	Glioma	Phase 2	Completed	-	France ... more >> Institut Gustave-Roussy Villejuif, France, 94805 United Kingdom Bristol Royal Hospital for Children Bristol, United Kingdom, BS2 8BJ Collapse <<
NCT00597402	-	-	Completed	-	-
NCT00597402	Glioblastoma ... more >>Gliosarcoma Brain Tumor Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> Duke University Health System Durham, North Carolina, United States, 27710 Collapse <<
NCT00946335	Childhood Atypical Teratoid/Rh... more >>abdoid Tumor Childhood Central Nervous System Germ Cell Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Brain Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Spinal Cord Neoplasm Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Collapse <<	Phase 1	Completed	-	United States, Tennessee ... more >> Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 Collapse <<
NCT03746080	Glioblastoma ... more >>Glioblastoma With Primitive Neuronal Component Gliosarcoma Malignant Glioma Oligodendroglial Component Present Collapse <<	Phase 2	Recruiting	January 11, 2027	United States, California ... more >> Stanford Cancer Institute Palo Alto Recruiting Palo Alto, California, United States, 94304 Contact: Lawrence Recht 650-725-8630 lrecht@stanford.edu Principal Investigator: Lawrence Recht Collapse <<
NCT02770378	Glioblastoma	Phase 1	Active, not recruiting	March 2020	Germany ... more >> University of Ulm School of Medicine Ulm, Baden-Württemberg, Germany, 89081 Collapse <<
NCT00544817	Glioblastoma Multiforme	Phase 2	Completed	-	United States, Florida ... more >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Collapse <<
NCT00404495	Glioma Medull... more >>oblastoma Collapse <<	Phase 2	Completed	-	Australia, New South Wales ... more >> Pfizer Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Queensland Pfizer Investigational Site Herston, Queensland, Australia, 4029 Australia, Victoria Pfizer Investigational Site Parkville, Victoria, Australia, 3052 Belgium Pfizer Investigational Site Gent, Belgium, 9000 Pfizer Investigational Site Leuven, Belgium, 3000 Denmark Pfizer Investigational Site Aarhus N, Denmark, 8200 Pfizer Investigational Site Koebenhavn OE, Denmark, 2100 France Pfizer Investigational Site Angers, France, 49000 Pfizer Investigational Site Bordeaux, France, 33000 Pfizer Investigational Site Lille, France, 59020 Pfizer Investigational Site Lyon Cedex 08, France, 69373 Pfizer Investigational Site Marseille, France, 13385 Pfizer Investigational Site Paris, France, 75005 Pfizer Investigational Site Villejuif, France, 94805 Italy Pfizer Investigational Site Padova, Italy, 35100 Poland Pfizer Investigational Site Warszawa, Poland, 04-730 Spain Pfizer Investigational Site Esplugues de Llobregat, Barcelona, Spain, 08950 Pfizer Investigational Site El Palmar, Murcia, Spain, 30120 Pfizer Investigational Site Barcelona, Spain, 08035 Pfizer Investigational Site Madrid, Spain, 28009 Pfizer Investigational Site Sevilla, Spain, 41013 Pfizer Investigational Site Valencia, Spain, 46026 United Kingdom Pfizer Investigational Site Soouthampton, Hampshire, United Kingdom, SO16 6YD Pfizer Investigational Site Birmingham, United Kingdom, B4 6NH Pfizer Investigational Site Leeds, United Kingdom, LS9 7TF Pfizer Investigational Site Manchester, United Kingdom, M27 4HA Pfizer Investigational Site Newcastle Upon Tyne, United Kingdom, NE1 4LP Pfizer Investigational Site Nottingham, United Kingdom, NG7 2UH Pfizer Investigational Site Sutton, United Kingdom, SM2 5PT Collapse <<
NCT00404495	-	-	Completed	-	-
NCT00104988	Melanoma (Skin)	Phase 2	Completed	-	-
NCT00335075	Glioblastoma ... more >>Astrocytoma Collapse <<	Phase 3	Completed	-	-
NCT01790503	Patients With Newly Diagnosed ... more >>Glioblastoma Collapse <<	Phase 1 Phase 2	Active, not recruiting	October 2019	United States, Illinois ... more >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio James Cancer Hospital/Ohio State University Columbia, Ohio, United States, 43210 United States, Utah Huntsman Cancer Institute University of Utah Salt Lake City, Utah, United States, 84132 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Collapse <<
NCT01085422	Prostate Cancer	Phase 1	Completed	-	-
NCT00544817	-	-	Completed	-	-
NCT00052780	Childhood Central Nervous Syst... more >>em Germ Cell Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Collapse <<	Phase 1	Completed	-	United States, Tennessee ... more >> Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 Collapse <<
NCT00508456	Glioblastoma Multiforme	Phase 1	Terminated(Low Accrual)	-	United States, Texas ... more >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02655601	High Grade Glioma, Glioblastom... more >>a Collapse <<	Phase 2	Recruiting	September 2022	United States, North Carolina ... more >> Duke Cancer Institute Recruiting Durham, North Carolina, United States, 27710 Contact: Sarah Woodring 919-684-5301 sarah.woodring@dm.duke.edu Contact: Susan Boulton, RN 919-684-5301 susan.boulton@duke.edu Collapse <<
NCT00437957	Brain Metastases	Phase 1	Terminated(Lack of enrollment)	-	United States, Florida ... more >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Collapse <<
NCT01514201	Anaplastic Astrocytoma ... more >> Brain Stem Glioma Childhood Mixed Glioma Fibrillary Astrocytoma Giant Cell Glioblastoma Glioblastoma Gliosarcoma Untreated Childhood Anaplastic Astrocytoma Untreated Childhood Brain Stem Glioma Untreated Childhood Fibrillary Astrocytoma Untreated Childhood Giant Cell Glioblastoma Untreated Childhood Glioblastoma Untreated Childhood Gliosarcoma Collapse <<	Phase 1 Phase 2	Completed	-	United States, California ... more >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Lurie Children's Hospital-Chicago Chicago, Illinois, United States, 60611 United States, Maryland National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 Collapse <<
NCT01076530	Childhood Atypical Teratoid/Rh... more >>abdoid Tumor Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal Tumor Childhood Central Nervous System Germinoma Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Teratoma Childhood Central Nervous System Yolk Sac Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Extra-adrenal Paraganglioma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Central Nervous System Embryonal Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Spinal Cord Neoplasm Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Collapse <<	Phase 1	Completed	-	United States, Illinois ... more >> Childrens Memorial Hospital Chicago, Illinois, United States, 60614 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Medical Center-Fairview Minneapolis, Minnesota, United States, 55455 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Hospital Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Collapse <<
NCT00916409	Glioblastoma Multiforme	Phase 3	Completed	-	-
NCT00591370	-	-	Completed	-	-
NCT02152982	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 2 Phase 3	Active, not recruiting	-	-
NCT01217437	Recurrent Childhood Medullobla... more >>stoma Recurrent Childhood Pineoblastoma Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified Collapse <<	Phase 2	Active, not recruiting	-	-
NCT00689221	Glioblastoma	Phase 3	Completed	-	United States, Massachusetts ... more >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please Contact the Merck KGaA Communication Center Located in Darmstadt, Germany Collapse <<
NCT01543464	Malignant Melanoma	Phase 2	Terminated(Diminished rectruit... more >>ment) Collapse <<	-	Denmark ... more >> Trine Zeeberg Iversen Brønshøj, Copenhagen, Denmark, 2700 Collapse <<
NCT01977677	Adult Ependymoblastoma ... more >> Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Medulloblastoma Adult Mixed Glioma Adult Oligodendroglial Tumors Adult Pineoblastoma Adult Supratentorial Primitive Neuroectodermal Tumor (PNET) Collapse <<	Phase 1 Phase 2	Completed	-	United States, California ... more >> Stanford University, School of Medicine Stanford, California, United States, 94305 Collapse <<
NCT01649830	Astrocytoma O... more >>ligodendroglioma Oligodendroastrocytoma Collapse <<	Phase 3	Recruiting	August 2022	China, Guangdong ... more >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Principal Investigator: Zhong-ping CHEN, MD, PhD Collapse <<
NCT00528437	Brain Tumors	Phase 2	Active, not recruiting	July 2019	United States, Arizona ... more >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85016 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Hawaii Hawaii Pacific Health Lihue, Hawaii, United States, 96766 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Minnesota Children's Hospital and Clinics of Minnesota Minneapolis, Minnesota, United States, 55404 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Steven and Alexandra Cohen Children's Medical Center of New York- North Shore LIJ New Hyde Park, New York, United States, 11040 NYU Hassenfeld Center New York, New York, United States, 10016 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical Univ. of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt Univ. Nashville, Tennessee, United States, 37240 United States, Texas Children's Medical Center of Dallas Dallas, Texas, United States, 75235 MD Anderson Cancer Center (MDACC) Houston, Texas, United States, 77030 United States, Virginia Virginia Commonwealth Univ. Richmond, Virginia, United States, 23284 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Collapse <<
NCT00068666	Melanoma (Skin) ... more >> Metastatic Cancer Collapse <<	Phase 2	Terminated	-	-
NCT00689221	-	-	Completed	-	-
NCT00731731	Adult Giant Cell Glioblastoma ... more >> Adult Glioblastoma Adult Gliosarcoma Cognitive Side Effects of Cancer Therapy Collapse <<	Phase 1 Phase 2	Active, not recruiting	-	-
NCT01977677	-	-	Completed	-	-
NCT01139970	Accelerated Phase of Disease ... more >> Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Promyelocytic Leukemia With PML-RARA Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Adult T Acute Lymphoblastic Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Blastic Phase Chronic Myelomonocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Disease Secondary Acute Myeloid Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Collapse <<	Phase 1	Active, not recruiting	-	United States, Illinois ... more >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Collapse <<
NCT01638546	-	-	Completed	-	-
NCT03212742	Malignant Gliomas ... more >> Radiotherapy PARP Inhibitor Collapse <<	Phase 1 Phase 2	Recruiting	June 30, 2022	France ... more >> CHU Not yet recruiting Bordeaux, France Contact: Aymeri HUCHET, MD Principal Investigator: Aymeri HUCHET, MD Centre François Baclesse Recruiting Caen, France, 14076 Contact: Dinu STEFAN, MD 33 2 31 45 50 50 d.stefan@baclesse.unicancer.fr Contact: Jean-Michel GRELLARD Principal Investigator: Dinu STEFAN, MD Sub-Investigator: Julien GEFFRELOT, MD Sub-Investigator: Ioana HRAB, MD Centre léon Bérard Not yet recruiting Lyon, France Contact: Marie-Pierre SUNYACH, MD Principal Investigator: Marie-Pierre SUNYACH, MD Hôpitaux universitaires La Pitié Salpétrière - Charles Foix Not yet recruiting Paris, France Contact: Loic FEUVRET, MD Principal Investigator: Loic FEUVRET, MD Sub-Investigator: Florence LAIGLE-DONADEY, MD Sub-Investigator: Khe HOANG-XUAN, MD Sub-Investigator: Ahmed IBDAIH, Pr Institut Curie Not yet recruiting Paris, France Contact: Hamid MAMMAR, MD Principal Investigator: Hamid MAMMAR, MD Sub-Investigator: Laurence BOZEC LE MOAL, MD Sub-Investigator: Coraline DUBOT, MD Sub-Investigator: Patricia TRESCA, MD Sub-Investigator: Patricia MOISSON, MD Institut Claudius Regaud Not yet recruiting Toulouse, France Contact: Elisabeth MOYAL COHEN-JONATHAN, Pr Principal Investigator: Elisabeth MOYAL COHEN-JONATHAN, Pr Sub-Investigator: Ioana CARPUC, MD Sub-Investigator: Jean-Pierre DELORD, MD Sub-Investigator: Cécile GANDY, MD Sub-Investigator: Carlos Alberto GOMEZ-ROCA, MD Sub-Investigator: Anouchka MODESTO, MD Sub-Investigator: Thibaud VALENTIN, MD Collapse <<
NCT00591370	Melanoma	Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse <<
NCT03567135	-	-	Recruiting	April 1, 2019	China, Fujian ... more >> Fuzhou General Hospital Recruiting Fuzhou, Fujian, China, 350025 Contact: Wenmin Ying, Bachelor 15080015210 18352770@qq.com Collapse <<
NCT01638546	Recurrent Small Cell Lung Carc... more >>inoma Collapse <<	Phase 2	Completed	-	United States, Florida ... more >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Collapse <<
NCT03204032	Extrapancreatic Neuroendocrine... more >> Tumor Collapse <<	Phase 2	Recruiting	September 2018	China, Beijing ... more >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Yihebali Chi, doctor yihebalichi@yahoo.com.cn Collapse <<
NCT00831545	Metastases of Central Nervous ... more >>System Melanoma Breast Neoplasm Carcinoma, Non-Small-Cell Lung Collapse <<	Phase 2	Completed	-	-
NCT00383851	Melanoma	Phase 2	Unknown	September 2008	United States, Arizona ... more >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, California Pacific Oncology and Hematology Encinitas, California, United States, 92024 Hematology - Oncology Group of Orange, Inc. Orange, California, United States, 92868 UCI Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 The Angeles Clinic Santa Monica, California, United States, 90404 United States, Colorado University of Colorado Health Science Center Denver, Colorado, United States, 80262 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Louisiana Hematology and Oncology Specialists, LLC Metairie, Louisiana, United States, 70006 United States, Maryland The Harry and Jeanette Weinberg Cancer Institute at Franklin Square Baltimore, Maryland, United States, 21237 Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Montana Billings Clinic Billings, Montana, United States, 59101 United States, New Jersey Mountainside Hospital Cancer Center - The Melanoma Center Montclair, New Jersey, United States, 07042 United States, Ohio Oncology Hematology Care Cincinati, Ohio, United States, 45242 United States, South Carolina Cancer Center of the Carolinas Greenville, South Carolina, United States, 29605 United States, Tennessee Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 Collapse <<
NCT00731731	-	-	Active, not recruiting	-	-
NCT00433381	-	-	Completed	-	-
NCT01285414	Glioblastoma Multiforme	Phase 2	Completed	-	United States, California ... more >> Stanford University Stanford, California, United States, 94305 United States, Texas University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Collapse <<
NCT00900757	Malignant Glioma	Phase 2	Completed	-	United States, North Carolina ... more >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Collapse <<
NCT02502708	Glioblastoma Multiforme ... more >> Glioma Gliosarcoma Malignant Brain Tumor Ependymoma Medulloblastoma Diffuse Intrinsic Pontine Glioma Primary CNS Tumor Collapse <<	Phase 1	Recruiting	December 2019	United States, Georgia ... more >> Children's Heathcare of Atlanta Recruiting Atlanta, Georgia, United States, 30342 Contact: Amy Autry-Bush 404-785-6011 amy.autry-bush@choa.org Principal Investigator: Tobey MacDonald, MD Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Robin Dobbins 706-721-2154 RDOBBINS@augusta.edu Principal Investigator: Theodore Johnson, MD Collapse <<
NCT00433381	Adult Glioblastoma ... more >> Adult Gliosarcoma Recurrent Adult Brain Neoplasm Collapse <<	Phase 2	Completed	-	-
NCT00900757	-	-	Completed	-	-
NCT01505608	Neuroblastoma	Phase 1 Phase 2	Terminated(Lack of Enrollment)	-	United States, Arizona ... more >> Phoenix Children's Hospital Phoenix, Arizona, United States United States, California Rady Children's Hospital San Diego, California, United States, 92123 United States, Connecticut Connecticut Children's Hospital Hartford, Connecticut, United States, 06106 United States, Florida Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States, 32806 United States, Michigan Helen DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 United States, Missouri Children's Mercy Hospitals and Clinics Kansas City, Missouri, United States, 64108 Cardinal Glennon Children's Medical Center St. Louis, Missouri, United States, 63104 United States, North Carolina Levine Children's Hospital Charlotte, North Carolina, United States, 28204 Collapse <<
NCT00301067	Metastatic Melanoma	Phase 1 Phase 2	Active, not recruiting	May 2020	United States, Illinois ... more >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Collapse <<
NCT01735747	Central Nervous System Tumors	Phase 2	Unknown	November 2013	China, Shandong ... more >> Neurosurgery, Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Collapse <<
NCT03405792	Glioblastoma ... more >>Glioblastoma, WHO Grade IV Collapse <<	Phase 2	Recruiting	February 2023	United States, Florida ... more >> University of Florida Health Recruiting Gainesville, Florida, United States, 32610 Collapse <<
NCT02023905	Low Grade Glioma ... more >> WHO Grade II Astrocytomas Oligodendrogliomas Mixed Oligoastrocytomas Collapse <<	Phase 2	Recruiting	January 2019	United States, California ... more >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143-0372 Contact: Jennifer Clarke, MD, MPH 415-353-2966 Jennifer.Clarke@ucsf.edu Contact: Tiffany Jones 415-353-9641 Tiffany.Jones@ucsf.edu Principal Investigator: Jennifer Clarke, MD Collapse <<
NCT00521001	Melanoma (Skin)	Phase 2	Completed	-	-
NCT00521001	-	-	Completed	-	-
NCT01505608	-	-	Terminated(Lack of Enrollment)	-	-
NCT02052648	Glioblastoma Multiforme ... more >> Glioma Gliosarcoma Malignant Brain Tumor Collapse <<	Phase 1 Phase 2	Active, not recruiting	October 2018	United States, California ... more >> Eden Medical Center Castro Valley, California, United States, 94546 Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 UC Irvine Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia University Cancer and Blood Center Athens, Georgia, United States, 30607 Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30342 Georgia Regents University Augusta, Georgia, United States, 30912 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Kentucky University of Kentucy Lexington, Kentucky, United States, 40536 United States, Minnesota John Nasseff Neuroscience Institute Minneapolis, Minnesota, United States, 55407 United States, New Mexico University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States, 87131 United States, North Carolina Wake Forest Baptist Health Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania Penn State Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, Texas Texas Oncology Austin, Texas, United States, 78705 United States, Utah Huntsman Cancer Center Salt Lake City, Utah, United States, 84112 United States, Virginia Virginia Cancer Specialists Fairfax, Virginia, United States, 22031 Collapse <<
NCT00091572	Melanoma	Phase 3	Completed	-	-
NCT00091572	-	-	Completed	-	-
NCT00109798	Central Nervous System Tumors ... more >> Lymphoma Collapse <<	Not Applicable	Withdrawn(Sub-Investigator rel... more >>oacted to another institution) Collapse <<	-	-
NCT00881595	Soft Tissue Sarcomas	Phase 2	Withdrawn(No patients accrued ... more >>since study opened) Collapse <<	-	-
NCT00077207	Brain Tumor C... more >>entral Nervous System Tumor Collapse <<	Not Applicable	Completed	-	United States, Pennsylvania ... more >> Childrens Oncology Group Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT00385853	Glioblastoma	Phase 1	Completed	-	United States, Massachusetts ... more >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Collapse <<
NCT00077207	-	-	Completed	-	-
NCT03323034	Recurrent Central Nervous Syst... more >>em Neoplasm Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Refractory Central Nervous System Neoplasm Refractory Lymphoma Refractory Malignant Solid Neoplasm Collapse <<	Phase 1	Recruiting	December 1, 2021	-
NCT02667587	Brain Neoplasms	Phase 3	Recruiting	August 1, 2023	-
NCT00022711	Lung Cancer	Phase 2	Completed	-	United States, New Jersey ... more >> Hunterdon Regional Cancer Center Flemington, New Jersey, United States, 08822 Kimball Medical Center Lakewood, New Jersey, United States, 08701 South Jersey Regional Cancer Center Millville, New Jersey, United States, 08332 Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States, 08060 Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States, 07701 Community Medical Center Toms River, New Jersey, United States, 08755 St. Francis Medical Center Trenton, New Jersey, United States, 08629 United States, Pennsylvania Bon Secours-Holy Family Health System Altoona, Pennsylvania, United States, 16602 Delaware County Memorial Hospital Drexel Hill, Pennsylvania, United States, 19026-1186 Pinnacle Health Hospitals Harrisburg, Pennsylvania, United States, 17105-8700 Conemaugh Memorial Hospital Johnstown, Pennsylvania, United States, 15905 Saint Mary Regional Center Langhorne, Pennsylvania, United States, 19047 Central Montgomery Medical Center Lansdale, Pennsylvania, United States, 19446-1200 Paoli Memorial Hospital Paoli, Pennsylvania, United States, 19301-1792 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Pottstown Memorial Regional Cancer Center Pottstown, Pennsylvania, United States, 19464 Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 Collapse <<
NCT00998010	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Active, not recruiting	June 30, 2019	United States, California ... more >> University of California Los Angeles Los Angeles, California, United States, 90095 Collapse <<
NCT00072163	Recurrent Melanoma ... more >> Stage IV Melanoma Tumors Metastatic to Brain Collapse <<	Phase 2	Completed	-	United States, Illinois ... more >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Collapse <<
NCT00705198	-	-	Completed	-	-
NCT01812603	Cancer	Phase 1 Phase 2	Completed	-	United Kingdom ... more >> The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom, CH63 4JY St James's Institute of Oncology, St James's University Hospital Leeds, Yorkshire, United Kingdom, LS9 7TF Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Guy's and St Thomas NHS Foundation Trust, of St Thomas' Hospital London, United Kingdom, SE1 7EH The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Collapse <<
NCT01355445	RHABDOMYOSARCOMA	Phase 2	Active, not recruiting	September 2023	France ... more >> Centre Hospitalier Universitaire Nord Amiens, France, 80000 Hôpital des Enfants, Groupe Hospitalier Pellegrin Bordeaux, France, 33076 CHU Morvan Brest, France CHU Estaing Clermont ferrand, France, 63003 Centre Oscar Lambret Lille cedex, France, 59020 Centre Léon Bérard Lyon, France CHU, Hôpital d'Enfants de la Timone Marseille, France Hôpital Arnaud de Villeneuve - CHU Montpellier, France CHU, Hôpital Mère enfants Nantes, France Hôpital Armand Trousseau Paris, France Institut Curie Paris, France Hôpital Jean Bernard Poitiers, France CHU - Hôpital Américain Reims, France CHU Rennes - Hôpital Sud Rennes, France CHU St Etienne - Hôpital Nord Saint-Etienne, France Hôpital de Hautepierre Strasbourg, France Hôpital des enfants Toulouse, France CHRU Tours, France CHRU Hôpital d'Enfants Vandoeuvre les Nancy, France Institut Gustave Roussy Villejuif, France Collapse <<
NCT01043536	Glioblastoma	Phase 1	Completed	-	France ... more >> Centre Georges François Leclerc Dijon, Bourgogne, France, 21000 Collapse <<
NCT00804908	Melanoma Meta... more >>static Melanoma Skin Cancer Collapse <<	Phase 2	Completed	-	-
NCT00804908	-	-	Completed	-	-
NCT00194766	Breast Cancer ... more >> Soft Tissue Sarcoma Collapse <<	Phase 2	Completed	-	United States, Washington ... more >> University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Collapse <<
NCT01005472	Metastatic Melanoma	Phase 1	Completed	-	United States, California ... more >> University of California Los Angeles (UCLA) Los Angeles, California, United States, 90095 Collapse <<
NCT02272270	Newly Diagnosed High Grade Gli... more >>oma Collapse <<	Phase 1	Active, not recruiting	October 2019	United States, Utah ... more >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Collapse <<
NCT00304200	Metastatic Malignant Melanoma	Phase 1 Phase 2	Terminated(Funding was inadequ... more >>ate to continue; Companies requested closure.) Collapse <<	-	United States, California ... more >> Northern California Melanoma Center San Francisco, California, United States, 94109 Collapse <<
NCT00616005	Glioblastoma	Phase 2	Completed	-	United States, North Carolina ... more >> Duke University Health System Durham, North Carolina, United States, 27710 Collapse <<
NCT03426891	Glioblastoma ... more >>Brain Tumor GBM Collapse <<	Phase 1	Recruiting	April 2022	United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Melissa Wicklund 813-745-3620 melissa.wicklund@moffitt.org Contact: Solmaz Sahebjam, M.D. 813-745-6101 solmaz.sahebjam@moffitt.org Collapse <<
NCT03079440	Neuroendocrine Tumors ... more >> Neuroendocrine Carcinoma Temozolomide Capecitabine Collapse <<	Phase 2	Recruiting	October 2020	Korea, Republic of ... more >> Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 05505 Contact: Changhoon Yoo, MD +82-2-3010-1727 yooc@amc.seoul.kr Collapse <<
NCT00311584	Neuroblastoma	Phase 2	Completed	-	-
NCT01465659	Pancreatic Alpha Cell Carcinom... more >>a Pancreatic Beta Islet Cell Carcinoma Pancreatic Delta Cell Carcinoma Pancreatic G-cell Carcinoma Recurrent Islet Cell Carcinoma Collapse <<	Phase 1 Phase 2	Recruiting	August 2020	United States, Illinois ... more >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Halla null. Nimeiri 312-695-4381 h-nimeiri@northwestern.edu Principal Investigator: Halla null. Nimeiri United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Mark M. Zalupski 734-615-3969 zalupski@med.umich.edu Principal Investigator: Mark M. Zalupski United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Steven J. Cohen 215-728-2570 Steven.Cohen@fccc.edu Principal Investigator: Steven J. Cohen United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Jordan D. Berlin 615-936-8422 jordan.berlin@Vanderbilt.edu Principal Investigator: Jordan D. Berlin United States, Washington University of Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Gabriela Chiorean, MD 855-557-0555 Collapse <<
NCT00704808	-	-	Completed	-	-
NCT00311584	-	-	Completed	-	-
NCT00182819	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 3	Completed	-	-
NCT00704808	-	-	Completed	-	-
NCT00725010	-	-	Completed	-	-
NCT00725010	-	-	Completed	-	-
NCT00612989	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 1	Completed	-	United States, North Carolina ... more >> Duke University Health System Durham, North Carolina, United States, 27710 Collapse <<
NCT01480479	Glioblastoma ... more >>Small Cell Glioblastoma Giant Cell Glioblastoma Gliosarcoma Glioblastoma With Oligodendroglial Component Collapse <<	Phase 3	Completed	-	-
NCT00006043	Ovarian Cancer ... more >> Testicular Germ Cell Tumor Collapse <<	Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Collapse <<
NCT00005955	Brain and Central Nervous Syst... more >>em Tumors Neuroblastoma Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00887146	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 3	Recruiting	-	-
NCT02311920	Gliosarcoma S... more >>upratentorial Glioblastoma Collapse <<	Phase 1	Active, not recruiting	-	United States, California ... more >> UCSF Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Georgia Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Columbia University/Herbert Irving Cancer Center New York, New York, United States, 10032 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Cancer Center/Fairview Hospital Cleveland, Ohio, United States, 44111 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00038493	Glioblastoma Multiforme	Phase 2	Completed	-	United States, Texas ... more >> UTMD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00555399	Glioblastoma Multiforme ... more >> Anaplastic Glioma Collapse <<	Phase 1 Phase 2	Active, not recruiting	November 2019	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00004204	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Unknown	-	United States, California ... more >> Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Florida Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States, 33140 United States, Illinois Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 United States, New York Cancer Center of Albany Medical Center Albany, New York, United States, 12208 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Nalitt Institute for Cancer And Blood Related Diseases Staten Island, New York, United States, 10305 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Oregon Neurological Clinic Portland, Oregon, United States, 97210 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 United States, Wisconsin Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Collapse <<
NCT00527761	Metastatic Melanoma	Phase 1	Completed	-	United States, Texas ... more >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00006024	Brain Tumor C... more >>entral Nervous System Tumor Collapse <<	Phase 1	Completed	-	-
NCT02805179	Glioma	Phase 2	Recruiting	June 2020	United States, Michigan ... more >> University of Michigan Hospital Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Jody Sharp 734-615-4909 sharpjd@umich.edu Principal Investigator: Michelle Kim, M.D. Collapse <<
NCT01450826	Nausea Vomiti... more >>ng Glioma Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Collapse <<
NCT00003062	Lung Cancer	Phase 2	Completed	-	Italy ... more >> Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Netherlands Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1001HV Poland Medical University of Gdansk Gdansk, Poland, 80-211 South Africa Medical Oncology Centre of Rosebank Johannesburg, South Africa, 2193 United Kingdom Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Collapse <<
NCT01450826	-	-	Completed	-	-
NCT00076856	Carcinoma, Non-Small-Cell Lung... more >> Neoplasm Metastasis Brain Neoplasms Collapse <<	Phase 2	Completed	-	-
NCT00248534	-	-	Terminated(slow accrual/lack o... more >>f resources/low priority due to combining 2 consortia) Collapse <<	-	-
NCT00248534	Lymphoma	Phase 2	Terminated(slow accrual/lack o... more >>f resources/low priority due to combining 2 consortia) Collapse <<	-	United States, California ... more >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Collapse <<
NCT00960492	Glioblastoma ... more >>Giant Cell Glioblastoma Gliosarcoma Collapse <<	Phase 1	Completed	-	United States, California ... more >> UCLA Los Angeles, California, United States, 90095 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, New York Beth Israel Medical Center New York, New York, United States, 10003 United States, North Carolina Duke University Medical Center; The Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health System/Division of Neuro-Oncology Charlottesville, Virginia, United States, 22908 United States, Washington University of Washington Seattle, Washington, United States, 98109 Collapse <<
NCT00006877	Lung Cancer	Phase 2	Completed	-	United States, Ohio ... more >> Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Collapse <<
NCT00004113	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Collapse <<
NCT01236560	Brain Stem Glioma ... more >> Cerebral Astrocytoma Childhood Cerebellar Anaplastic Astrocytoma Childhood Cerebral Anaplastic Astrocytoma Childhood Spinal Cord Neoplasm Untreated Childhood Brain Stem Glioma Untreated Childhood Cerebral Astrocytoma Collapse <<	Phase 2 Phase 3	Completed	-	-
NCT00003731	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	Belgium ... more >> Hopital Universitaire Erasme Brussels, Belgium, 1070 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Centre Hospitalier Regional de Lille Lille, France, 59037 CHU de la Timone Marseille, France, 13385 CHU de Nancy - Hopital Neurologique Nancy, France, 54035 Hopital Pasteur Nice, France, 06002 Centre Antoine Lacassagne Nice, France, 06189 Institut Gustave Roussy Villejuif, France, F-94805 Germany Nervenklinik Bamberg Bamberg, Germany, D-96049 Universitaetsklinikum Benjamin Franklin Berlin, Germany, D-12200 Klinikum der Universitat Regensburg Regensburg, Germany, DOH-9-3053 Italy Azienda Ospedaliera di Padova Padova (Padua), Italy, 35128 Istituti Fisioterapici Ospitalieri - Roma Rome, Italy, 00161 Netherlands University Medical Center Nijmegen Nijmegen, Netherlands, NL-6252 HB Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3508 GA Portugal Instituto Portugues de Oncologia de Francisco Gentil Lisbon, Portugal, 1093 Slovakia Postgraduate Medical Institute Bratislava, Slovakia, 833 03 Switzerland Kantonspital Aarau Aarau, Switzerland, 5001 University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Collapse <<
NCT00003718	Endometrial Cancer ... more >> Ovarian Cancer Sarcoma Collapse <<	Phase 2	Unknown	-	United States, New York ... more >> Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Collapse <<
NCT00703859	Glioblastoma	Phase 1	Withdrawn	-	-
NCT00257205	Melanoma	Phase 3	Completed	-	-
NCT01186406	Glioblastoma Multiforme ... more >> Gliosarcoma Collapse <<	Phase 2	Active, not recruiting	January 2019	United States, North Carolina ... more >> The Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States, 27710 Collapse <<
NCT02595424	Gastric Neuroendocrine Carcino... more >>ma Intestinal Neuroendocrine Carcinoma Pancreatic Neuroendocrine Carcinoma Collapse <<	Phase 2	Recruiting	January 1, 2029	-
NCT01430351	Brain Cancer	Phase 1	Active, not recruiting	September 2019	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01186406	-	-	Active, not recruiting	-	-
NCT01124240	Newly Diagnosed Non Methylated... more >> Glioblastoma Multiforme Grade 4 Collapse <<	Phase 2	Unknown	January 2014	Australia, New South Wales ... more >> Royal North Shore Hospital Recruiting Sydney, New South Wales, Australia, 2065 Contact: Sally McCowatt, Rn 61299265049 smccowat@nsccahs.health.nsw.gov.au Contact: Helen Wheeler, MBBS 61299267111 hrwheeler@optusnet.com.au Principal Investigator: Helen Wheeler, MBBS Collapse <<
NCT00338130	Melanoma	Phase 2	Completed	-	-
NCT01193140	Solid Tumor Cancers	Phase 2	Completed	-	United States, California ... more >> Site Reference ID/Investigator# 43022 Encinitas, California, United States, 92024 Site Reference ID/Investigator# 42662 Santa Monica, California, United States, 90404 Collapse <<
NCT01957956	Giant Cell Glioblastoma ... more >> Glioblastoma Gliosarcoma Collapse <<	Early Phase 1	Active, not recruiting	November 15, 2018	United States, Minnesota ... more >> Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse <<
NCT03477110	Glioblastoma	Early Phase 1	Recruiting	March 2020	United States, Pennsylvania ... more >> Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Wenyin Shi, MD 215-955-6702 wenyin.shi@jefferson.edu Collapse <<
NCT00978458	Brain and Central Nervous Syst... more >>em Tumors Neurotoxicity Collapse <<	Phase 3	Active, not recruiting	December 31, 2026	-
NCT02343549	Cancer of Brain and Nervous Sy... more >>stem Collapse <<	Phase 2	Recruiting	June 2021	United States, North Carolina ... more >> Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28204 Contact: Sylvia Rushing Collapse <<
NCT01812616	Cancer	Phase 1 Phase 2	Completed	-	Germany ... more >> Klinik für Onkologie, Hämatologie und Stammzelltransplantation, Universitätsklinikum Aachen RWTH Aachen, Germany, 52074 Neurologie des Klinikums Altenburger Land Altenburg, Germany, 04600 Zentrum für Neuroonkologie der Universität Duesseldorf Duesseldorf, Germany, 40225 Strahlenklinik der Universität Erlangen Erlangen, Germany, 91054 United Kingdom The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom, CH63 4JY St James's Institute of Oncology, St James's University Hospital Leeds, Yorkshire, United Kingdom, LS9 7TF Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Queen's Centre for Haematology & Oncology, Castle Hill Hospital Cottingham, United Kingdom, HU16 5JQ West of Scotland Beatson Cancer Centre Glasgow, United Kingdom, G12 0YN Guy's & St Thomas' NHS Foundation Trust, of St Thomas' Hospital London, United Kingdom, SE1 7EH The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Collapse <<
NCT00003304	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	-
NCT03181477	Glioblastoma, Adult	Not Applicable	Recruiting	August 4, 2020	France ... more >> CHU Besançon Not yet recruiting Besançon, France Principal Investigator: Patrick Dr Bontemps, MD Centre Georges François Leclerc Recruiting Dijon, France, 21850 Principal Investigator: Dr Gille TRUC, MD Centre d'oncologie et de radiothérapie Not yet recruiting Mâcon, France Principal Investigator: Valérie Dr POUCHARD, MD Institut de cancérologie de Lorraine Recruiting Nancy, France Principal Investigator: valérie Dr Bernier, MD Paul Strauss Not yet recruiting Strasbourg, France, 67000 Principal Investigator: Delphine Dr Antoni, MD Centre de Cancérologie Des Dentellières Not yet recruiting Valenciennes, France Principal Investigator: niolas Dr BLANCHARD, MD Collapse <<
NCT00884741	Glioblastoma ... more >>Gliosarcoma Supratentorial Glioblastoma Collapse <<	Phase 3	Completed	-	-
NCT00884741	-	-	Completed	-	-
NCT00970996	Melanoma	Phase 1	Completed	-	United States, Texas ... more >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03776071	Glioblastoma	Phase 2	Not yet recruiting	December 2022	-
NCT00629343	Soft Tissue Sarcoma ... more >> Mesothelioma Collapse <<	Phase 1	Unknown	August 2014	United States, New York ... more >> Columbia University Medical Center New York, New York, United States, 10032 Collapse <<
NCT00049387	Adult Giant Cell Glioblastoma ... more >> Adult Glioblastoma Adult Gliosarcoma Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 Collapse <<
NCT00100802	-	-	Unknown	-	-
NCT00262730	Glioblastoma Multiforme	Phase 2	Completed	-	United States, Alabama ... more >> Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Collapse <<
NCT01013285	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Unknown	January 2017	United States, California ... more >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Collapse <<
NCT02490930	Glioblastoma ... more >>Anaplastic Astrocytoma Collapse <<	Early Phase 1	Completed	-	United States, Maryland ... more >> The Johns Hopkins University Baltimore, Maryland, United States, 21287 Collapse <<
NCT00262730	-	-	Completed	-	-
NCT00612638	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 1	Completed	-	United States, North Carolina ... more >> Duke University Health System Durham, North Carolina, United States, 27710 Collapse <<
NCT01107522	Solid Tumors, Glioblastoma, Re... more >>current Malignant Gliomas Collapse <<	Phase 1	Active, not recruiting	-	United States, New York ... more >> New York University New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10017 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97213 Oregon Health and Sciences University Portland, Oregon, United States, 97239 Collapse <<
NCT01055314	Adult Rhabdomyosarcoma ... more >> Childhood Alveolar Rhabdomyosarcoma Childhood Embryonal Rhabdomyosarcoma Metastatic Childhood Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Untreated Childhood Rhabdomyosarcoma Collapse <<	Phase 2	Completed	-	-
NCT00100802	Brain Tumors ... more >>Central Nervous System Tumors Collapse <<	Phase 2	Unknown	-	-
NCT00276679	Neuroblastoma	Phase 2	Completed	-	France ... more >> Centre Hospitalier Regional de Purpan Toulouse, France, 31026 Ireland Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Collapse <<
NCT02599090	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 2	Withdrawn(Multi phase study di... more >>d not progress to Phase II. Phase I registered as NCT00734526.) Collapse <<	-	-
NCT01115491	Glioblastoma Multiforme	Phase 2	Completed	-	Spain ... more >> Barcelona, Spain, 08025 Barcelona, Spain, 08907 Barcelona, Spain, 08916 Madrid, Spain, 28040 Madrid, Spain, 28041 Madrid, Spain, 28046 Valencia, Spain, 41014 Valencia, Spain, 46026 Collapse <<
NCT01115491	-	-	Completed	-	-
NCT01830101	Recurrent Glioblastoma	Phase 3	Withdrawn(This study will not ... more >>be proceeding due to lack of funding from anticipated sources) Collapse <<	November 2017	Canada, Alberta ... more >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Collapse <<
NCT02871843	Glioblastoma ... more >>Oligodendroglioma Anaplastic Oligodendroglioma Collapse <<	Phase 1	Recruiting	December 2018	United States, California ... more >> University of California San Francisco (UCSF) Recruiting San Francisco, California, United States, 94143 Contact: Jane Rabbitt 415-353-2652 Jane.Rabbitt@ucsf.edu Contact: Thelma Munoz 415-353-2523 Thelma.Munoz@ucsf.edu Principal Investigator: Nicholas Butowski, MD United States, New Jersey The Cancer Institute of New Jersey (Rutgers University) Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Ling Zheng 732-235-8865 Zhengl1@cinj.rutgers.edu Principal Investigator: Robert Aiken, MD United States, New York Weill Cornell Brain Tumor Center Recruiting New York, New York, United States, 10021 Contact: Kate Carbonell 646-962-6137 kac2051@med.cornell.edu Principal Investigator: Howard A Fine, MD Collapse <<
NCT00302159	High Grade Gliomas ... more >> Brain Tumors Collapse <<	Phase 2	Completed	-	United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-6056 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23284 Collapse <<
NCT01525082	Gastrinoma Gl... more >>ucagonoma Insulinoma Pancreatic Polypeptide Tumor Recurrent Islet Cell Carcinoma Recurrent Pancreatic Cancer Somatostatinoma Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Collapse <<	Phase 2	Active, not recruiting	July 2019	United States, California ... more >> University of California San Francisco San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305 United States, Florida Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Collapse <<
NCT01055314	-	-	Completed	-	-
NCT00302159	-	-	Completed	-	-
NCT00304031	-	-	Completed	-	-
NCT00768911	Glioblastoma Multiforme	Phase 1	Unknown	June 2011	United States, Arkansas ... more >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Kentucky University of Kentucky Hospital Lexington, Kentucky, United States, 40536 United States, Missouri Washington University Cancer Center St. Louis, Missouri, United States, 63110 United States, New York SUNY Upstate Medical University Syracuse, New York, United States, 13210 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT03149575	Glioblastoma Multiforme ... more >> Glioblastoma Glioma GBM Brain Cancer Collapse <<	Phase 3	Active, not recruiting	August 2019	United States, California ... more >> Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States, 90027 University of California, San Francisco - Division of Neuro-Oncology San Francisco, California, United States, 94143 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey Atlantic Neuroscience Institute - Brain Tumor Center of NJ Summit, New Jersey, United States, 07901 United States, New York Dent Neurosciences Research Center Amherst, New York, United States, 14226 Collapse <<
NCT00316849	Adult Giant Cell Glioblastoma ... more >> Adult Glioblastoma Adult Gliosarcoma Collapse <<	Phase 1	Completed	-	United States, Florida ... more >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Iowa Medical Oncology and Hematology Associates-West Des Moines Clive, Iowa, United States, 50325 Mercy Capitol Des Moines, Iowa, United States, 50307 Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Iowa Oncology Research Association CCOP Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates-Des Moines Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates Des Moines, Iowa, United States, 50314 Mercy Medical Center - Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Dakota Altru Cancer Center Grand Forks, North Dakota, United States, 58201 Collapse <<
NCT01364064	Glioblastoma	Phase 3	Completed	-	-
NCT02343406	Glioblastoma Multiforme	Phase 2	Recruiting	December 13, 2020	-
NCT01044966	Glioblastoma Multiforme ... more >> Glioma Astrocytoma Brain Tumor Collapse <<	Phase 1 Phase 2	Terminated(The study was termi... more >>nated due to lack of adequate patient enrollment into trial.) Collapse <<	-	United States, South Carolina ... more >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Collapse <<
NCT00304031	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 3	Completed	-	-
NCT00613028	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> Duke University Health System Durham, North Carolina, United States, 27710 Collapse <<
NCT00004106	Lymphoma	Phase 2	Terminated(Per Data Monitoring... more >> Committee given the poor/inadequate accrual.) Collapse <<	-	United States, Connecticut ... more >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520-8028 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Collapse <<
NCT00734526	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 1	Terminated	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00817284	Glioblastoma Multiforme	Phase 2	Completed	-	Denmark ... more >> Rigshospitalet Copenhagen, Denmark Odense Hospital Odense, Denmark Århus Hospital Århus, Denmark Collapse <<
NCT01019434	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	Belgium ... more >> UZ Leuven Leuven, Belgium France Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau Nantes-Saint Herblain, France, 44805 CHU Pitie-Salpetriere AP-HP Paris, France, FR 75651 Germany Universitaetsklinikum Freiburg Freiburg, Germany, DE 79106 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69120 Italy Ospedale Bellaria Bologna, Italy, I-40139 Netherlands Medisch Centrum Haaglanden - Westeinde Den Haag, Netherlands, NL 2501 Erasmus MC - Daniel den Hoed Cancer Center Rotterdam, Netherlands, NL 3008 Spain ICO Badalona - Hospital Germans Trias i Pujol Badalona, Spain, ES 08916 Switzerland Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 United Kingdom Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom Western General Hospital Edinburgh, United Kingdom Collapse <<
NCT00813943	Glioblastoma	Phase 2	Completed	-	United States, Massachusetts ... more >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please Contact the Merck KGaA Communication Center Located in Darmstadt, Germany Collapse <<
NCT00813943	-	-	Completed	-	-
NCT00187486	-	-	Completed	-	-
NCT00613028	-	-	Completed	-	-
NCT00187486	Glioblastoma Multiforme ... more >> Gliosarcoma Collapse <<	Phase 2	Completed	-	United States, California ... more >> UCSF Department of Neurological Surgery San Francisco, California, United States, 94143-0372 Collapse <<
NCT00481455	Recurrent Glioblastoma Multifo... more >>rme Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> The Brain Tumor Center, Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT01907165	Glioblastoma	Early Phase 1	Completed	-	United States, Missouri ... more >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Collapse <<
NCT00003466	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Collapse <<
NCT00033280	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	-
NCT02044120	Ewing Sarcoma	Phase 1	Active, not recruiting	April 2021	United States, California ... more >> Children's Hospital of Los Angeles Los Angeles, California, United States, 90027 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48106 United States, Washington Seattle's Children Cancer Center Seattle, Washington, United States, 98101 United Kingdom University College London Hospital London, United Kingdom, W1T 7HA Collapse <<
NCT01105702	Brain Cancer	Phase 2	Terminated(Due to slow accrual... more >>) Collapse <<	-	United States, New Jersey ... more >> Overlook Hospital Summit, New Jersey, United States, 07902 United States, New York New York University Clinical Cancer Center New York, New York, United States, 10016 Collapse <<
NCT01105702	-	-	Terminated(Due to slow accrual... more >>) Collapse <<	-	-
NCT00617539	Breast Cancer ... more >> Metastatic Cancer Collapse <<	Phase 2	Completed	-	United States, California ... more >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Collapse <<
NCT01143402	-	-	Completed	-	-
NCT00717210	Anaplastic Astrocytoma ... more >> Oligodendroglioma Oligoastrocytoma Collapse <<	Phase 3	Completed	-	Germany ... more >> University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 Neurology and Radiotherapy Tübingen, Baden-Württemberg, Germany, 72076 Klinikum Aschaffenburg Aschaffenburg, Germany Nervenklinik Bamberg, Germany Charite Berlin, Germany Neurosurgery Düsseldorf, Germany Radiotherapy Erlangen, Germany Neurology Essen, Germany Neurosurgery Frankfurt, Germany Neurosurgery Kiel, Germany Neurosurgery Mainz, Germany County District Hospital Regensburg, Germany Collapse <<
NCT00138216	Brain and Central Nervous Syst... more >>em Tumors Unspecified Childhood Solid Tumor, Protocol Specific Collapse <<	Phase 1	Completed	-	United States, Alabama ... more >> Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States, 35294 United States, California Children's Hospital of Orange County Orange, California, United States, 92868 Stanford Cancer Center Stanford, California, United States, 94305-5824 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 SUNY Upstate Medical University Hospital Syracuse, New York, United States, 13210 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Oregon Oregon Health and Science University Cancer Institute Portland, Oregon, United States, 97239-3098 United States, Pennsylvania Lehigh Valley Hospital - Muhlenberg Bethlehem, Pennsylvania, United States, 18107 Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-9786 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Hopital Sainte Justine Montreal, Quebec, Canada, H3T 1C5 Collapse <<
NCT01143402	Iris Melanoma ... more >> Medium/Large Size Posterior Uveal Melanoma Ocular Melanoma With Extraocular Extension Recurrent Uveal Melanoma Small Size Posterior Uveal Melanoma Stage IV Uveal Melanoma Collapse <<	Phase 2	Completed	-	-
NCT00512798	-	-	Terminated(This study was term... more >>inated due to lack of efficacy) Collapse <<	-	-
NCT03554473	Carcinoma, Small Cell ... more >> Lung Cancer Small Cell Lung Cancer Collapse <<	Phase 1 Phase 2	Recruiting	January 15, 2022	United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse <<
NCT00503594	Lymphoma	Phase 2	Unknown	July 2012	France ... more >> Groupe hospitalier la Pitié Salpétrière Recruiting Paris, France, 75013 Contact: Antonio OMURO, MD,PhD + 33(0) 1 42 16 41 60 antonio.omuro@psl.aphp.fr Collapse <<
NCT00617539	-	-	Completed	-	-
NCT00077454	Previously Treated Childhood R... more >>habdomyosarcoma Recurrent Childhood Brain Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Malignant Germ Cell Tumor Recurrent Childhood Medulloblastoma Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Soft Tissue Sarcoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Neuroblastoma Recurrent Osteosarcoma Collapse <<	Phase 1	Completed	-	United States, California ... more >> COG Phase I Consortium Arcadia, California, United States, 91006-3776 Collapse <<
NCT00505635	Melanoma	Phase 2	Terminated(Slow accrual)	-	United States, Texas ... more >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00512798	Brain and Central Nervous Syst... more >>em Tumors Melanoma Solid Tumor Collapse <<	Phase 1 Phase 2	Terminated(This study was term... more >>inated due to lack of efficacy) Collapse <<	-	United States, Tennessee ... more >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Collapse <<
NCT00905060	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, California ... more >> UCSF Department of Neurosurgery San Francisco, California, United States, 94115 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, New Jersey The Valley Hospital Paramus, New Jersey, United States, 07652 United States, New York Northern Westchester Hospital Mount Kisco, New York, United States, 10549 Columbia University New York, New York, United States, 10032 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT00505635	-	-	Terminated(Slow accrual)	-	-
NCT00615186	Glioblastoma Multiforme	Phase 3	Terminated(Due to delay in sit... more >>e initiation and funding considerations) Collapse <<	December 2013	-
NCT00875355	Breast Cancer ... more >> Metastatic Cancer Collapse <<	Phase 2	Unknown	-	France ... more >> Institut Curie Hopital Recruiting Paris, France, 75248 Contact: Youlia Kirova 33-44-32-4000 Collapse <<
NCT02308527	Neuroblastoma	Phase 2	Recruiting	January 2022	Austria ... more >> St Anna Children's Hospital and CCRI/Studies and Statistics Recruiting Vienna, Austria, A-1090 Contact: Ruth Ladenstein, MD 43 1 40470 4750 ruth.ladenstein@ccri.at Principal Investigator: Ruth Ladenstein, MD Denmark University Hospital Rigshospitalet Recruiting Copenhagen, Denmark, DK-2100 Contact: Karsten Nysom, MD 45 35 45 08 09 Karsten.Nysom@regionh.dk Principal Investigator: Karsten Nysom, MD France Hopital des Enfants Recruiting Toulouse, France, 31059 Contact: Herve Rubie, MD 33 534 55 86 11 rubie.h@chu-toulouse.fr Principal Investigator: Herve Rubie, MD Ireland Our Ladys Children's Hospital Dublin Recruiting Dublin, Ireland, Dublin 12 Contact: Cormac Owens, MD 35 31 409 6659 cormac.owens@olchc.ie Principal Investigator: Cormac Owens, MD Italy Ospedale Pediatrico Bambino Gseu Recruiting Rome, Italy, 00165 Contact: Aurora Castellano, MD aurora.castellano@opbg.net Principal Investigator: Aurora Castellano, MD Spain Instituto de Investigacion Sanitaria Recruiting Valencia, Spain, 46026 Contact: Victoria Castel, MD 34 963 862 758 castel_vic@gva.es Principal Investigator: Victoria Castel, MD Switzerland Swiss Paediatric Oncology Group Recruiting Bern, Switzerland, 3008 Contact: Nicolas Gerber +41 (0)31 508 42 38 'nicolas.gerber@kispi.uzh.ch' Contact: TuMy DiepLai +41 (0)31 508 42 38 Tu-My.Diep@spog.ch Principal Investigator: Nicolas Gerber` United Kingdom The Royal Marsden NHS Foundation Trust and Institute of Cancer Research Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Andrew DJ Pearson, MD Contact: Lucas Moreno, MD Principal Investigator: Andrew DJ Pearson, MD Collapse <<
NCT01767194	Ganglioneuroblastoma ... more >> Recurrent Neuroblastoma Collapse <<	Phase 2	Completed	-	-
NCT00274833	CNS Tumor, Adult	Phase 2	Completed	-	United States, Ohio ... more >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Collapse <<
NCT01009515	-	-	Terminated(Low accrual; target... more >> accrual not met) Collapse <<	-	-
NCT00548938	Glioblastoma Multiforme ... more >> High-Grade Glioma Collapse <<	Phase 2	Terminated(Principal Investiga... more >>tor has left the institution) Collapse <<	October 2010	United States, Tennessee ... more >> Methodist University Hospital Memphis, Tennessee, United States, 38104 Collapse <<
NCT00498927	-	-	Completed	-	-
NCT01196416	Recurrent Melanoma ... more >> Stage IV Skin Melanoma Collapse <<	Phase 1 Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse <<
NCT00892385	Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Collapse <<
NCT01196416	-	-	Completed	-	-
NCT01009515	Melanoma	Phase 2	Terminated(Low accrual; target... more >> accrual not met) Collapse <<	-	United States, New Mexico ... more >> Hematology Oncology Associates Albuquerque, New Mexico, United States, 87106 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 The Cancer Center at Presbyterian Albuquerque, New Mexico, United States, 87110 Collapse <<
NCT01845675	Advanced Well-differentiated P... more >>ancreatic Neuroendocrine Tumor Collapse <<	Phase 2	Completed	-	China ... more >> Division of Medical Oncology, Peking Union Medical College Hospital Beijing, China, 100730 Collapse <<
NCT00724841	Metastatic Melanoma	Phase 1 Phase 2	Terminated(Study terminated pr... more >>ematurely due to financial contraints.) Collapse <<	-	United States, Pennsylvania ... more >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT00498927	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse <<
NCT01478854	Glioblastoma Multiforme	Not Applicable	Active, not recruiting	July 2020	United States, Maryland ... more >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Collapse <<
NCT03119064	Glioblastoma Multiforme ... more >> Glioblastoma GBM Collapse <<	Phase 1 Phase 2	Recruiting	July 2020	United States, Rhode Island ... more >> Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Kayla Rosati 401-863-3000 kayla_rosati@brown.edu Principal Investigator: Heinrich Elinzano, MD Collapse <<
NCT01213407	Glioblastoma Multiforme	Phase 2	Completed	-	Austria ... more >> Landesnervenklinik Wagner-Jauregg Linz, Oberösterreich, Austria, 4020 Landeskrankenhaus Feldkirch Feldkirch, Austria, 6807 Department of Neurosurgery, Medical University Graz Graz, Austria, 8036 Clinical Department of Neurology, Medical University Innsbruck Innsbruck, Austria, 6020 Department of Neurosurgery, Christian Doppler Klinik, Paracelsus Medizinische Privatuniversität Salzburg, Austria, 5020 Neuroonkologisches Tumorboard KFJ-KA; Rudolfsstiftung Vienna, Austria, 1030 Department of Paediatrics, Medical University Vienna Vienna, Austria, 1090 Medical Department of Oncology, Donauspital, SMZ-Ost Vienna, Austria, 1220 Collapse <<
NCT00662506	Adult Giant Cell Glioblastoma ... more >> Adult Glioblastoma Adult Gliosarcoma Collapse <<	Phase 1 Phase 2	Completed	-	United States, Massachusetts ... more >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Collapse <<
NCT00086879	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	Belgium ... more >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 CHU Pitie-Salpetriere Paris, France, 75651 Institut Gustave Roussy Villejuif, France, F-94805 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Netherlands Medisch Centrum Haaglanden 's-Gravenhage, Netherlands, 2501 CK University Medical Center Rotterdam at Erasmus Medical Center Rotterdam, Netherlands, 3000 CA United Kingdom Western Infirmary Glasgow, Scotland, United Kingdom, G11 6NT Collapse <<
NCT00283543	Newly Diagnosed Supratentorial... more >> Malignant Glioma Collapse <<	Phase 2	Unknown	April 2008	United States, Kentucky ... more >> Kentuckiana Cancer Institute Louisville, Kentucky, United States, 40202 Collapse <<
NCT00072345	Intraocular Melanoma ... more >> Melanoma (Skin) Collapse <<	Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Collapse <<
NCT00993044	-	-	Completed	-	-
NCT01127178	Solid Tumors	Phase 1	Completed	-	United States, Massachusetts ... more >> Boston, Massachusetts, United States United States, New Hampshire Lebanon, New Hampshire, United States United States, South Carolina Greensville, South Carolina, United States United States, Texas San Antonio, Texas, United States United States, Virginia Charlottesville, Virginia, United States Collapse <<
NCT00525525	-	-	Completed	-	-
NCT00993044	Refractory Solid Tumors in Chi... more >>ldren Collapse <<	Phase 1	Completed	-	United States, California ... more >> Childrens Hospital los Angeles Los angeles, California, United States, 90027 Collapse <<
NCT00525525	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 2	Completed	-	United States, California ... more >> University of California San Francisco San Francisco, California, United States, 94143 Collapse <<
NCT00763750	Brain Tumor	Phase 2	Completed	-	United States, Rhode Island ... more >> Lifespan Hospitals Providence, Rhode Island, United States, 02906 Collapse <<
NCT00763750	-	-	Completed	-	-
NCT00003464	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Collapse <<
NCT03018288	Glioblastoma	Phase 2	Recruiting	January 9, 2024	United States, Arizona ... more >> Barrow Neurological Institute Recruiting Phoenix, Arizona, United States, 85013 Contact: Kathryn Gilbert 602-406-6274 United States, Florida UF Health Cancer Center at Orlando Health Recruiting Orlando, Florida, United States, 32806 Contact: Helen Tran 321-841-3812 helen.tran@orlandohealth.com United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Anne Mendelke 312-695-4772 anne.mendelke@nm.org Northshore University Health System Recruiting Glenview, Illinois, United States, 60026 Contact: Patricia Lada 847-570-2025 plada@northshore.org Advocate Health Care Recruiting Park Ridge, Illinois, United States, 60068 Contact: Sheri Velez 847-723-5579 sherri.velez@advocate.com United States, Maryland National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 United States, Michigan Henry Ford Health Systems Recruiting Detroit, Michigan, United States, 48202 Contact: Francesca Picotte, M.D. 313-916-3181 fpicott1@hfhs.org United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27514 Contact: Michael Roxas 919-962-8834 michael_roxas@med.unc.edu United States, South Carolina MUSC Hollings Cancer Center Recruiting Charleston, South Carolina, United States, 29425 Contact: Michele DeCandio 843-792-9016 decandio@musc.edu United States, Texas Texas Oncology-Austin Brain Tumor Center Recruiting Austin, Texas, United States, 78705 Contact: Michele Harris 972-490-2963 michelle.harris2@usoncology.com Baylor University Medical Center Recruiting Dallas, Texas, United States, 75246 Contact: Amy Solis 214-820-8685 amy.solis@BSW.edu United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Lisa Angelos 801-587-4702 Lisa.Angelos@hci.uah.edu United States, Washington University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Valeria Martin 206-221-1538 avmartin@uw.edu United States, Wisconsin Aurora Recruiting Milwaukee, Wisconsin, United States, 53215 Contact: Gary Dennison 414-385-7129 gary.dennison@aurora.org Collapse <<
NCT00869401	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1 Phase 2	Active, not recruiting	-	-
NCT01313884	-	-	Terminated(Study did not reach... more >> primary objective; study did not accrue enough patients.) Collapse <<	-	-
NCT00869401	-	-	Active, not recruiting	-	-
NCT00499798	-	-	Completed	-	United States, North Carolina ... more >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Collapse <<
NCT02455557	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 2	Active, not recruiting	May 30, 2019	United States, Massachusetts ... more >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Ohio Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Collapse <<
NCT01119599	Acoustic Schwannoma ... more >> Adult Anaplastic (Malignant) Meningioma Adult Anaplastic Astrocytoma Adult Anaplastic Ependymoma Adult Brain Stem Glioma Adult Choroid Plexus Neoplasm Adult Craniopharyngioma Adult Diffuse Astrocytoma Adult Ependymoblastoma Adult Ependymoma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Grade I Meningioma Adult Grade II Meningioma Adult Medulloblastoma Adult Mixed Glioma Adult Myxopapillary Ependymoma Adult Oligodendroglioma Adult Papillary Meningioma Adult Pilocytic Astrocytoma Adult Pineal Gland Astrocytoma Adult Pineoblastoma Adult Pineocytoma Adult Primary Melanocytic Lesion of Meninges Adult Subependymal Giant Cell Astrocytoma Adult Subependymoma Adult Supratentorial Primitive Neuroectodermal Tumor Malignant Adult Intracranial Hemangiopericytoma Collapse <<	Phase 1	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Collapse <<
NCT01313884	Bone Cancer E... more >>wing's Sarcoma Collapse <<	Phase 2	Terminated(Study did not reach... more >> primary objective; study did not accrue enough patients.) Collapse <<	-	United States, California ... more >> Stanford University School of Medicine Stanford, California, United States, 94305 Collapse <<
NCT00601289	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Withdrawn(funding term ended)	-	-
NCT02137759	Glioblastoma Multiforme of Bra... more >>in Collapse <<	Phase 2	Recruiting	June 2022	United States, Georgia ... more >> Emory University/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Rikesh Patel 404-778-2981 rikesh.b.patel@emory.edu Contact: Lily Masoumy 404-778-1960 lily.masoumy@emory.edu United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Matthias Holdhoff, MD, PhD 410-955-8837 mholdho1@jhmi.edu Collapse <<
NCT00027742	Intraocular Melanoma ... more >> Melanoma (Skin) Collapse <<	Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Collapse <<
NCT00004200	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, California ... more >> Agouron Pharmaceuticals, Inc. La Jolla, California, United States, 92037 Collapse <<
NCT00354068	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, North Carolina ... more >> Duke Cancer Institute Durham, North Carolina, United States, 27710 Collapse <<
NCT00096265	Metastatic Malignant Neoplasm ... more >>in the Brain Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Collapse <<	Phase 3	Terminated	-	-
NCT02270034	Glioblastoma Multiforme (Grade... more >> IV) of Cerebellum Collapse <<	Phase 1	Recruiting	February 2019	Spain ... more >> Institut Català D'Oncologia L'Hospitalet (Ico) Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Ana Márquez, Pharmacist +34934344412 ana.marquez@mfar.net Principal Investigator: Miguel Gil, MD Hospital Del Mar Active, not recruiting Barcelona, Spain, 08003 Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Ana Márquez, Pharmacist +34 934344412 ana.marquez@mfar.net Principal Investigator: Estela Pineda, MD Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Ana Márquez, Pharmacist +934344412 ana.marquez@mfar.net Principal Investigator: Juan Sepulveda, MD Collapse <<
NCT00096265	-	-	Terminated	-	-
NCT00027625	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, California ... more >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0128 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75390-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Collapse <<
NCT02663440	Glioblastoma Multiforme	Phase 2	Unknown	-	China, Zhejiang ... more >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xiaozhong Chen, MD 86-571-88122098 cxzfyun@sina.com Principal Investigator: Xiaozhong Chen, MD Collapse <<
NCT00112502	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, Arkansas ... more >> Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States, 72913 United States, Florida University of Texas MD Anderson Cancer Center at Orlando Orlando, Florida, United States, 32806-2134 United States, Georgia CCOP - Atlanta Regional Atlanta, Georgia, United States, 30342-1701 United States, Illinois CCOP - Central Illinois Decatur, Illinois, United States, 62526 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Grand Rapids Grand Rapids, Michigan, United States, 49503 CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Missouri CCOP - Kansas City Kansas City, Missouri, United States, 64131 Cancer Research for the Ozarks Springfield, Missouri, United States, 65804 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, South Carolina CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Collapse <<
NCT02378532	Glioblastoma Multiforme	Phase 1	Recruiting	June 2019	Netherlands ... more >> Maastricht Radiation Oncology Recruiting Maastricht, Netherlands, 6202 AZ Collapse <<
NCT03234595	Recurrent High Grade Glioma	Phase 1 Phase 2	Recruiting	December 31, 2021	Taiwan ... more >> Hualien Tzu Chi Hospital Recruiting Hualien City, Taiwan, 970 Contact: Jui-Hao Lee, Ph.D. +886-3-863-0108 juihaolee@efbiotech.com Collapse <<
NCT01328535	-	-	Active, not recruiting	-	-
NCT01217398	Intraocular Melanoma	Phase 2	Unknown	-	France ... more >> Institut Curie Hopital Recruiting Paris, France, 75248 Contact: Contact Person 33-1-4432-4068 sophie.piperno-neumann@curie.net Collapse <<
NCT00003747	Melanoma (Skin)	Phase 1	Unknown	-	United Kingdom ... more >> Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Collapse <<
NCT01502241	Glioblastoma ... more >>Anaplastic Astrocytoma Collapse <<	Phase 3	Completed	-	Germany ... more >> University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 University of Frankfurt Frankfurt, Hessen, Germany, 60528 Charite Berlin Berlin, Germany University of Bochum Bochum, Germany University of Bonn Bonn, Germany University of Dresden Dresden, Germany University of Düsseldorf Düsseldorf, Germany University of Erlangen Erlangen, Germany University of Essen Essen, Germany University of Freiburg Freiburg, Germany University of Hamburg Hamburg, Germany University of Hannover II Hannover, Germany University of Hannover Hannover, Germany University of Homburg Homburg, Germany University of Kiel Kiel, Germany University of Leipzig Leipzig, Germany University of Mainz Mainz, Germany University of Heidelberg Mannheim, Germany University of Marburg Marburg, Germany University of Regensburg Regensburg, Germany University of Tübingen Tübingen, Germany University of Ulm Ulm, Germany Switzerland University of Zurich Zurich, Switzerland, 8091 Collapse <<
NCT00014261	Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse <<	Phase 1	Completed	-	United States, New Hampshire ... more >> Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756-0002 Collapse <<
NCT00020150	Brain and Central Nervous Syst... more >>em Tumors Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Collapse <<
NCT01864109	Newly Diagnosed Ewing Sarcoma	Phase 2	Recruiting	May 2020	United States, New Jersey ... more >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Paul Meyers, MD 212-639-5952 Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Paul Meyers, MD 212-639-5952 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Paul Meyers, MD 212-639-5952 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Paul Meyers, MD 212-639-5952 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Paul Meyers, MD 212-639-5952 Contact: Emily Slotkin, MD 212-639-8856 Principal Investigator: Paul Meyers, MD Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Paul Meyers, MD 212-639-5952 Collapse <<
NCT01328535	Recurrent Melanoma ... more >> Stage IV Melanoma Collapse <<	Phase 2	Active, not recruiting	December 15, 2018	United States, Minnesota ... more >> Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse <<
NCT03008148	Glioblastoma	Phase 2 Phase 3	Not yet recruiting	October 2023	Taiwan ... more >> Taipei Veterans General Hospital Not yet recruiting Taipei City, Taiwan, 11217 Principal Investigator: Yu-Ming Liu Tri-Service General Hospital Not yet recruiting Taipei City, Taiwan, 11490 Principal Investigator: Hsin-I Ma Collapse <<
NCT00601614	Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse <<	Phase 1	Withdrawn(no enrollment)	-	-
NCT00006025	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, California ... more >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Collapse <<
NCT00021307	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1 Phase 2	Withdrawn(Study not activated.... more >>) Collapse <<	-	-
NCT00006358	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, California ... more >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Maryland Neuro-Oncology Branch Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Collapse <<
NCT01390571	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United Kingdom ... more >> Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 0QQ Christie Hospital Manchester, England, United Kingdom Royal Marsden Hospital Sutton, England, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH Western General Hospital Edinburgh, United Kingdom, EH4 2XU Collapse <<
NCT00458601	Malignant Glioma	Phase 2	Completed	-	-
NCT00033709	Sarcoma	Phase 2	Unknown	-	United States, New York ... more >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 Collapse <<
NCT02661282	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 1 Phase 2	Recruiting	June 2020	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Collapse <<
NCT00003176	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, California ... more >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, Pennsylvania Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Collapse <<
NCT01062425	Adult Glioblastoma ... more >> Adult Gliosarcoma Collapse <<	Phase 2	Active, not recruiting	-	-
NCT02991456	Chemo-radiation Induced Nausea... more >> and Vomiting Collapse <<	Phase 2	Recruiting	April 27, 2021	United States, North Carolina ... more >> The Preston Robert Tisch Brain Tumor Center at Duke Recruiting Durham, North Carolina, United States, 27710 Contact: Mary Lou Affronti, DNP, RN, ANP, MHSc 919-684-5301 Contact: Edythe Parker, BS, MBA 919-684-5301 Principal Investigator: Katherine Peters, MD, PhD Collapse <<
NCT01851369	Lymphomas Sol... more >>id Tumors NSCLC Metastatic Colon Carcinoma Granulosa Cell Ovarian Cancer Collapse <<	Phase 1 Phase 2	Recruiting	February 1, 2020	United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse <<
NCT01062425	-	-	Active, not recruiting	-	-
NCT00412503	Refractory Tumors ... more >> Malignant Tumors Collapse <<	Phase 1	Completed	-	France ... more >> Institut Gustave Roussy Villejuif, Ille de France, France, 94805 Collapse <<
NCT02903069	Glioblastoma ... more >>Malignant Glioma Collapse <<	Phase 1	Recruiting	May 31, 2020	United States, California ... more >> University of California, Irvine Medical Center Comprehensive Brain Tumor Program Recruiting Irvine, California, United States, 92697 Contact: Jinah Chung 714-456-8442 jinahec@uci.edu Principal Investigator: Daniela Bota, MD, PhD University of California, San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92037 Contact: Brian Churas 858-534-7996 bchuras@ucsd.edu Principal Investigator: David Piccioni, MD, PhD John Wayne Cancer Institute at the Providence Saint John's Health Center Recruiting Santa Monica, California, United States, 90404 Contact: Najee Boucher 310-582-7460 najee.boucher@providence.org Principal Investigator: Santosh Kesari, MD, PhD United States, Illinois Northwestern Brain Tumor Institute at Northwestern University Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Anne Mendelke anne.mendelke@northwestern.edu Contact: Roger Stupp, MD (855) 695-6284 United States, North Carolina Duke University Medical Center, Preston Robert Tisch Brain Tumor Center Recruiting Durham, North Carolina, United States, 27710 Contact: Sarah Woodring 919-684-2527 sarah.woodring@duke.edu Contact: Denise Jaggers 919-613-6803 denise.jaggers@dm.duke.edu Principal Investigator: Annick Desjardins, MD United States, Pennsylvania Penn State Health Milton S. Hershey Medical Center Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Scott Murphy 717-531-0003 ext 283114 smurphy6@pennstatehealth.psu.edu Principal Investigator: Dawit G Aregawi, MD Canada, Ontario Princess Margaret Hospital, Gerry and Nancy Pencer Brain Tumour Centre Recruiting Toronto, Ontario, Canada Contact: Mariya Bakalets 416-946-4603 mariya.bakalets@uhn.ca Contact: Elena Chizhov 416-946-4624 elena.chizhov@uhn.ca Principal Investigator: Warren Mason, MD Switzerland University Hospital Zurich Brain Tumor Center Recruiting Zurich, Switzerland, 8091 Contact: Carola Keding +41 44 255 55 00 carola.keding@usz.ch Principal Investigator: Patrick Roth, MD Collapse <<
NCT00083096	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Unknown	-	France ... more >> Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Collapse <<
NCT01149850	Giant Cell Glioblastoma ... more >> Glioblastoma Gliosarcoma Collapse <<	Phase 2	Active, not recruiting	January 1, 2019	United States, California ... more >> Kaiser Foundation Hospital Los Angeles, California, United States, 90027 University of California, Los Angeles Los Angeles, California, United States, 90095 Kaiser Permanente at San Diego San Diego, California, United States, 92120 Collapse <<
NCT01822275	Histologically Proven Diagnosi... more >>s of Glioblastoma or Gliosarcoma (WHO Grade IV) Collapse <<	Phase 2	Recruiting	December 2018	United States, Maryland ... more >> Ummc Msgcc Recruiting Baltimore, Maryland, United States, 21201 Contact: Caroline Poff, RN 410-369-5264 caroline.poff@umm.edu Collapse <<
NCT00085254	-	-	Completed	-	-
NCT00003708	Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse <<	Phase 1	Completed	-	United States, Texas ... more >> Brooke Army Medical Center Fort Sam Houston, Texas, United States, 78234 San Antonio Cancer Institute San Antonio, Texas, United States, 78229 Collapse <<
NCT00006353	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 3	Completed	-	Canada, Alberta ... more >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia British Columbia Cancer Agency - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 British Columbia Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 British Columbia Cancer Agency - Vancouver Island Cancer Centre Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Doctor Leon Richard Oncology Centre Moncton, New Brunswick, Canada, E1C 8X3 Saint John Regional Hospital Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Newfoundland Cancer Treatment and Research Foundation St. Johns, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 1C4 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Cancer Care Ontario - Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec Centre Hospitalier de l'Universite de Montreal Montreal, Quebec, Canada, H2L-4M1 Collapse <<
NCT03189706	Neuroblastoma (NB)	Early Phase 1	Recruiting	June 2019	United States, New York ... more >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Shakeel Modak, MD 212-639-7623 Contact: Brian Kushner, MD 212-639-6793 Principal Investigator: Shakeel Modak Collapse <<
NCT00272415	Melanoma	Phase 1	Terminated	-	-
NCT01740258	Malignant Glioma ... more >> Grade 4 Malignant Glioma Glioblastoma Gliosarcoma Collapse <<	Phase 2	Active, not recruiting	December 2019	United States, North Carolina ... more >> Duke Cancer Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00626405	Melanoma (Skin)	Phase 2	Completed	-	-
NCT00165230	Neuroendocrine Tumor	Phase 2	Completed	-	United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconness Medical Center Boston, Massachusetts, United States, 02215 Collapse <<
NCT00385398	Lung Cancer M... more >>etastatic Cancer Collapse <<	Phase 2	Withdrawn(lack of funding and ... more >>drug supply) Collapse <<	-	-
NCT01480050	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, Alabama ... more >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Collapse <<
NCT00876993	Central Nervous System Tumors	Phase 1	Completed	-	United States, Florida ... more >> Johns Hopkins All Children's Hospital Saint Petersburg, Florida, United States, 33701 Collapse <<
NCT00085254	Adult Giant Cell Glioblastoma ... more >> Adult Glioblastoma Adult Gliosarcoma Collapse <<	Phase 1 Phase 2	Completed	-	United States, Alabama ... more >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT02085304	Glioblastoma	Phase 1 Phase 2	Unknown	December 2017	United States, Arizona ... more >> Barrow Neurological Institute at St. Joseph's Hospital and Medical Center Recruiting Phoenix, Arizona, United States, 85013 Contact: Norissa Honea, PhD, RN 602-406-6267 Norissa.Honea@dignityhealth.org Contact: Charlotte Myers, MS, ANP-C 602-406-5157 Charlotte.Myers@bnaneuro.net Principal Investigator: Kris A Smith, MD Collapse <<
NCT03345095	Newly Diagnosed Glioblastoma	Phase 3	Recruiting	July 2023	Belgium ... more >> GasthuisZusters Antwerpen - Sint-Augustinus Recruiting Antwerpen, Belgium Principal Investigator: Paul Meijnders, Dr Grand Hopital de Charleroi - Grand Hôpital de Charleroi - Site Notre Dame Recruiting Charleroi, Belgium Principal Investigator: Vincent Verschaeve, Dr Canada, Ontario Windsor Regional Cancer Centre Recruiting Windsor, Ontario, Canada Principal Investigator: Kay Amin, Dr Canada CHUM - Centre Hospitalier de l'Université de Montreal - Hopital Notre-Dame Recruiting Montréal, Canada Principal Investigator: Laura Masucci Giuseppina CHU de Quebec-Hopital l'Enfant-Jesus (HEJ) Recruiting Québec, Canada Principal Investigator: Andre Blaise Allan Blair Cancer Centre Recruiting Regina, Canada Principal Investigator: Ibrahim Chalchal Haji Odette Cancer Centre - Sunnybrook Health Sciences Centre Recruiting Toronto, Canada Principal Investigator: James Perry University Health Network - Oci / Princess Margaret Hospital Recruiting Toronto, Canada Principal Investigator: Mason Warren Centre hospitalier regional de Trois-Rivieres Recruiting Trois-Rivières, Canada Principal Investigator: Anouk Tremblay, Dr France CHRU de Lille Recruiting Lille, France Principal Investigator: Emilie Le Rhun, Dr Institut de Cancerologie de l'Ouest Recruiting Nantes, France Principal Investigator: Jean-Sebastien Frenel Netherlands Spaarne Gasthuis - Vrije Universiteit Medisch Centrum Recruiting Amsterdam, Netherlands Principal Investigator: Myra van Linde Universitair Medisch Centrum - Academisch Ziekenhuis Recruiting Utrecht, Netherlands, 3584 Contact f.devos@umcutrecht.nl Principal Investigator: Filip De Vos Norway Oslo University Hospital - Radiumhospitalet Recruiting Oslo, Norway Contact petter.brandal@ous-hf.no Principal Investigator: Petter Brandal Spain Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) Recruiting Badalona, Spain Contact cbalana@iconcologia.net Principal Investigator: Carmen Balana Clinica Universidad de Navarra - Clinica Universitaria De Navarra Recruiting Pamplona, Spain Principal Investigator: Gallego Jaime Switzerland University Hospital of Geneva Recruiting Geneva, Switzerland Contact: Anna Patrikidou, MD Principal Investigator: Anna Patrikidou Centre Hospitalier Universitaire Vaudois Not yet recruiting Lausanne, Switzerland Contact: Andreas Hottinger, MD Principal Investigator: Andreas Hottinger Kantonsspital Not yet recruiting Saint Gallen, Switzerland Principal Investigator: Thomas Hundsberger UniversitaetsSpital Recruiting Zürich, Switzerland Contact: Patrick Roth, MD Principal Investigator: Patrick Roth Collapse <<
NCT02715609	Glioblastoma Multiforme	Phase 1 Phase 2	Suspended(Waiting to see if a ... more >>dose expansion phase will be added) Collapse <<	February 28, 2022	United States, Missouri ... more >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Collapse <<
NCT01026493	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1 Phase 2	Completed	-	United States, California ... more >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Hawaii Leeward Radiation Oncology 'Ewa Beach, Hawaii, United States, 96706 Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 Queen's Cancer Institute at Queen's Medical Center Honolulu, Hawaii, United States, 96813 Hawaii Medical Center - East Honolulu, Hawaii, United States, 96817 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Kansas CCOP - Kansas City Prairie Village, Kansas, United States, 66208 United States, Kentucky Central Baptist Hospital Lexington, Kentucky, United States, 40503-9985 Louisville Oncology at Norton Cancer Institute - Louisville Louisville, Kentucky, United States, 40202 United States, Mississippi Regional Cancer Center at Singing River Hospital Pascagoula, Mississippi, United States, 39581 United States, Nevada Renown Institute for Cancer at Renown Regional Medical Center Reno, Nevada, United States, 89502 United States, New Hampshire Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756-0002 United States, New Jersey Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York Highland Hospital of Rochester Rochester, New York, United States, 14620 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Oregon Legacy Good Samaritan Hospital & Comprehensive Cancer Center Portland, Oregon, United States, 97210 Collapse <<
NCT00003465	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Collapse <<
NCT01026493	-	-	Completed	-	-
NCT00805961	Glioblastoma Multiforme	Phase 2	Completed	-	United States, Alabama ... more >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Virginia Cancer Institute Richmond, Virginia, United States, 23235 Collapse <<
NCT00626405	-	-	Completed	-	-
NCT01062399	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1 Phase 2	Active, not recruiting	-	-
NCT02780024	Glioblastoma Multiforme	Phase 2	Recruiting	December 2021	Canada, Quebec ... more >> Montreal Neurological Institute - McGill University Health Centre Recruiting Montréal, Quebec, Canada, H3A 2B4 Contact: Marianna Perna, CCRP,CCRC 514-934-1934 ext 43191 marianna.perna@muhc.mcgill.ca Contact: Tatiana Carvalho, CCRP 514-934-1934 ext 43698 tatiana.carvalho@muhc.mcgill.ca Sub-Investigator: Bassam Abdulkarim, M.D. Sub-Investigator: Marie-Christine Guiot, M.D. Sub-Investigator: Scott Owen, M.D. Sub-Investigator: Kevin Petrecca, M.D. Sub-Investigator: Valerie Panet-Raymond, M.D. Sub-Investigator: Luis Souhami, M.D. Collapse <<
NCT03190967	Breast Cancer ... more >> Brain Metastasis Brain Cancer Collapse <<	Phase 1 Phase 2	Recruiting	June 30, 2023	United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse <<
NCT00401180	Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse <<	Phase 1	Completed	-	United States, Ohio ... more >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Collapse <<
NCT01062399	-	-	Active, not recruiting	-	-
NCT02836028	Ovarian Cancer	Phase 2	Withdrawn	-	-
NCT00005954	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, North Carolina ... more >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00471653	-	-	Terminated(low accrual)	-	United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Collapse <<
NCT00394628	Glioblastoma Multiforme	Phase 1 Phase 2	Unknown	-	United States, California ... more >> University of California, Los Angeles Recruiting Los Angeles, California, United States Contact: Emese Filka 310-794-3521 Principal Investigator: Tim Clughsey, MD United States, Illinois Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Lilia Gallot 312-695-1363 Principal Investigator: Jeffrey Raizer, MD United States, Michigan Henry Ford Health Systems Recruiting Detroit, Michigan, United States, 48202 Contact: Ruth Ann Beasse 313-916-3731 rbeasse1@hfhs.org Principal Investigator: Tom Mikkelsen, MD United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Velmeca McCrea 919-684-5632 velmeca.mccrea@duke.edu Principal Investigator: David Reardon, MD United States, Texas Baylor Research Institute Recruiting Dallas, Texas, United States Contact: Stephanie Peschka, RN 214-820-8685 Principal Investigator: Karen Fink, MD Collapse <<
NCT01220271	Glioma	Phase 1 Phase 2	Completed	-	United States, California ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Jolla, California, United States, 92093 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States, 94143 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States, 33612 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60611 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46202 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durham, North Carolina, United States, 27710 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60596 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69120 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 Collapse <<
NCT00805961	-	-	Completed	-	-
NCT01452854	-	-	Terminated(Low recruitment, sp... more >>onsor withdrew funding.) Collapse <<	-	-
NCT00602576	Melanoma (Skin)	Phase 2	Unknown	-	United States, Pennsylvania ... more >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Collapse <<
NCT00238251	Lung Cancer M... more >>etastatic Cancer Collapse <<	Phase 2	Completed	-	Switzerland ... more >> Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Collapse <<
NCT03480867	Glioblastoma Multiforme, Adult	Phase 1	Recruiting	July 31, 2022	Canada, Québec, Canada ... more >> McGill University Health Centre-Cedars Cancer Centre Recruiting Montréal, Québec, Canada, Canada, H4A 3J1 Contact: Valerie Panet-Raymond, M.D. 514-934-4440 valerie.panet-raymond@mcgill.ca Contact: Marianna Perna, CCRP 514-934-1934 ext 43191 marianna.perna@muhc.mcgill.ca Sub-Investigator: Bassam Abdulkarim, M.D. Sub-Investigator: Kevin Petrecca, M.D. Sub-Investigator: Scott Owen, M.D. Sub-Investigator: Donatella Tampieri, M.D. Sub-Investigator: Marie-Christine Guiot, M.D. Collapse <<
NCT01729260	Newly Diagnosed High-Grade Gli... more >>oma Collapse <<	Phase 1	Active, not recruiting	September 2020	United States, Maryland ... more >> The Johs Hopkins Hospital Baltimore, Maryland, United States, 21287 Collapse <<
NCT01452854	-	-	Terminated(Low recruitment, sp... more >>onsor withdrew funding.) Collapse <<	-	United States, California ... more >> UCSF Center for Reproductive Health San Francisco, California, United States, 94115 Collapse <<
NCT00547131	Brain and Central Nervous Syst... more >>em Tumors Metastatic Cancer Collapse <<	Phase 1	Completed	-	United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Collapse <<
NCT00005054	Breast Cancer	Phase 2	Unknown	-	United Kingdom ... more >> Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Collapse <<
NCT00920595	Solid Tumor	Phase 1	Completed	-	France ... more >> Cephalon Investigational Site Nantes, France, 44805 United Kingdom Cephalon Investigational Site Newcastle upon Tyne, United Kingdom, NE7 7DN Collapse <<
NCT00098436	Leukemia	Phase 1	Completed	-	United States, Indiana ... more >> American Health Network - North Illinois Street Indianapolis, Indiana, United States, 46202 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Collapse <<
NCT03150810	Locally Advanced or Metastatic... more >> Solid Tumors Collapse <<	Phase 1 Phase 2	Recruiting	August 1, 2020	United States, Michigan ... more >> START Midwest Recruiting Grand Rapids, Michigan, United States, 49503 Contact: Kathy Estkowski, BS, CCRP Contact: Yvette C. Cole, RN, BSN, OCN Principal Investigator: Nehal Lakhani, MD, PhD United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Melissa Meredith, MD Principal Investigator: Haesong Park, MD United States, New York Mount Sinai - PRIME Recruiting New York, New York, United States, 10029 Principal Investigator: Matthew Galsky, MD Montefiore Medical Center PRIME Recruiting New York, New York, United States, 10461 Principal Investigator: Sanjay Goel, MD United States, Tennessee Sarah Cannon Research Institute (Tennessee Oncology) Recruiting Nashville, Tennessee, United States, 37203 Principal Investigator: Melissa Johnson, MD United States, Texas Mary Crowley Cancer Research Center Recruiting Dallas, Texas, United States, 75230 Contact: Angela Streck Contact: Jessica Bondurant Principal Investigator: John Nemunaitis, MD Collapse <<
NCT01478321	Adult Anaplastic Astrocytoma ... more >> Adult Anaplastic Ependymoma Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Collapse <<	Phase 2	Active, not recruiting	November 2020	United States, Illinois ... more >> Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Chicago, Illinois, United States, 60637 Northwestern Lake Forest Hospital Lake Forest, Illinois, United States, 60045 Edward Cancer Center Naperville, Illinois, United States, 60540 Central Dupage Hospital Warrenville, Illinois, United States, 60555 Collapse <<
NCT00305864	Adult Giant Cell Glioblastoma ... more >> Adult Glioblastoma Adult Gliosarcoma Collapse <<	Phase 1 Phase 2	Completed	-	-
NCT00034697	Metastases, Neoplasm ... more >> Carcinoma, Non-Small-Cell Lung Brain Neoplasms Collapse <<	Phase 2	Terminated(Slow Enrollment)	-	-
NCT01700569	Grade IV Astrocytoma ... more >> Glioblastoma Collapse <<	Phase 1	Unknown	March 2018	France ... more >> ICO site Gauducheau Recruiting Nantes, France, 44805 Contact: Mario Campone, MD, PhD +33240679900 mario.campone@ico.unicancer.fr Principal Investigator: Mario CAMPONE, MD, PhD Sub-Investigator: Jean S FRESNEL, MD Collapse <<
NCT00268684	Carcinoma, Non-Small-Cell Lung... more >> Neoplasm Metastasis Collapse <<	Phase 3	Unknown	-	Israel ... more >> Tel Aviv Sourasky Medical Center Recruiting Tel Aviv, Israel, 63409 Contact: Felix Bokstein, M.D. 972-524266532 fbok@netvision.net.il Contact: Debora Blumenthal, M.D. 972-524266403 dvorab@tasmc.gov.il Collapse <<
NCT00639262	Brain Metastases ... more >> Primary Brain Tumors Collapse <<	Phase 1	Completed	-	United States, Pennsylvania ... more >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Collapse <<
NCT00516607	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Unknown	-	United Kingdom ... more >> Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Collapse <<
NCT00305864	-	-	Completed	-	-
NCT03623347	-	-	Completed	-	-
NCT01345370	-	-	Completed	-	France ... more >> CHRU Hautepierre Strasbourg, Alsace, France, 67 CHU de Bordeaux Bordeaux, Aquitaine, France, 33000 CHU Cote de Nacre Caen, Basse Normandie, France, 14000 Center Eugene Marquis Rennes, Brittany, France, 35000 CHU La Salpetriere Paris, Ile de France, France, 75000 CHRU de Lille Lille, Nord Pas-de-Calais, France, 59000 CHU La Timone Marseille, Paca, France, 13000 CHU de Poitiers Poitiers, Poitou-Charentes, France, 86000 CHU de Grenoble Grenoble, Rhone-Alpes, France, 38000 CHU de Lyon Lyon, Rhone-Alpes, France, 69000 Collapse <<
NCT01260103	Optic Nerve Glioma	Phase 3	Withdrawn(Withdrawn study halt... more >>ed prematurely, prior to enrollment of first participant) Collapse <<	December 2018	-
NCT02943733	Neuroendocrine Tumors ... more >> Neoplasms Cancer Tumors Collapse <<	Phase 1	Recruiting	August 2020	United States, Wisconsin ... more >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53792 Contact: Cancer Connect 800-622-8922 cancerconnect@uwcarbone.wisc.edu Principal Investigator: Nataliya Uboha Collapse <<
NCT00504660	Anaplastic Glioma of Brain ... more >> Glioblastoma Multiforme Brain Cancer Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01467986	Neuroblastoma Recurrent	Phase 2	Recruiting	December 2019	Germany ... more >> University Hospital Regensburg, Department of Pediatric Hematology and Oncology Recruiting Regensburg, Germany, 93053 Contact: Selim Corbacioglu, MD +49(0)941 944-2101 selim.corbacioglu@ukr.de Principal Investigator: Selim Corbacioglu, MD Collapse <<
NCT00720356	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, California ... more >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Florida M.D. Anderson Cancer Center at Orlando Orlando, Florida, United States, 32806-2134 United States, Illinois Northwestern University, Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611-3013 Evanston Hospital Evanston, Illinois, United States, 60201-1781 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Neuro-Oncology Associates at Baylor University Medical Center, Dallas Dallas, Texas, United States, 75246 M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 The Methodist Hospital Neurological Institute Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 19024 Collapse <<
NCT00005815	Intraocular Melanoma ... more >> Melanoma (Skin) Collapse <<	Phase 1 Phase 2	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Collapse <<
NCT02799238	Glioblastoma	Phase 2	Recruiting	January 2022	Sweden ... more >> Sahlgrenska University Hospital Recruiting Göteborg, Sweden Contact: Katja Werlenius, Dr. Med Principal Investigator: Katja Werlenius Sub-Investigator: Marie Sjögren Ryhov hospital Recruiting Jönköping, Sweden, 55185 Contact: Mickael Stradeus, MD mickael.stradeus@rjl.se Skånes university hospital Recruiting Lund, Sweden, 221 85 Contact: Sara Kinhult, MD sara.kinhult@skane.se Karolinska University hospital Recruiting Stockholm, Sweden, 171 76 Contact: Giuseppe Stragliotto, MD giuseppe.stragliotto@karolinska.se Contact: Sofia Hylin, MD sofia.hylin@karolinska.se Collapse <<
NCT00504660	-	-	Completed	-	-
NCT00720356	-	-	Completed	-	-
NCT00222443	Lymphomas Tum... more >>ors Collapse <<	Phase 1	Completed	-	United States, Oklahoma ... more >> Oklahoma University Health Sciences Center-Jimmy Everest Center Oklahoma City, Oklahoma, United States, 73104 Collapse <<
NCT00121680	Metastatic Melanoma	Phase 1	Completed	-	United States, Texas ... more >> Dallas, Texas, United States Houston, Texas, United States Collapse <<
NCT02815410	Glioblastoma Multiforme	Phase 2	Not yet recruiting	June 2022	-
NCT00016055	Melanoma (Skin)	Phase 1	Unknown	-	United States, Wisconsin ... more >> Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 Collapse <<
NCT02227576	Thrombocytopenia ... more >> Glioblastoma Collapse <<	Phase 2	Terminated(Study halted for ef... more >>ficacy following the results of the interim analysis provided for in the protocol on 20 patients.) Collapse <<	-	France ... more >> CHRU de Lille, Hôpital Roger Salengro,Clinique de Neurochirurgie Lille, France, 59037 Cedex Hôpital Neurologique Pierre Wertheimer, Lyon, Lyon, France AP-HM,Hôpital La Timone, AP-HM, Marseille Marseille, France AH-HP, Hôpital Pitié-Salpêtrière, Service de Neurologie 2 Paris, France, 75013 Collapse <<
NCT03393000	Glioblastoma	Phase 3	Recruiting	June 23, 2022	United States, California ... more >> University of California Recruiting Irvine, California, United States, 92868 Contact: Ricardo Avalos 714-509-2495 ravalos2@uci.edu Contact: Mohamad Alsharif 714-509-2371 alsharim@uci.edu Principal Investigator: Daniela Bota, MD, PhD Scott Peak, M.D. Recruiting Redwood City, California, United States, 94063 Contact: Nancy Mendelssohn 650-299-4165 nancy.d.mendelssohn@kp.org John Wayne Cancer Institute @ Providence Saint John's Health Center Recruiting Santa Monica, California, United States, 90404 Contact: Naj Boucher 310 582 7460 Najee.Boucher@Providence.Org Principal Investigator: Santosh Kesari, MD, PhD, FANA, FAAN United States, Georgia Piedmont Cancer Recruiting Atlanta, Georgia, United States, 30318 Contact: Jane R Myrie 404-425-7927 jacene.myrie@piedmont.org Principal Investigator: Erin Dunbar, MD John B. Amos Cancer Center Recruiting Columbus, Georgia, United States, 31904 Contact: Felicia Irvin 706-478-7968 firvin@iacthealth.com Contact: Katrina Quidley 706-321-0495 Principal Investigator: Douglas Ciuba, M.D. United States, Minnesota Abbott Northwestern Hospital Recruiting Minneapolis, Minnesota, United States, 55407 Contact: Amy Ellenberger, CCRC 612-863-6562 Contact: Emily Shoemaker, MPH 612-863-0324 Principal Investigator: John Trusheim, M.D. United States, New Jersey John Theurer Cancer Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Lori Cappello, RN, BSN, CCRP 551-996-5098 lori.cappello@hackensackmeridian.org Principal Investigator: Samuel A Goldlust, MD United States, New Mexico UNM Comprehensive Cancer Center Recruiting Albuquerque, New Mexico, United States, 87102 Contact: Melissa Gibson 505-272-5237 mngibson@salud.unm.edu Contact: Sariat Ibrahim 505-272-7412 SIbrahim@salud.unm.edu Principal Investigator: Ben Liem, MD United States, New York North Shore University Hospital Recruiting Manhasset, New York, United States, 11030 Contact: Louise A Purcell, NP 516-941-1260 LPurcell@Northwell.edu Principal Investigator: Michael Schulder, MD Mount Sinai Hospital Recruiting New York, New York, United States, 10029 Contact: Angela Stangarone 212-241-9843 Angela.stangarone@mssm.edu Principal Investigator: Adilia Hormingo, MD, PhD United States, Oregon Providence Portland Medical Center Recruiting Portland, Oregon, United States, 97213 Contact: Larisa Lindgren 503-215-2614 Principal Investigator: Herschel D Wallen, M.D. United States, South Carolina Scott Lindhorst, M.D. Recruiting Charleston, South Carolina, United States, 29425 Contact: John "Bo" Keller 843-792-2209 kellej@musc.edu Contact: Michele DeCandio 843-792-9016 decandio@musc.edu United States, Texas Neuro Oncology Associates Recruiting Dallas, Texas, United States, 75246 Contact: Oghenevovwero Sido 214-820-6168 Oghenevovwero.sido@BSWhealth.org Contact: Carolyn Nwankwo 214-865-4978 carolyn.nwankwo@BSWhealth.org Principal Investigator: Karen Fink, MD, PhD Collapse <<
NCT02065466	Metastatic Melanoma ... more >> Brain Metastases Collapse <<	Phase 1 Phase 2	Withdrawn(lack of accrual)	-	United States, Arizona ... more >> Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 University of Arizona Cancer Center Tucson, Arizona, United States, 85742 Collapse <<
NCT02203526	Primary Central Nervious Syste... more >>m Lymphoma Collapse <<	Phase 1	Recruiting	June 15, 2023	United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse <<
NCT01044225	Glioblastoma	Phase 2	Terminated(Results of the phas... more >>e III RTOG0525 trial made the manufacturer of cilengitide decide to end their support to the trial) Collapse <<	-	Belgium ... more >> Onze-Lieve-Vrouwziekenhuis Aalst, Belgium, 9300 ZNA Middelheim Antwerpen, Belgium, 2020 GHdC Charleroi Charleroi, Belgium, 6000 ZOL Campus Sint-Jan Genk, Belgium, 3600 UZ Gent Gent, Belgium, 9000 UCL de Mont-Godinne Yvoir, Belgium, 5530 Collapse <<
NCT02681705	Medulloblastoma	Phase 2	Unknown	December 2016	China, Shanghai ... more >> The Department of Radiation Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200092 Contact: Chuanying zhu, MD 862125076994 sdnanhai123@163.com Principal Investigator: Mawei Jiang, MD Collapse <<
NCT00944801	Glioblastoma	Phase 1 Phase 2	Completed	-	Germany ... more >> University of Regensburg, Department of Neurology Regensburg, Germany, 93053 Collapse <<
NCT03396575	Diffuse Intrinsic Pontine Glio... more >>ma (DIPG) Collapse <<	Phase 1	Recruiting	June 2022	United States, Florida ... more >> UF Health Shands Children's Hospital Recruiting Gainesville, Florida, United States, 32610 Contact: Marcia Hodik, RN 352-273-6971 marcia.hodik@neurosurgery.ufl.edu Principal Investigator: Sridharan Gururangan, FRCP University of Florida Not yet recruiting Gainesville, Florida, United States, 32610 Collapse <<
NCT01702610	Glioblastoma Mutliforme	Not Applicable	Completed	-	Canada, Quebec ... more >> McGill University Health Center Montreal, Quebec, Canada, H3G 1A4 Collapse <<
NCT00311857	Glioblastoma Multiforme	Phase 1 Phase 2	Unknown	-	Germany ... more >> University of Heidelberg Recruiting Heidelberg, Baden-Württemberg, Germany, 69120 Contact: Daniela Schulz-Ertner, MD +49-6221-56 ext 8201 Daniela.Ertner@med.uni-heidelberg.de Contact: Stephanie E Combs, MD +49-6221-56 ext 8201 Stephanie.Combs@med.uni-heidelberg.de Principal Investigator: Daniela Schulz-Ertner, MD Sub-Investigator: Stephanie E Combs, MD Collapse <<
NCT01605162	Wild Type BRAF Stage IV Melano... more >>ma Unresectable Stage III Melanoma Collapse <<	Phase 2	Terminated	-	United States, Pennsylvania ... more >> Pittsburgh, Pennsylvania, United States Collapse <<
NCT02970448	High Grade Glioma	Early Phase 1	Recruiting	January 2020	United States, Ohio ... more >> Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Jennifer Yu, MD, PhD 216-445-9799 yuj2@ccf.org Collapse <<
NCT00080054	Glioma Gliobl... more >>astoma Astrocytoma Oligodendroglioma Brain Neoplasm Collapse <<	Phase 1	Completed	-	United States, Arizona ... more >> Barrow Neurological Institute Phoenix, Arizona, United States, 85013 Collapse <<
NCT01310868	Glioblastoma	Phase 2	Completed	-	United Kingdom ... more >> Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Royal Preston Hospital Preston, Lancashire, United Kingdom Ninewells Hospital Dundee, United Kingdom Southern General Hospital Glasgow, United Kingdom Hull Royal Infirmary Hull, United Kingdom Leeds General Infirmary Leeds, United Kingdom The Walton Centre Liverpool, United Kingdom King's College Hospital London, United Kingdom University College London Hospital/ National Hospital for Neurology and Neurosurgery London, United Kingdom Royal Hallamshire Hospital Sheffield, United Kingdom Collapse <<
NCT00626483	Malignant Neoplasms Brain	Phase 1	Active, not recruiting	June 2019	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT01310868	-	-	Completed	-	-
NCT02520635	Glioblastoma	Phase 4	Unknown	December 2017	China, Beijing ... more >> Beijing Tiantan Hospital Recruiting Beijing, Beijing, China, 100005 Collapse <<
NCT00267592	Glioblastoma Multiforme	Phase 2	Completed	-	-
NCT00369590	Adult Anaplastic Astrocytoma ... more >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor Collapse <<	Phase 2	Completed	-	United States, California ... more >> University of California Los Angeles Los Angeles, California, United States, 90095 University of California San Francisco San Francisco, California, United States, 94115 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Collapse <<
NCT00369590	-	-	Completed	-	-
NCT01465347	-	-	Completed	-	-
NCT00154375	Glioblastoma Multiforme ... more >> Astrocytoma Collapse <<	Phase 3	Completed	-	Germany ... more >> Novartis Investigative Site Duelmen, Germany Collapse <<
NCT02976441	Astrocytoma B... more >>rainstem Glioma Ependymoma Mixed Glioma Oligodendroglioma Optic Nerve Glioma Collapse <<	Early Phase 1	Withdrawn(Physician decided no... more >>t to go through with study) Collapse <<	February 2018	-
NCT01465347	Glioblastoma ... more >>GBM Glioma Collapse <<	Phase 1 Phase 2	Completed	-	United States, Arizona ... more >> St. Joseph's Medical Center Barrow Neurology Clinics Phoenix, Arizona, United States, 85013 United States, Arkansas University of Arkansas Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States, 72205 United States, California USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, District of Columbia The George Washington University Medical Center Washington, D.C., District of Columbia, United States, 20037 United States, Florida University of Florida McKnight Brain Institute Gainesville, Florida, United States, 32611 United States, Georgia Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Kentucky University of Kentucky Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, New York North Shore University Hospital Manhasset, New York, United States, 11030 United States, North Carolina Forsyth Regional Cancer Center Winston-Salem, North Carolina, United States, 27103 United States, Pennsylvania Penn State University Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 University of Texas Health Science Center Memorial Hermann Medical Center Houston, Texas, United States, 77030 United States, Virginia UVA Health Sciences Center Emily Couric Clinical Cancer Center Charlottesville, Virginia, United States, 22908 United States, Wisconsin Froedtert & Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Collapse <<
NCT00667953	Melanoma Adva... more >>nced Melanoma Collapse <<	Phase 1 Phase 2	Completed	-	United States, Pennsylvania ... more >> Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT00473408	-	-	Terminated(Moved to another co... more >>untry, not possible to recruit from abroad.) Collapse <<	-	Norway ... more >> Dept. of Oncology & Dept. of Radiology, Haukeland University Hospital Bergen, Norway, Hordaland, Norway, 5021 Collapse <<
NCT00687765	Glioblastoma	Phase 1 Phase 2	Completed	-	United States, Alabama ... more >> Research Site Birmingham, Alabama, United States, 35294 United States, Florida Research Site Tampa, Florida, United States, 33612 United States, Georgia Research Site Atlanta, Georgia, United States, 30322 United States, Maryland Research Site Baltimore, Maryland, United States United States, Massachusetts Research Site Boston, Massachusetts, United States, 92114 United States, Michigan Research Site Detroit, Michigan, United States, 48202 United States, North Carolina Research Site Winston Salem, North Carolina, United States, 27157 United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT00154375	-	-	Completed	-	-
NCT01528046	Solid Tumors ... more >>Primary Brain Tumors Collapse <<	Phase 1	Recruiting	December 2020	United States, Connecticut ... more >> Connecticut Children's Medical Center Recruiting Hartford, Connecticut, United States, 06106 Contact: Robin Arens 860-545-9637 Rarens@ccmckids.org Principal Investigator: Michael Isakoff, M.D. Sub-Investigator: Donna Boruchov, M.D. Sub-Investigator: Kerry Moss, M.D. Sub-Investigator: Andrea Orsey, M.D. Sub-Investigator: Nehal Parikh, M.D. Sub-Investigator: Arnold Altman, M.D. United States, Delaware Nemours/Alfred I. duPont Hospital for Children, Delaware Recruiting Wilmington, Delaware, United States, 19803 Contact: Debra J. Bertz 302-651-5757 debra.bertz@nemours.org Principal Investigator: Edward A. Kolb, M.D. Sub-Investigator: Andrew Walter, M.D. Sub-Investigator: Jonathan Powell, M.D. Sub-Investigator: Emi Caywood, M.D. Sub-Investigator: Robin Miller, M.D. Sub-Investigator: Gregory Griffin, M.D. United States, Florida University of Florida Terminated Gainesville, Florida, United States, 32611 Nemours Children's Clinic Recruiting Jacksonville, Florida, United States, 32207 Contact: Ingrid Ingram 904-697-3985 iingram@nemours.org Principal Investigator: Scott Bradfield, M.D. Sub-Investigator: Eric Sandler, M.D. Sub-Investigator: Michael Joyce, M.D. Sub-Investigator: Cynthia Gauger, M.D. Sub-Investigator: Manisha Bansal, M.D. Sub-Investigator: Paul Pitel, M.D. Holtz Children's Hospital at the University of Miami Recruiting Miami, Florida, United States, 33124 Contact: Myriam Zayas 305-243-7846 MZayas2@med.miami.edu Principal Investigator: John Goldberg, M.D. Sub-Investigator: Cristina Fernandes, M.D. Sub-Investigator: Joanna Davis, M.D. Sub-Investigator: Antonello Podda, M.D. Sub-Investigator: Martin Andreansky, M.D. Sub-Investigator: Julio Barredo, M.D. Sub-Investigator: Ofelia Alvarez, M.D. Johns Hopkins All Children's Hospital Recruiting Saint Petersburg, Florida, United States, 33701 Contact: Ashley Repp, RN 727-767-4784 Ashley.Repp@allkids.org Contact: Frances Hamblin 727-767-2423 frances.hamblin@allkids.org Principal Investigator: Damon Reed, M.D. Sub-Investigator: Irmel Ayala, M.D. Sub-Investigator: Gregory Hale, M.D. Sub-Investigator: Nanette Grana, M.D. Sub-Investigator: Stacie Stapleton, M.D. Sub-Investigator: Kelly Sawczyn, M.D. Sub-Investigator: Jennifer Mayer, M.D. Sub-Investigator: Jody Kerr, M.D. Tampa General Hospital Recruiting Tampa, Florida, United States, 33606 Contact: Denise Fife 813-844-7829 dafife@tgh.org Principal Investigator: Cameron Tebbi, M.D. H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Tiffany Smith 813-745-6250 tiffany.smith@moffitt.org Principal Investigator: Damon Reed, M.D. United States, Kentucky University of Kentucky Recruiting Lexington, Kentucky, United States, 40536 Contact: Tammy Taylor 859-323-6975 tammy.taylor@uky.edu Principal Investigator: Lars Wagner, M.D. United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: David Loeb, M.D. 410-502-7247 loebda@jhmi.edu Principal Investigator: David Loeb, M.D. United States, New York The Children's Hospital at Montefiore Recruiting Bronx, New York, United States, 10467 Contact: Noam Zeffren 718-741-2356 nzeffren@montefiore.org Principal Investigator: Jonathan Gill, M.D. United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Sharon Guerry 919-966-1178 Contact: Patrick Thompson, M.D 919-966-1178 patom@email.unc.edu Principal Investigator: Patrick Thompson, M.D. United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Amy Yekisa 614-722-6570 Amy.Yekisa@nationwidechildrens.org Principal Investigator: Bhuvana Setty, M.D. United States, Utah Primary Children's Medical Center/Utah Recruiting Salt Lake City, Utah, United States, 84113 Contact: Melissa Bolton 801-213-3909 melissa.bolton@hsc.utah.edu Principal Investigator: Holly Spraker-Perlman, M.D. Sub-Investigator: Richard Lemons, M.D., Ph.D. Sub-Investigator: Jennifer Wright, M.D. Collapse <<
NCT00004068	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, Tennessee ... more >> Saint Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-2794 Collapse <<
NCT00390403	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, Alabama ... more >> Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Collapse <<
NCT01022918	Naive Unresectable Glioblastom... more >>a Collapse <<	Phase 2	Completed	-	France ... more >> Centre Georges François Leclerc Dijon, Bourgogne, France, 21000 Collapse <<
NCT00974987	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	Japan ... more >> Osaka Medical College Takatsuki, Osaka, Japan, 569-8686 Collapse <<
NCT01866449	Glioblastoma Multiforme (GBM) ... more >>WHO Grade IV Collapse <<	Phase 2	Completed	-	Germany ... more >> Hämatologisch onkologische Praxis Augsburg, Germany, 86150 Stiftungsklinikum Mittelrhein GmbH Koblenz, Germany, 56068 Lars Bullinger, MD Ulm, Germany, 89081 Collapse <<
NCT01020292	Glioma	Phase 1	Active, not recruiting	-	United States, Pennsylvania ... more >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Collapse <<
NCT03763422	Low-grade Glioma ... more >> Temozolomide Phase III Wait or Treat Collapse <<	Phase 3	Not yet recruiting	October 2031	-
NCT00052455	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 3	Completed	-	United Kingdom ... more >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Collapse <<
NCT00734864	Glioblastoma Multiforme ... more >> Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligodendroglioma Glioma Collapse <<	Phase 1	Withdrawn(Study drug supplier ... more >>withdrew support for the study. Study was withdrawn from the Duke IRB.) Collapse <<	June 2012	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00068250	Brain and Central Nervous Syst... more >>em Tumors Lymphoma Collapse <<	Phase 1 Phase 2	Completed	-	United States, Florida ... more >> Integrated Community Oncology Network Jacksonville Beach, Florida, United States, 32250 Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States, 32207 Integrated Community Oncology Network at Southside Cancer Center Jacksonville, Florida, United States, 32207 Baptist Medical Center South Jacksonville, Florida, United States, 32258 Integrated Community Oncology Network - Orange Park Orange Park, Florida, United States, 32073 Florida Cancer Center - Palatka Palatka, Florida, United States, 32177 Flagler Cancer Center Saint Augustine, Florida, United States, 32086 United States, Michigan Borgess Medical Center Kalamazoo, Michigan, United States, 49001 West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007-3731 Bronson Methodist Hospital Kalamazoo, Michigan, United States, 49007 United States, Missouri CCOP - Kansas City Kansas City, Missouri, United States, 64131 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, Nevada CCOP - Nevada Cancer Research Foundation Las Vegas, Nevada, United States, 89106 United States, New Jersey John F. Kennedy Medical Center Edison, New Jersey, United States, 08818 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Oregon Providence Milwaukie Hospital Milwaukie, Oregon, United States, 97222 Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States, 97213-2967 CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 Providence St. Vincent Medical Center Portland, Oregon, United States, 97225 United States, Pennsylvania Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States, 19107-5541 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Utah Jon and Karen Huntsman Cancer Center at Intermountain Medical Center Murray, Utah, United States, 84157 Utah Valley Regional Medical Center - Provo Provo, Utah, United States, 84604 United States, Washington Southwest Washington Medical Center Cancer Center Vancouver, Washington, United States, 98668 United States, Wisconsin Community Memorial Hospital Cancer Care Center Menomonee Falls, Wisconsin, United States, 53051 Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Collapse <<
NCT00409383	Melanoma	Phase 1	Unknown	June 2013	United States, New York ... more >> New York University Cancer Center New York, New York, United States, 10016 Collapse <<
NCT01777919	Glioblastoma Multiforme	Phase 2	Not yet recruiting	January 2020	Greece ... more >> Olympion Medical Center Not yet recruiting Patras, Greece, 26443 Contact: Petros N Karamanakos, MD, PhD Principal Investigator: Petros N Karamanakos, MD, PhD Collapse <<
NCT00884416	Glioblastoma ... more >>Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligoastrocytoma Anaplastic Oligodendroglioma Collapse <<	Phase 1	Completed	-	Switzerland ... more >> Geneva University Hospital (Hopitaux Universitaires de Geneve), Department of Oncology Geneva, GE, Switzerland, 1211 Collapse <<
NCT00936052	Glioblastomas ... more >> Gliosarcoma Collapse <<	Phase 2	Unknown	December 2010	United States, New York ... more >> Long Island Brain Tumor Center at Neurological surgery P.C. Recruiting Commack, New York, United States, 11725 Contact: Julia Trojanowski, RN 631-864-3900 ext 18 neurooncologyli2@gmail.com Contact: Kerry E McConie, RN 516-478-0010 ext 14 neurooncologyli@gmail.com Principal Investigator: J Paul Duic, MD Principal Investigator: Jai Grewal, MD Long Island Brain Tumor Center at Neurological Surgery P.C. Recruiting Great Neck, New York, United States, 11021 Contact: Kerry E McConie, RN 516-478-0010 ext 14 neurooncologyli@gmail.com Contact: Julia Trojanowski, RN 631-864-3900 ext 18 neurooncologyli2@gmail.com Principal Investigator: J Paul Duic, MD Principal Investigator: Jai Grewal, MD Collapse <<
NCT03687034	Glioblastoma	Phase 1	Not yet recruiting	December 31, 2019	-
NCT02046187	Glioblastoma (GBM)	Phase 1 Phase 2	Terminated(excessive protocol ... more >>deviations due to strict nature of diet requirements) Collapse <<	-	United States, Arizona ... more >> Barrow Neurological Institute at St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States, 85013 Collapse <<
NCT01342757	-	-	Completed	-	-
NCT01342757	Adult Glioblastoma ... more >> Depression Recurrent Adult Brain Tumor Collapse <<	Not Applicable	Completed	-	United States, Georgia ... more >> Emory University Atlanta, Georgia, United States, 30322 Collapse <<
NCT00068250	-	-	Completed	-	-
NCT00943462	-	-	Withdrawn(No eligible patients... more >> could be recruited.) Collapse <<	June 2011	-
NCT00360945	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Unknown	-	France ... more >> Institut Gustave Roussy Villejuif, France, F-94805 Ireland Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Middlesex Hospital London, England, United Kingdom, W1T 3AA Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton University Hospital NHS Trust Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Collapse <<
NCT00486603	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1 Phase 2	Unknown	-	United States, Alabama ... more >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Collapse <<
NCT02092038	Glioblastoma	Phase 1	Completed	-	United States, Florida ... more >> Tampa General Hospital Tampa, Florida, United States, 33606 Collapse <<
NCT00673361	Melanoma	Phase 2	Terminated	-	-
NCT01402063	Glioblastoma Multiforme	Phase 2	Completed	-	United States, California ... more >> UCSD Cancer Center La Jolla, California, United States, 92093 United States, Maine Maine Medical Center Scarborough, Maine, United States, 04074 United States, Massachusetts UMASS Medical Center Cancer Center Worcester, Massachusetts, United States, 01605 United States, New York SUNY Medical Center Syracuse, New York, United States, 13210 United States, Pennsylvania PSU Hershey, Pennsylvania, United States, 17033 Thomas Jefferson University Cancer Center Philadelphia, Pennsylvania, United States, 19107 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02906 United States, Texas UT Southwestern Cancer Center Dallas, Texas, United States, 75235 United States, Washington University of Washington Seattle, Washington, United States, 98109 Collapse <<
NCT00626990	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 3	Active, not recruiting	January 2024	-
NCT01402063	-	-	Completed	-	-
NCT00714181	Unspecified Adult Solid Tumor,... more >> Protocol Specific Collapse <<	Phase 1	Completed	-	United States, Pennsylvania ... more >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Collapse <<
NCT00006474	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, North Carolina ... more >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00492687	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Unknown	-	United States, California ... more >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD 760-452-3340 emcclay@pacificoncology.com Collapse <<
NCT00402116	Glioblastoma ... more >>Glioblastoma Multiforme Gliosarcoma Collapse <<	Phase 1 Phase 2	Completed	-	United States, California ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician San Francisco, California, United States Collapse <<
NCT00770471	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, Alabama ... more >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, California UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Collapse <<
NCT00673361	-	-	Terminated	-	-
NCT01247623	Malignant Melanoma	Phase 1 Phase 2	Completed	-	Norway ... more >> Oslo University Hospital Oslo, Postbox 4953, Norway, 0424 Collapse <<
NCT00811759	Melanoma (Skin)	Phase 1 Phase 2	Unknown	-	France ... more >> Institut Gustave Roussy Villejuif, France, F-94805 Collapse <<
NCT03709680	Solid Tumors ... more >>Ewing Sarcoma Rhabdoid Tumor Rhabdomyosarcoma Neuroblastoma Medulloblastoma Collapse <<	Phase 1	Not yet recruiting	September 27, 2023	-
NCT03519412	Colorectal Neoplasms ... more >> Microsatellite Instability Collapse <<	Phase 2	Not yet recruiting	June 2022	Italy ... more >> Grande Ospedale Metropolitano Niguarda Not yet recruiting Milano, Italy Contact: Andrea Sartore Bianchi, MD Istituto Nazionale Tumori di Milano Not yet recruiting Milano, Italy Contact: Filippo Pietrantonio, MD Istituto oncologico Veneto Not yet recruiting Padova, Italy Contact: Sara Lonardi, MD Collapse <<
NCT02331498	Glioblastoma Multiforme	Phase 1 Phase 2	Recruiting	December 2018	France ... more >> Centre Antoine Lacassagne Recruiting Nice, Cedex 2, France, 06189 Contact: Esma SAADA BOUZID, Md +33492031618 esma.saada-bouzid@nice.unicancer.fr Contact: Christine LOVERA +33492031618 christine.lovera@nice.unicancer.fr Principal Investigator: Esma SAADA BOUZID, Dr Sub-Investigator: Jérôme BARRIERE, Pr. Sub-Investigator: Pierre Yves BONDIAU, Dr. Collapse <<
NCT00068952	Glioblastoma	Phase 3	Completed	-	-
NCT00047294	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	United States, Massachusetts ... more >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Virginia Cancer Center at the University of Virginia Charlottesville, Virginia, United States, 22908 Collapse <<
NCT00099125	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	-
NCT00720564	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, California ... more >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Collapse <<
NCT02942264	Brain Tumor A... more >>strocytoma Astroglioma Glioblastoma Gliosarcoma Collapse <<	Phase 1 Phase 2	Recruiting	August 2, 2022	United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse <<
NCT03150862	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1 Phase 2	Recruiting	October 31, 2021	-
NCT03705351	Glioblastoma ... more >>Cancer of Brain Glioblastoma Multiforme Brain Tumor Collapse <<	Phase 1	Not yet recruiting	December 1, 2024	United States, Oregon ... more >> Providence St. Vincent Medical Center Not yet recruiting Portland, Oregon, United States, 97225 Contact: Tiffany Gervasi-Follmar 503-216-1023 tiffany.gervasi@providence.org Collapse <<
NCT01164189	Central Nervous System Tumors	Phase 2	Unknown	-	-
NCT00005952	Brain and Central Nervous Syst... more >>em Tumors Childhood Germ Cell Tumor Head and Neck Cancer Kidney Cancer Neuroblastoma Ovarian Cancer Sarcoma Testicular Germ Cell Tumor Collapse <<	Phase 1 Phase 2	Completed	-	United States, North Carolina ... more >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00020839	Melanoma (Skin) ... more >> Metastatic Cancer Collapse <<	Phase 3	Terminated(low accrual)	-	-
NCT00568451	-	-	Terminated(Slow accrual.)	-	-
NCT02880410	Glioblastoma	Phase 1	Active, not recruiting	December 2020	United States, Missouri ... more >> Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00568451	Melanoma (Skin)	Phase 2	Terminated(Slow accrual.)	-	United States, Minnesota ... more >> Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Collapse <<
NCT00005951	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, North Carolina ... more >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00006263	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Withdrawn	-	United States, New York ... more >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Collapse <<
NCT00093353	Diarrhea Drug... more >>/Agent Toxicity by Tissue/Organ Neuroblastoma Collapse <<	Phase 1	Completed	-	United States, California ... more >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States, 30322 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0718 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston, Texas, United States, 77030-2399 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Collapse <<
NCT03243461	Glioblastoma WHO Grade IV ... more >> Diffuse Midline Glioma Histone 3 K27M WHO Grade IV Anaplastic Astrocytoma WHO Grade III Diffuse Intrinsic Pontine Glioma Gliomatosis Cerebri Collapse <<	Phase 3	Recruiting	June 1, 2023	Germany ... more >> Klinikum Augsburg Recruiting Augsburg, Germany Contact: Michael Frühwald, Prof. Evangelisches Krankenhaus Bielefeld Recruiting Bielefeld, Germany Contact: Norbert Jorch, Dr. Universitätsklinikum Bonn Recruiting Bonn, Germany Contact: Carola Weber, Dr. Klinikum Bremen-Mitte gGmbH Recruiting Bremen, Germany Contact: Arnulf Pekrun, Prof. Klinikum Chemnitz gGmbH Recruiting Chemnitz, Germany Contact: André Hofmann, Dr. Carl-Thiem-Klinikum Cottbus gGmbH Recruiting Cottbus, Germany Contact: Georg Schwabe, PD Dr. Sana Kliniken Duisburg GmbH - Wedau Kliniken Recruiting Duisburg, Germany Contact: Tanja Höll, Dr. Universitätsklinikum Erlangen Recruiting Erlangen, Germany Contact: Markus Metzler, Prof. Universitätsklinikum Freiburg Recruiting Freiburg, Germany Contact: Charlotte Niemeyer, Prof. Universitätsmedizin Greifswald Recruiting Greifswald, Germany Contact: Holger Lode, Prof. Universitätsmedizin Göttingen Recruiting Göttingen, Germany Contact: Christof Kramm, Prof. Universitätsklinikum Halle Recruiting Halle, Germany Contact: Toralf Bernig, Dr. Universitätsklinikum des Saarlandes Recruiting Homburg, Germany Contact: Norbert Graf, Prof. Gesundheit Nordhessen - Klinikum Kassel Recruiting Kassel, Germany Contact: Michaela Nathrath, Prof. Universitätsklinikum Leipzig Recruiting Leipzig, Germany Contact: Holger Christiansen, Prof. UMM Universitätsmedizin Mannheim Recruiting Mannheim, Germany Contact: Matthias Dürken, PD Dr. Johannes Wesling Klinikum Minden Recruiting Minden, Germany Contact: Bernhard Erdlenbruch, Prof. Universitätsklinikum Münster Recruiting Münster, Germany Contact: Ronald Sträter, PD Dr. Klinikum Oldenburg gGmbH Recruiting Oldenburg, Germany Contact: Hermann Müller, Prof. Universitätsklinikum Regensburg Recruiting Regensburg, Germany Contact: Marcus Jakob, Dr. ASKLEPIOS Klinik St. Augustin Recruiting Sankt Augustin, Germany Contact: Harald Reinhard, PD Dr. Klinikum Stuttgart - Olgahospital Recruiting Stuttgart, Germany Contact: Stefan Bielack, Prof. Universitätsklinikum Tübingen Recruiting Tübingen, Germany Contact: Martin Ebinger, PD Dr. Collapse <<
NCT03332355	Glioblastoma Multiforme ... more >> Anaplastic Astrocytoma Collapse <<	Phase 1	Recruiting	June 30, 2019	United States, Illinois ... more >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Oana C Danciu, M.D. United States, Maryland Johns Hopkins Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Matthias Holdhoff, M.D. United States, Minnesota Regions Hospital Recruiting Saint Paul, Minnesota, United States, 55101 Contact: Richard Peterson, MD 651-254-3572 Richard.A.Peterson@HealthPartners.Com Principal Investigator: Richard Peterson, MD Sub-Investigator: Daniel Anderson, MD Sub-Investigator: Kurt Demel, MD Sub-Investigator: Randolph Hurley, MD Sub-Investigator: Balkrishna Jahagirdar, MD Sub-Investigator: Pryia Kumar, MD Sub-Investigator: Steven McCormack, MD Sub-Investigator: Gary Shapiro, MD Sub-Investigator: Peter Hurley, MD Sub-Investigator: Stephanie Kroon, PA-C Sub-Investigator: Angela Martizna, RN Sub-Investigator: Joanna Hill Collapse <<
NCT00303940	Brain and Central Nervous Syst... more >>em Tumors Childhood Germ Cell Tumor Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Collapse <<	Phase 1	Completed	-	United States, Maryland ... more >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Collapse <<
NCT00715793	Malignant Melanoma	Phase 1 Phase 2	Completed	-	United States, Pennsylvania ... more >> UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 Collapse <<
NCT00514397	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Unknown	-	Ireland ... more >> Our Lady's Hospital for Sick Children Crumlin Recruiting Dublin, Ireland, 12 Contact: Contact Person 44-353-1-409-6659 United Kingdom Birmingham Children's Hospital Recruiting Birmingham, England, United Kingdom, B4 6NH Contact: Martin W. English, MD 44-121-333-8412 martin.english@bch.nhs.uk Bristol Royal Hospital for Children Recruiting Bristol, England, United Kingdom, BS2 8AE Contact: Contact Person 44-117-342-0205 Addenbrooke's Hospital Recruiting Cambridge, England, United Kingdom, CB2 2QQ Contact: Amos Burke, MD 44-1223-348-151 Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Adam Glaser, MD 44-113-206-4984 adam.glaser@leedsth.nhs.uk Leicester Royal Infirmary Recruiting Leicester, England, United Kingdom, LE1 5WW Contact: Johann Visser, MD 44-116-258-5309 johannes.visser@uhl-tr.nhs.uk Royal Liverpool Children's Hospital, Alder Hey Recruiting Liverpool, England, United Kingdom, L12 2AP Contact: Contact Person 44-151-252-5294 University College Hospital Recruiting London, England, United Kingdom, NW1 2BU Contact: Contact Person 44-20-7380-9950 Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Contact Person 44-20-7829-7924 Royal Manchester Children's Hospital Recruiting Manchester, England, United Kingdom, M27 4HA Contact: Bernadette Brennan, MD 44-161-922-2227 bernadette.brennan@cmmc.nhs.uk Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Contact Person 44-113-206-4985 Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Contact Person 44-115-823-0620 Oxford Radcliffe Hospital Recruiting Oxford, England, United Kingdom, 0X3 9DU Contact: Contact Person 44-1865-234-205 Children's Hospital - Sheffield Recruiting Sheffield, England, United Kingdom, S10 2TH Contact: Contact Person 44-114-271-7366 Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person 44-2380-794-101 Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Contact Person 44-20-8661-3455 Royal Belfast Hospital for Sick Children Recruiting Belfast, Northern Ireland, United Kingdom, BT12 6BE Contact: Anthony McCarthy, MD 44-289-063-3631 anthonymcarthy@royalhospital.n.i.nhs.uk Royal Aberdeen Children's Hospital Recruiting Aberdeen, Scotland, United Kingdom, AB25 2ZG Contact: Veronica Neefjes 44-1224-550-217 Royal Hospital for Sick Children Recruiting Edinburgh, Scotland, United Kingdom, EH9 1LF Contact: W. Hamish Wallace, MD 44-131-536-0426 Royal Hospital for Sick Children Recruiting Glasgow, Scotland, United Kingdom, G3 8SJ Contact: Milind D. Ronghe, MD 44-141-201-9309 Childrens Hospital for Wales Recruiting Cardiff, Wales, United Kingdom, CF14 4XW Contact: Heidi Traunecker, MD, PhD 44-29-2074-2285 heidi.traunecker@cardiffandvale.wales.nhs.uk Collapse <<
NCT00089427	Glioblastoma Multiforme ... more >> Anaplastic Astrocytoma Oligoastrocytoma Collapse <<	Phase 1	Completed	-	United States, California ... more >> University of California San Francisco - Dept. of Neurological Surgery San Francisco, California, United States, 94143 United States, North Carolina Carolina Neurosurgery & Spine Assoc. Charlotte, North Carolina, United States, 28204 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Foundation Department of Neurological Surgery Cleveland, Ohio, United States, 44195 United States, Texas University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health Systems - Department of Neurological Surgery Charlottesville, Virginia, United States, 22908 Collapse <<
NCT00387400	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	Canada, Alberta ... more >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Collapse <<
NCT01587144	Glioblastoma Multiforme	Phase 2	Terminated(Sponsor's decision)	-	United States, California ... more >> UCSD Moores Cancer Center La Jolla, California, United States, 92093 UCI Medical Center Orange, California, United States, 92868 United States, New York Dent Neurologic Institute Amherst, New York, United States, 14226 United States, Ohio Fairview Hospital Moll Cancer Center/Cleveland Clinic Cleveland, Ohio, United States, 44111 Cleveland Clinic Cleveland, Ohio, United States, 44195 Hillcrest Hospital Hirsh Cancer Center/Cleveland Clinic Mayfield, Ohio, United States, 44124 India Gujarat Cancer Research Institute Ahmedabad, Gujarat, India, 380016 Jaslok Hospital & Research Centre Mumbai, Maharashtra, India, 400062 Bhagwan Mahaveer Cancer Hospital & Reseach Centre Jaipur, Rajasthan, India, 302017 Chittaranjan National Cancer Institute Kolkata, West Bengal, India, 700026 Collapse <<
NCT00715793	-	-	Completed	-	-
NCT00238277	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Terminated(Terminated - due to... more >> low accrual) Collapse <<	-	United States, Maryland ... more >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Collapse <<
NCT00128700	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1 Phase 2	Completed	-	Belgium ... more >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Germany Klinikum der Universitaet Regensburg Regensburg, Germany, D-93053 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Netherlands Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3075 EA Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Collapse <<
NCT02772107	Extensive-stage Small Cell Lun... more >>g Cancer Collapse <<	Phase 2 Phase 3	Unknown	January 2018	China, Beijing ... more >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: haitao tao, PhD +861066937875 whatyouknow@126.com Collapse <<
NCT00376103	Glioblastoma Multiforme	Phase 1 Phase 2	Terminated(Loss of funding fro... more >>m sponsor) Collapse <<	-	United States, Tennessee ... more >> Methodist University Hospital Memphis, Tennessee, United States, 38104 Collapse <<
NCT00049361	Brain and Central Nervous Syst... more >>em Tumors Unspecified Adult Solid Tumor, Protocol Specific Collapse <<	Phase 2	Completed	-	United States, Illinois ... more >> CCOP - Central Illinois Decatur, Illinois, United States, 62526 United States, North Carolina CCOP - Southeast Cancer Control Consortium Goldsboro, North Carolina, United States, 27534-9479 Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1030 United States, South Carolina CCOP - Greenville Greenville, South Carolina, United States, 29615 CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 Collapse <<
NCT00650923	Adult Anaplastic Astrocytoma ... more >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Recurrent Adult Brain Tumor Collapse <<	Phase 1	Completed	-	United States, California ... more >> University of California at Los Angeles (UCLA ) Los Angeles, California, United States, 90095 UCSF-Mount Zion San Francisco, California, United States, 94115 University of California San Francisco Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Maryland Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Charlestown, Massachusetts, United States, 02129 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT00807027	Glioblastoma	Phase 3	Completed	-	Korea, Republic of ... more >> Hanyang University Guri Hospital Guri, Gyeonggi-Do, Korea, Republic of Gyunghee University Medical Center Seoul, Korea, Republic of Konkuk University Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Samsung Seoul Medical Center Seoul, Korea, Republic of Seoul Asan Medical Center Seoul, Korea, Republic of Yeonsei University Medical Center Seoul, Korea, Republic of Collapse <<
NCT02049593	Metastatic Cancer ... more >> Unspecified Adult Solid Tumor Collapse <<	Phase 1	Active, not recruiting	June 30, 2019	United States, California ... more >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Collapse <<
NCT01014767	Brain Cancer ... more >>Choroid Plexus Tumors Collapse <<	Phase 3	Suspended(PI departure from co... more >>ordinating institution) Collapse <<	-	United States, Massachusetts ... more >> Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Texas Children's Cancer Hospital at UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Germany St. Hedwig Children's Hospital, University of Regensburg (International Study Center) Regensburg, Germany Hungary Semmelweis University Budapest, Hungary New Zealand Christchurch Hospital Christchurch, New Zealand Collapse <<
NCT00694837	Glioblastoma	Phase 1	Completed	-	Netherlands ... more >> Maastricht Radiation Oncology Maastricht, Netherlands, 6202 AZ Collapse <<
NCT02590263	Malignant Glioma ... more >> Glioblastoma Multiforme Collapse <<	Phase 1 Phase 2	Recruiting	December 31, 2020	Japan ... more >> Nagoya University Hospital /ID# 138559 Completed Nagoya-shi, Aichi, Japan, 466-8560 Iwate Medical University Hospital /ID# 149145 Recruiting Morioka-shi, Iwate, Japan, 020-8505 Kitasato University Hospital /ID# 148493 Recruiting Sagamihara-shi, Kanagawa, Japan, 252-0375 Kyoto Prefect Univ Med /ID# 149093 Recruiting Kyoto-shi, Kyoto, Japan, 602-8566 Tohoku University Hospital /ID# 138464 Recruiting Sendai-shi, Miyagi, Japan, 980-8574 Okayama University Hospital /ID# 148674 Recruiting Okayama-shi, Okayama, Japan, 700-8558 Osaka University Hospital /ID# 140438 Recruiting Suita-shi, Osaka, Japan, 565-0871 Shizuoka Cancer Center /ID# 148673 Recruiting Sunto-gun, Shizuoka, Japan, 411-8777 National Cancer Center Hospital /ID# 140435 Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Kyorin University Hospital /ID# 140360 Recruiting Mitaka-shi, Tokyo, Japan, 181-8611 Tokyo Women's Medical University Hospital /ID# 140436 Recruiting Shinjuku-ku, Tokyo, Japan, 162-8666 Chiba Cancer Center /ID# 164375 Recruiting Chiba, Japan, 260-0801 Saitama Med Univ Int Med Ctr /ID# 140361 Recruiting Hidaka, Japan, 350-1241 Hiroshima University Hospital /ID# 139399 Recruiting Hiroshima, Japan, 734-8551 Kumamoto University Hospital /ID# 138558 Recruiting Kumamoto, Japan, 860-0862 NHO Kyoto Medical Center /ID# 140437 Recruiting Kyoto, Japan, 612-0861 Osaka Inter. Cancer Institute /ID# 148494 Recruiting Osaka, Japan, 541-8567 Kyoto University Hospital /ID# 163206 Recruiting Sakyo-ku, Japan, 606-8507 Hokkaido University Hospital /ID# 150589 Recruiting Sapporo, Japan, 060-8648 Dokkyo Medical University Hosp /ID# 150990 Recruiting Shimotsuga, Japan, 321-0293 Nihon University Itabashi Hosp /ID# 149385 Recruiting Tokyo, Japan, 173-0032 Tsukuba University Hospital /ID# 140433 Recruiting Tsukuba, Japan, 305-8576 Collapse <<
NCT00431561	Glioblastoma ... more >>Anaplastic Astrocytoma Collapse <<	Phase 2	Completed	-	Austria ... more >> Universitätsklinik Innsbruck; Abteilung für Neurochirurgie Innsbruck, Austria, 6020 Landes-Nervenklinik Wagner-Jauregg Linz, Austria, 4020 Kaiser Franz Josef Spital, Abteilung für Neurologie Wien, Austria, 1100 Georgia Sarajishvili Institute of Clinical Neurology and Neurosurgery Tbilisi, Georgia, 0114 Germany Medizinische Klinik und Poliklinik mit Schwerpunkt Onkologie und Hämatologie, Charité Campus Mitte Berlin, Germany, 10117 Klinik und Poliklinik für Neurologie Cottbus, Germany, 03048 Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Dresden, Germany, 01307 Universitätsklinikum Gießen, Neurochirurgische Universitätsklinik Gießen, Germany, 35392 Universitätsklinikum Kiel, Klinik für Neurochirurgie Kiel, Germany, 24106 Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie Leipzig, Germany, 04103 Universitätsklinik Magdeburg, Klinik für Neurochirurgie Magdeburg, Germany, 39120 Universitätskliniken Mainz, Neurochirurgische Klinik und Poliklinik Mainz, Germany, 55131 Universitätsklinikum Münster, Klinik und Poliklinik für Neurochirurgie Münster, Germany, 48149 Klinikum und Poliklinik für Neurologie, Universität Regensburg Regensburg, Germany, 93053 Klinikum Saarbrücken, Neurochirurgie Saarbrücken, Germany, 66119 Neurologische Universitätsklinik Tübingen Tübingen, Germany, 72076 India Department of Neurosurgery, Amrita Institute of Medical Sciences & Research Centre Cochin, Kerala, India, 682026 Sree Chitra Tirunal Institute for Medical Sciences & Technology, Department of Neurosurgery Trivandrum, Kerala, India, 695011 Manipal Hospital; Manipal Institute for Neurological Disorders Bangalore, India, 560017 Department of Neurosurgery, National Institute of Mental Health and Neurosciences Bangalore, India, 560029 Department of Medical Oncology, Nizam's Institute of Medical Sciences Hyderabad, India, 500082 Department of Neurosurgery, LTMG Hospital & LTM Medical College Mumbai, India, 400022 Department of Neurosurgery, Neurosciences Center New Dehli, India, 110029 Department of Neurological Sciences, Christian Medical College & Hospital Vellore, India, 632004 Israel Soroka Medical Center, Neurosurgery Department Beer Sheva, Israel Rambam Medical Center, Neurosurgery Department Haifa, Israel, 31096 Rabin Medical Center, Neurosurgery Department Petach Tikva, Israel, 49100 Russian Federation Sverdlovsk Regional Oncological Clinic Ekaterinburg, Russian Federation, 620036 Republican Clinical Hospital of Ministry of Health of Tatarstan Republic Kazan, Russian Federation, 420064 Burdenko Neurosurgery Research Institute Moscow, Russian Federation, 125047 Omsk State Medical Academy; State Educational Institution of Higher Professional Education Omsk, Russian Federation, 644099 State Institution of Healthcare, Samara Regional Clinical Hospital in the name of M.I. Kalinin Samara, Russian Federation, 443095 Polenov Neurosurgery Research Institute St. Petersburg, Russian Federation, 191104 Military Medical Academy named after I.S.M. Kirov, Neurosurgery Department St. Petersburg, Russian Federation, 194175 Medical Center "XXI century" St. Petersburg, Russian Federation, 194354 Tcheliabinsk Regional Clinical Hospital; State Medical Institution for Prophylaxis and Treatment Tcheliabinsk, Russian Federation, 454076 Collapse <<
NCT00761280	Anaplastic Astrocytoma ... more >> Glioblastoma Collapse <<	Phase 3	Terminated(Unable to recruit t... more >>he projected patient number. All analyses are descriptive, only.) Collapse <<	-	-
NCT01991977	Malignant Glioma	Phase 2	Suspended(per study design)	July 1, 2019	United States, Minnesota ... more >> Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse <<
NCT00761280	-	-	Terminated(Unable to recruit t... more >>he projected patient number. All analyses are descriptive, only.) Collapse <<	-	-
NCT00915694	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Unknown	-	United States, Pennsylvania ... more >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Collapse <<
NCT00272870	Glioblastoma Multiforme (WHO G... more >>rade IV) Anaplastic Astrocytoma (WHO Grade III) Collapse <<	Phase 1	Terminated(Slow accrual; drug ... more >>availability) Collapse <<	-	United States, Ohio ... more >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Collapse <<
NCT00639639	Malignant Neoplasms of Brain	Phase 1	Active, not recruiting	December 2019	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT03495960	Primary Central Nervous System... more >> Lymphoma Collapse <<	Phase 2	Not yet recruiting	October 31, 2023	Italy ... more >> Bari IRCCS Istituto Tumori Bari, Italy Meldola, IRST - ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI Meldola, Italy Milano, IRCCS Ospedale San Raffaele Milan, Italy, 20132 Milano - Îstituto Besta Milan, Italy Milano Niguarda Milan, Italy Modena, Policlinico Universitario Modena, Italy Padova, Istituto Oncologico Veneto Padova, Italy Parma, Azienda Ospedaliera Parma, Italy Pescara, Presidio Ospedaliero UOS dipartimentale centro di diagnosi e terapia Linfomi Pescara, Italy Piacenza Piacenza, Italy Ravenna - Ospedale di Ravenna - IRST Ravenna, Italy Reggio Emilia - Arcispedale Santa Maria Nuova - IRCCS Reggio Emilia, Italy Roma - Ospedale S. Andrea Roma, Italy Roma - Unicampus-Bio Roma, Italy S. Giovanni Rotondo - Casa Sollievo della sofferenza San Giovanni Rotondo, Italy Siena - Azienda Ospedaliera Universitaria Senese Siena, Italy Terni - Ospedale di Terni Terni, Italy Torino neurooncologia - AOU CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO Torino, Italy Tricase - Ospedale "Card. G. Panico" Tricase, Italy Udine, Azienda Ospedaliera Universitaria Udine, Italy Switzerland Basel - Universitätsspital Recruiting Basel, Switzerland Contact: Benjamin kasenda, MD Principal Investigator: Benjamin Kasenda IOSI - Oncology Institute of Southern Switzerland Bellinzona, Switzerland, 6500 Bern - Inselspital Bern, Switzerland Lausanne - CHUV Lausanne, Switzerland St. Gallen - Kantonsspital Saint Gallen, Switzerland Collapse <<
NCT02685605	Glioblastoma	Phase 3	Recruiting	February 2021	United States, Arizona ... more >> Barrow Neurological Institute (SJHMC) Not yet recruiting Phoenix, Arizona, United States, 85013 Contact: Rima Woo Rima.Woo@barrowbrainandspine.com Principal Investigator: Peter Nakaji, MD United States, Illinois Stritch School of Medicine Loyola University Recruiting Maywood, Illinois, United States, 60153 Contact: Beth A Chiappetta, RN, BSN, CCRP 708-216 ext 2568 BCHIAPPETTA@lumc.edu Principal Investigator: William Small Jr, MD, FACRO, FACR, FASTRO United States, New York Long Island Jewish Medical Center, North Shore University Hospital Recruiting Lake Success, New York, United States, 11042 Contact: Louise A Purcell, MS ANP-C CCRN-CMC +1 516-941 ext 1263 LPurcell@northwell.edu Sub-Investigator: Michael Schulder, MD Lenox Hill Hospital, Hofstra Northwell School of Medicine Recruiting New York, New York, United States, 10028 Contact: Tamika A Wong, MPH 212-434-4836 twong4@northwell.edu Principal Investigator: John A. Boockvar, MD United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506-9260 Contact: Joseph Brunetti 304-293-7360 Principal Investigator: Christopher P Cifarelli, MD, PhD, FAANS, FACS Canada, Quebec Montreal Neurological Institute and Hospital Recruiting Montréal, Quebec, Canada, H3A 2B4 Contact: Anna Pietromonaco +1-514-398- ext 2591 anna.pietromonaco@mcgill.ca Contact: Gregory Ringkamp +1-514-398- ext 2667 gregory.ringkamp@mcgill.ca Principal Investigator: Kevin Petrecca, MD Sub-Investigator: Luis Souhami, MD Germany Klinikum Augsburg Recruiting Augsburg, Germany, 86156 Contact: Sabine Schill, PhD +49 821 400 25 42 Sabine.Schill@klinikum-augsburg.de Principal Investigator: Klaus H Kahl, MD University Hospital Mannheim Recruiting Mannheim, Germany, 68167 Contact: Anke Keller, MSc 00496213834960 anke.keller@medma.uni-heidelberg.de Principal Investigator: Frank A Giordano, MD Sub-Investigator: Daniel Haenggi, MD Sub-Investigator: Michael Platten, MD Technical University of Munich (TUM), Department of Radiation Oncology Recruiting Munich, Germany, 81675 Contact: Carmen Kessel, PhD +49 89 4140-4501 carmen.kessel@tum.de] Principal Investigator: Stephanie E Combs, MD Klinikum Stuttgart Recruiting Stuttgart, Germany, 70174 Contact: Ulrike Arzbach +49 711/ 278-33700 u.arzbach@klinikum-stuttgart.de Principal Investigator: Oliver Ganslandt, MD Sub-Investigator: Marc Münter, MD Spain Catalan Institute of Oncology (ICO) Recruiting Barcelona, Spain, 08908 Contact: Montserrat Ventura Bujalance + 34 93 260 77 22 montseventura@iconcologia.net Principal Investigator: Ferran Guedea, MD, PhD United Kingdom The London Clinic Not yet recruiting London, United Kingdom, W1G 6BW Contact: Christine Topham 020 3219 3570 ext 8389 C.Topham@thelondonclinic.co.uk Contact: Alistair Gifford-Moore 020 3219 3570 ext 8384 A.Gifford-Moore@thelondonclinic.co.uk Principal Investigator: n.n. n.n. Collapse <<
NCT03137888	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 2	Recruiting	September 2019	United States, Florida ... more >> University of Miami Miller School of Medicine-Sylvester Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Lilly Sanchez 305-243-0974 lsanchez@med.miami.edu Contact: Eric Mellon, MD, PhD eric.mellon@med.miami.edu Principal Investigator: Eric Mellon, MD, PhD United States, Georgia Emory University/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Lily Masoumy 404-778-1960 lily.masoumy@emory.edu Contact: Hui-Kuo Shu, MD, PhD hgshu@emory.edu Principal Investigator: Hui-Kuo Shu, MD, PhD United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Deborah Epstein 410-955-8866 epstede@jhmi.edu Contact: Lawrence Kleinberg, MD kleinla@jhmi.edu Principal Investigator: Lawrence Kleinberg, MD Collapse <<
NCT03276286	Glioblastoma Multiforme	Not Applicable	Recruiting	December 31, 2019	United States, Alabama ... more >> University of Alabama at Birmingham (UAB) Not yet recruiting Birmingham, Alabama, United States, 35233 Contact: Thiru Pillay, RN BSN 205-934-1842 tpillay@uab.edu Principal Investigator: Burt Nabors, MD United States, Arizona Center for Neurosciences Recruiting Tucson, Arizona, United States, 85718 Contact: Margie Pazzi, RN, MSN 520-320-2147 mpazzi@neurotucson.com Contact 520.795.7750 Principal Investigator: Michael Badruddoja, MD United States, California California Cancer Care Associates Recruiting Encinitas, California, United States, 92024 Contact: Beth Kimball, RN OCN 760-452-3909 bkimball@ccare.com Principal Investigator: Edward McClay, MD John Wayne Cancer Institute @ Providence St Johns Health Center Recruiting Santa Monica, California, United States, 90404 Contact: Anand Moses 310-582-7097 mosesa@jwci.org Principal Investigator: Garni Barkhoudarian, MD United States, Connecticut Associated Neurologists of Southern CT, PC Recruiting Fairfield, Connecticut, United States, 06824 Contact: Tori Pascoe, CRC 203-333-1151 ext 4 tpascoe@anscneuro.com Principal Investigator: Nicholas Blondin, MD United States, District of Columbia George Washington University Not yet recruiting Washington, District of Columbia, United States, 20037 Contact: Lindsey Covington Principal Investigator: Jonathan Sherman United States, Florida Boca Raton Regional Hospital Recruiting Boca Raton, Florida, United States, 33486 Contact: Pilar Zuniga, MD 561-955-4800 pzuniga@brrh.com Principal Investigator: Sajeel Chowdhary, MD United States, Kansas University of Kansas Medical Center (KUMC) Not yet recruiting Kansas City, Kansas, United States, 66205 Contact: Sasha Moores 913-588-5520 smoores@kumc.edu Principal Investigator: Michael Salacz, MD United States, Texas Cancer Care Collaborative Recruiting Austin, Texas, United States, 78705 Contact: Heidi Herndon, RN 512-324-7000 ext 77713 hherndon@ascension.org Principal Investigator: Brian D Vaillant, MD Baylor Scott and White Health Recruiting Temple, Texas, United States, 98101 Contact: Dedra Preece 254-724-5939 dedra.preece@bswhealth.org Contact: Gates Anderson 254.724.5889 Gates.Anderson@bswhealth.org Principal Investigator: Ekokobe Fonkem, DO Collapse <<
NCT01752491	Glioblastoma ... more >>GBM Glioblastoma Multiforme Collapse <<	Phase 1	Active, not recruiting	December 31, 2021	United States, Iowa ... more >> Holden Comprehensive Cancer Center at the University of Iowa Iowa City, Iowa, United States, 52242 Collapse <<
NCT01400958	Malignant Glioma	Phase 2	Terminated(Slow Accrual, Initi... more >>ating Principal Investigator (PI) left Moffitt) Collapse <<	-	United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Collapse <<
NCT02099487	Glioma	Phase 2	Completed	-	Italy ... more >> ICH Humanitas Cancer Center Milan, Lombardia, Italy, 20090 Collapse <<
NCT03344250	Glioblastoma ... more >>Glioblastoma Multiforme Collapse <<	Phase 1	Recruiting	December 1, 2020	United States, Virginia ... more >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Melissa Otoya, RN, MSN-CNL 434-982-3365 mo9w@virginia.edu Principal Investigator: Camilo Fadul, MD Collapse <<
NCT02796261	Anaplastic Astrocytoma ... more >> Recurrent Anaplastic Astrocytoma Collapse <<	Phase 3	Recruiting	August 2019	-
NCT02853565	Glioblastoma Multiforme	Phase 1	Completed	-	Taiwan ... more >> Chang Gung Memorial Hospital, Linkou Taipei, Taiwan, 100 National Taiwan University Hospital Taipei, Taiwan, 100 Collapse <<
NCT01800695	Glioblastoma Multiforme	Phase 1	Completed	-	-
NCT02223884	Malignant Melanoma	Phase 2	Completed	-	Korea, Republic of ... more >> Severance Hospital Seoul, Korea, Republic of, 120-752 Collapse <<
NCT03506139	Glioblastoma ... more >>Glioblastoma Multiforme Collapse <<	Phase 2	Not yet recruiting	December 31, 2026	-
NCT01400958	-	-	Terminated(Slow Accrual, Initi... more >>ating Principal Investigator (PI) left Moffitt) Collapse <<	-	-
NCT03351296	Pancreatic Cancer	Phase 2	Not yet recruiting	June 2023	France ... more >> Gustave Roussy Not yet recruiting Villejuif, Val De Marne, France, 94805 Contact: Michel Ducreux, MD, PhD 0142116017 ext +33 michel.ducreux@gustaveroussy.fr Contact: Dune Lemettre 0142116643 ext +33 dune.lemettre@gustaveroussy.fr Collapse <<
NCT00643097	-	-	Completed	-	-
NCT01952886	Malignant Glioma	Phase 2	Withdrawn(Lack of approval and... more >> funding from company) Collapse <<	-	United States, North Carolina ... more >> Duke Cancer Center Durham, North Carolina, United States, 27710 Collapse <<
NCT03197506	Glioblastoma ... more >>Gliosarcoma Supratentorial Glioblastoma Collapse <<	Phase 2	Suspended(The study is tempora... more >>rily closed to enrollment per study design. Patients currently on study are being followed according to the protocol.) Collapse <<	July 31, 2022	United States, Minnesota ... more >> Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse <<
NCT03246113	Glioblastoma	Phase 1	Recruiting	December 31, 2019	United States, New York ... more >> Columbia University Medical Center- Department of Radiation Oncology Recruiting New York, New York, United States, 10032 Contact: Tony J Wang, MD 212-305-7077 tjw2117@cumc.columbia.edu Contact: Mariamne Reyna 646-317-4244 mo2213@cumc.columbia.edu New York State Psychiatric Institute Recruiting New York, New York, United States, 10032 Contact: Margaret Haney, PhD 646-774-6153 Meg.Haney@nyspi.columbia.edu Collapse <<
NCT02313389	Primary Central Nervous System... more >> Lymphoma Collapse <<	Phase 3	Recruiting	June 2021	France ... more >> Groupe Hospitalier Pitie Salpetriere Recruiting Paris, France, 75013 Contact: Khe HOANG-XUAN, MD, PhD +33 - 1.42.16.03.81 khe.hoang-xuan@psl.aphp.fr Collapse <<
NCT00820963	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 3	Completed	-	France ... more >> Centre Leon Berard Lyon, France, 69373 Collapse <<
NCT00643097	Malignant Neoplasms of Brain	Phase 2	Completed	-	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Collapse <<
NCT02208336	-	-	Completed	-	United States, North Carolina ... more >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Collapse <<
NCT03387592	Neuroendocrine Carcinoma	Phase 2	Recruiting	January 2021	Italy ... more >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Recruiting Meldola, FC, Italy, 47014 Contact: Toni Ibrahim, MD 0543739100 toni.ibrahim@irst.emr.it Principal Investigator: Toni Ibrahim, MD Sub-Investigator: Albero Bongiovanni, MD Istituto Nazionale Tumori Milano Recruiting Milano, MI, Italy Contact: Sara Pusceddu Azienda Ospedaliera-Universitaria di Modena Recruiting Modena, MO, Italy Contact: Gabriele Luppi, MD Ospedale Civile degli Infermi Recruiting Faenza, RA, Italy Contact: Stefano Tamberi Ospedale di Bolzano Recruiting Bolzano, Italy Contact: Giovanni Di Meglio, MD IRCCS "Saverio De Bellis" Recruiting Castellana Grotte, Italy Contact: Ivan Lolli Ospedale "Vito Fazzi" Recruiting Lecce, Italy Contact: Silvana Leo Istituto Oncologico Veneto Recruiting Padova, Italy Contact: Francesca Bergamo, MD Azienda Ospedaliera-Universitaria di Parma Recruiting Parma, Italy Contact: Francesca Pucci, MD Ospedale S.Chiara - AOU Pisana Recruiting Pisa, Italy Contact: Sergio Ricci, MD Collapse <<
NCT02254954	Glioblastoma	Phase 1	Terminated(Sponsor decision du... more >>e to low recruitment) Collapse <<	-	United States, Texas ... more >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03739411	Glioma	Phase 1	Recruiting	August 1, 2020	United States, California ... more >> University of California, San Francisco Recruiting San Francisco, California, United States, 94115 Contact: Susan M. Chang 415-353-2383 ChangS@neurosurg.ucsf.edu Principal Investigator: Susan M. Chang Collapse <<
NCT02189109	Glioblastoma Multiforme	Phase 1	Unknown	December 2017	Australia, New South Wales ... more >> St. Vincents Hospital Sydney Darlinghurst, New South Wales, Australia, 2010 Australia, South Australia Flinders Medical Centre Adelaide, South Australia, Australia, 5042 Australia, Victoria Nucleus Network Melbourne, Victoria, Australia, 3004 Epworth Center Melbourne, Victoria, Australia, 3121 Collapse <<
NCT02510950	Glioblastoma Multiforme ... more >> Astrocytoma, Grade IV Collapse <<	Phase 1	Terminated(Low accrual)	-	United States, Missouri ... more >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Collapse <<
NCT02458508	-	-	Completed	-	Italy ... more >> Division of Radiotherapy, Department Of Oncology, University Hospital of Pisa Pisa, Italy, 56126 Collapse <<
NCT00025558	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, New York ... more >> NYU Cancer Institute at New York University Medical Center New York, New York, United States, 10016 United States, Ohio Columbus Children's Hospital Columbus, Ohio, United States, 43205-2696 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Australia, Western Australia Princess Margaret Hospital for Children Perth, Western Australia, Australia, 6001 Collapse <<
NCT01409174	Melanoma	Phase 1	Terminated(Slow accrual, close... more >>d in Phase I.) Collapse <<	-	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02206230	Glioblastoma	Phase 2	Recruiting	August 2020	Canada, Alberta ... more >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Samir Patel, MD 780-432-8518 samir.patel2@albertahealthservices.ca Collapse <<
NCT02511132	Ewing's Sarcoma	Phase 2	Active, not recruiting	December 2018	United States, Arkansas ... more >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72202 United States, Florida Nicklaus Children's Hospital (Miami Children's Health System) Miami, Florida, United States, 33155 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Cleveland Clinic Children's Cleveland, Ohio, United States, 44195 United States, Texas Mary Crowley Cancer Research Centers Dallas, Texas, United States, 75230 TOPA - Medical City Dallas Pediatric Hematology-Oncology Dallas, Texas, United States, 75230 Collapse <<
NCT03688178	Glioblastoma	Phase 2	Not yet recruiting	March 1, 2025	United States, North Carolina ... more >> Duke University Medical Center Not yet recruiting Durham, North Carolina, United States, 27710 Contact: Stevie Threatt 919-684-5301 dukebrain1@dm.duke.edu Contact: Susan Boulton, RN, BSN 919-684-5301 dukebrain1@dm.duke.edu Collapse <<
NCT01390948	High Grade Glioma	Phase 2	Active, not recruiting	March 10, 2020	-
NCT01939574	Glioblastoma	Not Applicable	Unknown	September 2016	China, Shandong ... more >> Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Collapse <<
NCT03650257	Glioma of Brain	Phase 2	Not yet recruiting	August 20, 2023	China, Beijing ... more >> Beijing Tiantan Hospital Affiliated to Capital Medical University Not yet recruiting Beijing, Beijing, China, 100050 Contact: hua Gao 18600678822 gh2004518@163.com Collapse <<
NCT00028795	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 2	Completed	-	-
NCT02414165	Glioblastoma Multiforme ... more >> Anaplastic Astrocytoma Collapse <<	Phase 2 Phase 3	Active, not recruiting	March 2023	-
NCT01390948	-	-	Active, not recruiting	-	-
NCT02287428	Glioblastoma ... more >>Gliosarcoma Glioblastoma With Oligodendroglial Features Giant Cell Glioblastoma Glioblastoma Multiforme MGMT-unmethylated Glioblastoma MGMT-methylated Glioblastoma GBM Collapse <<	Phase 1	Active, not recruiting	August 2020	United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02113 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Collapse <<
NCT03548571	Glioblastoma	Phase 2 Phase 3	Recruiting	May 1, 2023	Norway ... more >> Oslo University Hospital Recruiting Oslo, Norway Contact: Einar O Vik-Mo, MD, PhD +47 23074340 uxvieb@ous-hf.no Contact: Solveig Bringsli solbri@ous-hf.no Collapse <<
NCT01507506	Glioblastoma	Phase 3	Active, not recruiting	March 2023	France ... more >> Clinique Claude Bernard Albi, France, 81000 Centre Jean Perrin Clermont-ferrand, France, 63011 Centre Georges François Leclerc Dijon, France, 21000 Hospices Civils de Lyon (Hôpital Lyon Sud/Hôpital P. Wertheimer) Lyon, France, 69002 Centre Leon Berard Lyon, France, 69373 AP HM - Hôpital La Timone Marseille, France, 13385 Centre Val d'Aurelle Montpellier, France, 34298 Institut de Cancerologie Lucien Neuwirth Saint-Priest-En-Jarez, France, 42271 Centre Paul Strauss Strasbourg, France, 67065 CHU de Strasbourg Strasbourg, France, 67065 Institut Claudius REGAUD Toulouse, France, 31052 Centre Marie Curie Valence, France, 26953 Collapse <<
NCT00897377	Astrocytomas ... more >>Oligodendrogliomas Oligoastrocytoma Collapse <<	Phase 3	Terminated(Difficulty in recru... more >>iting patients) Collapse <<	-	China, Guangdong ... more >> Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Collapse <<
NCT00253487	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Not Applicable	Completed	-	-
NCT00014092	Melanoma (Skin)	Phase 2	Completed	-	United States, California ... more >> Saint Francis Memorial Hospital San Francisco, California, United States, 94109 John Wayne Cancer Institute at Saint John's Health Center Santa Monica, California, United States, 90404 United States, Colorado University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States, 80010 Collapse <<
NCT03212235	Glioblastoma Multiforme	Phase 2	Recruiting	June 1, 2020	Brazil ... more >> Instituto do Cancer do Estado de São Paulo (ICESP) - FMUSP Recruiting São Paulo, Sao Paulo, Brazil, 01246-000 Contact: Gustavo N Marta, PhD 55+11+38934538 gustavo.marta@hc.fm.usp.br Collapse <<
NCT01458730	Central Nervous System Lymphom... more >>a Collapse <<	Phase 2	Active, not recruiting	October 2020	Denmark ... more >> Elisa Jacobsen Pulczynski Aarhus, Denmark, DK-8000 Collapse <<
NCT00004259	-	-	Completed	-	-
NCT00004259	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 3	Completed	-	-
NCT00005637	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Collapse <<
NCT03395587	Glioblastoma	Phase 2	Recruiting	June 6, 2023	Germany ... more >> Klinik für Neurologie, Knappschaftskrankenhaus Bochum Recruiting Bochum, Northrhine Westphalia, Germany, 44829 Contact: Uwe Schlegel, Prof. MD 00492342993719 neurologie@kk-bochum.de Contact: Rekowski Sylvia 00492342993719 sylvia.rekowski@kk-bochum.de Sub-Investigator: Thomas Kowalski Principal Investigator: Uwe Schlegel, Prof. MD Klinik für Neurochirurgie, Sana Kliniken Duisburg Not yet recruiting Duisburg, Northrhine Westphalia, Germany, 47055 Contact: Jung Su Zin, Dr. med. 00492037332401 suzin.jung@sana.de Principal Investigator: Catharina Junghans, Dr. med. Sub-Investigator: Lutz Schreiber, Dr. med. Neurochirurgische Klinik, Universitätsklinikum Düsseldorf Recruiting Düsseldorf, Northrhine Westphalia, Germany, 40225 Contact: Michael C. Sabel, Prof. MD 00492118116276 michael.sabel@med.uni-duesseldorf.de Contact: Natalie Sevens 00492118117881 Sub-Investigator: Marion Rapp, PD MD Principal Investigator: Michael Sabel, Prof. MD Klinik für Allgemeine Neurologie, Universitätsklinikum Münster Recruiting Münster, Northrhine Westphalia, Germany, 48149 Contact: Oliver Grauer, PD Dr. med. 0492518346814 oliver.grauer@ukmuenster.de Principal Investigator: Oliver Grauer, PD Dr. med. Sub-Investigator: Ole Simon, Dr. med. Collapse <<
NCT00867568	Neuroblastoma ... more >> Medulloblastoma Relapse Collapse <<	Phase 1	Completed	-	United States, California ... more >> Rady Children's Hospital San Diego, California, United States, 92123 United States, Florida Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States, 32806 United States, Missouri Cardinal Glennon Children's Medical Center St. Louis, Missouri, United States, 63104 United States, North Carolina Levine Children's Hospital Charlotte, North Carolina, United States, 28204 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Vermont UVM/FAHC Burlington, Vermont, United States, 05401 Collapse <<
NCT02288897	Cutaneous Melanoma	Phase 3	Active, not recruiting	April 2019	-
NCT00867568	-	-	Completed	-	-
NCT03660761	Efficacy and Safety	Phase 2	Completed	-	China, Shandong ... more >> Neurosurgery, Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Collapse <<
NCT00890786	Newly Diagnosed High-Grade Gli... more >>omas Diffuse Intrinsic Pontine Glioma Collapse <<	Early Phase 1	Completed	-	United States, Illinois ... more >> Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60614 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Collapse <<
NCT03180502	1p/19q Co-deletion ... more >> Anaplastic Astrocytoma Diffuse Astrocytoma Glioma IDH1 Gene Mutation IDH2 Gene Mutation Oligoastrocytoma Oligodendroglioma WHO Grade III Glioma Collapse <<	Phase 2	Recruiting	August 31, 2027	United States, Illinois ... more >> Northwestern Medicine Cancer Center Delnor Recruiting Geneva, Illinois, United States, 60134 Contact: Site Public Contact 630-315-1918 Claudine.Gamster@CadenceHealth.org Principal Investigator: Vinai Gondi Northwestern Medicine Cancer Center Warrenville Recruiting Warrenville, Illinois, United States, 60555 Contact: Site Public Contact 630-315-1918 Claudine.Gamster@CadenceHealth.org Principal Investigator: Vinai Gondi United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact 877-726-5130 Principal Investigator: Helen A. Shih United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Site Public Contact 855-776-0015 Principal Investigator: Anita Mahajan United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu Principal Investigator: Christina I. Tsien United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact 877-312-3961 Principal Investigator: David R. Grosshans United States, Washington Seattle Cancer Care Alliance at Northwest Hospital Recruiting Seattle, Washington, United States, 98133 Contact: Site Public Contact 206-606-5800 Principal Investigator: Yolanda D. Tseng University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Site Public Contact 800-804-8824 Principal Investigator: Yolanda D. Tseng Collapse <<
NCT01182350	Diffuse Intrinsic Pontine Glio... more >>ma Collapse <<	Phase 2	Completed	-	-
NCT03257618	Glioma	Not Applicable	Recruiting	December 2020	France ... more >> Institut regional du Cancer - Val d Aurelle Recruiting Montpellier, France, 34298 Contact: Bleuse Jean Pierre +33467612344 jean-pierre.bleuse@icm.unicancer.fr Principal Investigator: darlix amelie Collapse <<
NCT02010606	Glioblastoma ... more >>Glioblastoma Multiforme Glioma Astrocytoma Brain Tumor Collapse <<	Phase 1	Active, not recruiting	January 2021	United States, California ... more >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Collapse <<
NCT00416819	Brain and Central Nervous Syst... more >>em Tumors Lymphoma Collapse <<	Not Applicable	Completed	-	-
NCT01269424	Glioblastoma Multiforme	Phase 1	Terminated(Revisions due - Enr... more >>oll to cohort 2) Collapse <<	-	United States, Ohio ... more >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5047 Collapse <<
NCT01222221	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1	Completed	-	United Kingdom ... more >> Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ UCL Cancer Institute London, England, United Kingdom, WC1E 6DD Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Western General Hospital Edinburgh, United Kingdom, EH4 2XU St James' University Hospital Leeds, United Kingdom, LS9 7TF The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Collapse <<
NCT00660543	Adult Brain Glioblastoma	Not Applicable	Completed	-	United States, Oregon ... more >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Collapse <<
NCT01618136	Malignant Solid Tumour ... more >> Ovarian Cancer Triple Negative Breast Cancer Advanced Melanoma B-cell Malignancy, Low-grade Collapse <<	Phase 1 Phase 2	Completed	-	United Kingdom ... more >> King's College London Guy's Hospital Campus London, United Kingdom, SE1 9RT Newcastle Upon Tyne NHS Foundation Trust Newcastle Upon Tyne and Wear, United Kingdom, NE7 7DN Collapse <<
NCT00660543	-	-	Completed	-	-
NCT02364206	Adult Glioblastoma	Phase 1 Phase 2	Active, not recruiting	June 2019	France ... more >> CHU Amiens Sud-Salouel Amiens, France Institut Bergonié Bordeaux, France Centre François Baclesse Caen, France Centre Jean Perrin Clermont-Ferrand, France Centre Georges François Leclerc Dijon, France Centre Paul Strauss Strasbourg, France Collapse <<
NCT01670890	Malignant Gliomas	Phase 2	Unknown	-	China, Beijing ... more >> Beijing Tiantan Hospital Affiliated to Capital Medial University Recruiting Beijing, Beijing, China, 100050 Contact: Jiang tao, MD 86-010-67021832 jiangtao369@sohu.com Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: wang ren zhi, MD 86-010-69156071 wangrz@126.com Principal Investigator: Ma wen bin, MD Sub-Investigator: wang yu, MD China, Tianjin Tianjin medical university general university Recruiting Tianjin, Tianjin, China, 300052 Contact: Yang xue jun, MD ydenny@yahoo.com Collapse <<
NCT00014105	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1 Phase 2	Unknown	-	United States, New Jersey ... more >> Overlook Hospital Summit, New Jersey, United States, 07902-0220 Collapse <<
NCT00455286	Primary Central Nervous System... more >> Lymphoma Collapse <<	Phase 2	Unknown	November 2011	Taiwan ... more >> Changhua Christian Hospital Recruiting Changhua, Taiwan Contact: Cheng-Shyong Chang, M.D. 886-4-7238595 15120@cch.org.tw China Medical University Hospital Recruiting Taichung, Taiwan Contact: Chang-Fang Chiu Chiu, M.D. 886-4-22052121 d5686@www.cmuh.org.tw National Cheng Kung University Hospital Recruiting TaiNan, Taiwan Contact: Wu-Chou Su, M.D. 886-6-2353535 sunnysu@mail.ncku.edu.tw Mackay Memorial Hospital Recruiting Taipei, Taiwan Contact: Ming-Chih Chang, M.D. 886-2-25433535 ext 3454 mmhdonald@yahoo.com.tw Contact: Ming-Jer Huang Collapse <<
NCT03168919	Glioma	Not Applicable	Terminated(PI is leaving insti... more >>tution) Collapse <<	-	United States, Alabama ... more >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35249 Collapse <<
NCT00961844	Metastatic Malignant Melanoma	Phase 1 Phase 2	Terminated(Logistical problems... more >>) Collapse <<	-	Norway ... more >> The Norwegian Radium Hospital, Department of Clinical Cancer Research Oslo, Montebello, Norway, NO-0310 Collapse <<
NCT02546102	Glioblastoma Multiforme	Phase 3	Suspended(Company at this time... more >> unable to secure sufficient financial resources to complete) Collapse <<	December 2021	-
NCT02193347	Brain Cancer ... more >>Brain Neoplasm, Primary Brain Neoplasms, Recurrent Brain Tumor Cancer of the Brain Collapse <<	Phase 1	Active, not recruiting	June 2019	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT02573324	Glioblastoma Multiforme ... more >> Gliosarcoma Collapse <<	Phase 3	Recruiting	February 13, 2021	-
NCT00588523	CNS Cancer CN... more >>S BRAIN Collapse <<	Phase 2	Active, not recruiting	September 2019	United States, New Jersey ... more >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center Commack, New York, United States Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Collapse <<
NCT01860638	Glioblastoma	Phase 2	Completed	-	-
NCT02617745	Glioblastoma	Phase 2	Recruiting	December 2020	France ... more >> Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Frederic Di Fiore, MD, PhD +33232082554 frederic.difiore@chb.unicancer.fr Contact: Doriane Richard, PhD +33232082985 doriane.richard@orange.fr Sub-Investigator: Isabelle Tennevet, MD Sub-Investigator: Cristina Alexandru, MD Sub-Investigator: Ovidiu Veresezan, MD Sub-Investigator: Chantal Hanzen, MD Sub-Investigator: Bernard Dubray, MD, PhD Collapse <<
NCT00395070	Metastatic Melanoma	Phase 3	Completed	-	-
NCT03425292	Newly Diagnosed Glioblastoma	Phase 1	Recruiting	February 1, 2020	United States, California ... more >> John Wayne Cancer Institute Recruiting Santa Monica, California, United States, 90404 Contact: Jaya Gill, RN 310-582-7437 jaya.gill@providence.org Principal Investigator: Santosh Kesari, MD, PhD Collapse <<
NCT02758366	Glioblastoma (GBM) ... more >> DIPG Brainstem Glioma, Pediatric Diffuse Spinal Glioma Bilateral Thalamic Glioma Gliomatosis Cerebri Anaplastic Astrocytoma Midline Diffuse Glioma Collapse <<	Phase 2	Recruiting	July 2020	Italy ... more >> Meyer Children's Hospital Recruiting Florence, Italy, 50145 Contact: Iacopo Sardi, MD, PhD +390555662631 iacopo.sardi@meyer.it Collapse <<
NCT02977780	Glioblastoma	Phase 2	Recruiting	May 2021	United States, Alabama ... more >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35294 Contact: L. Burt Nabors, MD 205-934-1432 bnabors@uab.edu United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Isabel Arrillaga-Romany, MD PhD 617-724-8770 iarrillaga@mgh.harvard.edu Principal Investigator: Isabel Arrillaga-Romany, MD PhD Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Brian Alexander, MD MPH 617-732-7560 Brian_Alexander@dfci.harvard.edu Contact: Lisa Doherty, NP 617-632-2166 lisa_doherty@dfci.harvard.edu Principal Investigator: Brian Alexander, MD MPH United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Eva Galanis, MD 507-284-2511 galanis.evanthia@mayo.edu United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Mary Welch, MD 212-342-0571 mw2517@cumc.columbia.edu United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Manmeet Ahluwalia,, MD 216-444-6145 ahluwam@ccf.org United States, Pennsylvania University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Jan Drappatz, MD 412-864-7791 drappatzj@upmc.edu United States, Texas UT MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: John DeGroot, MD 713-745-3072 jdegroot@mdanderson.org United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Howard Colman, MD 801-587-4042 Howard.colman@hci.utah.edu United States, Virginia University of Virginia Health System Recruiting Charlottesville, Virginia, United States, 22908 Contact: David Schiff, MD 434-924-5610 Ds4jd@virginia.edu Collapse <<
NCT00786669	Solid Tumor	Phase 1	Completed	-	United States, Ohio ... more >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Collapse <<
NCT03631823	-	-	Not yet recruiting	May 1, 2020	-
NCT03338075	-	-	Completed	-	-
NCT02850744	Glioblastoma Multiforme	Phase 2	Terminated	-	Switzerland ... more >> University Hospital Zurich, Neurology Zurich, Switzerland, 8091 Collapse <<
NCT00967330	Glioblastoma Multiforme	Phase 2	Completed	-	Germany ... more >> Aachen, Germany, 52074 Berlin, Germany, 13353 Bochum, Germany, 44892 Bonn, Germany, 53127 Chemnitz, Germany, 09113 Dresden, Germany, 01307 Düsseldorf, Germany, 40225 Erfurt, Germany, 99089 Erlangen, Germany, 91054 Frankfurt am Main, Germany, 60528 Freiburg, Germany, 79106 Göttingen, Germany, 37075 Idar-Oberstein, Germany, 55743 Kiel, Germany, 24105 Köln, Germany, 50937 Leipzig, Germany, 04103 Mannheim, Germany, 68167 Marburg, Germany, 35043 Muenchen, Germany, 81377 München, Germany, 81675 Münster, Germany, 48149 Regensburg, Germany, 93053 Tübingen, Germany, 72076 Ulm, Germany, 89081 Collapse <<
NCT01920191	CNS Tumor, Adult	Phase 1 Phase 2	Completed	-	Switzerland ... more >> Geneva University Hospitals, Centre of Oncology Geneva, Switzerland, CH-1211 Collapse <<
NCT00967330	-	-	Completed	-	-
NCT02082119	Glioma	Phase 2	Completed	-	Italy ... more >> Istituto Clinico Humanitas Milan, Italy, 20100 Collapse <<
NCT00991250	Malignant Melanoma	Phase 2	Unknown	September 2011	Sweden ... more >> Lunds Universitetssjukhus Recruiting Lund, Skåne, Sweden, 22185 Contact: Christian Ingvar, MD +46 (0)46-17 10 00 christian.ingvar@skane.se Principal Investigator: Christian Ingvar, MD Södersjukhuset Recruiting Stockholm, Stockholms Län, Sweden, 11883 Contact: Peter Gillgren, MD +46 (0)8-616 23 84 peter.gillgren@sodersjukhuset.se Principal Investigator: Peter Gillgren, MD Karolinska Sjukhuset Recruiting Stockholm, Stockholms Län, Sweden, 17176 Contact: Johan Hansson, MD +46 (0)8-5177 36 40 johan.hansson@karolinska.se Principal Investigator: Johan Hansson, MD Norrlands Universitetssjukhus Recruiting Umeå, Västerbottens Län, Sweden, 90185 Contact: Peter Naredi, MD +46 (0)90- 785 00 00 peter.naredi@surgery.umu.se Principal Investigator: Peter Naredi, MD Sahlgrenska Universitetssjukhuset Not yet recruiting Göteborg, Västra Götalands Län, Sweden, 41685 Contact: Jan E Mattsson, MD +46 (0)31-342 84 58 jan.e.mattsson@vgregion.se Principal Investigator: Jan E Mattsson, MD Collapse <<
NCT02832635	Brain Metastasis ... more >> Radiation Therapy Complication Collapse <<	Phase 2	Unknown	December 2017	China, Guangdong ... more >> Department of Radiation Oncology, Sun Yat-Sen University Cancer Center Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Yun-fei Xia, Professor 86-13602805461 xiayf@sysucc.org.cn Contact: Xiaohui Wang, MD 86-18826260661 wangxh@sysucc.org.cn Principal Investigator: Yun-fei Xia, Professor Sub-Investigator: Xiaohui Wang, MD Guangdong Three Nine Brain Hospital Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Lin-bo Cai, Prof. 86-13503030491 Principal Investigator: Linbo Cai, Prof. Guangzhou First People's Hospital Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Guo-long Liu, Prof. 86-13802527172 Principal Investigator: Guo-long Liu, Prof. Guangzhou People's Liberation Army Hospital 421 Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Si-Lang Zhou, Prof. 86-13189099597 Principal Investigator: Si-Lang Zhou, Prof. Panyu Central Hospital Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Xiao-long Cao, Prof. 86-18922238053 Principal Investigator: Xiao-long Cao, Prof. The First Affiliated Hospital, Jinan University Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Yi-ou Wang, Prof. 86-13602751067 Principal Investigator: Yi-ou Wang, Prof. The Affiliated Cancer Hospital Of Guangzhou Medical Collage Not yet recruiting Guangzhou, Guangdong, China, 510095 Contact: Xun-fan Shao, Prof. +86-13902770926 xunfanshao@yahoo.com.cn Principal Investigator: Xun-fan Shao, Prof. Guangdong Provincial Hospital Of Chinese Medicine Not yet recruiting Guangzhou, Guangdong, China, 510120 Contact: Gong Li, Prof. +86-13802915171 leegong@21cn.com Principal Investigator: Gong Li, Prof. The First Affiliated Hospital Of Guangzhou Medical Collage Not yet recruiting Guangzhou, Guangdong, China, 510120 Contact: Dao-li Niu, Prof. +86-13711101855 daoliniu@163.com Principal Investigator: Dao-li Niu, Prof. The Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting Zhuhai, Guangdong, China, 519000 Contact: Zhibin Cheng, Professor 86-13926946708 Principal Investigator: Zhibin Cheng, Professor Collapse <<
NCT01837862	Pilomyxoid Astrocytoma ... more >> Pilocytic Astrocytoma Glioma, Astrocytic Optic Nerve Glioma Pleomorphic Xanthoastrocytoma Glioblastoma Multiforme Anaplastic Astrocytoma Gliosarcoma Diffuse Intrinsic Pontine Glioma DIPG Low-grade Glioma Brainstem Glioma Collapse <<	Phase 1 Phase 2	Recruiting	April 2020	United States, New York ... more >> Cohen Children's Medical Center of New York Recruiting New Hyde Park, New York, United States, 11040 Contact: Mark P Atlas, MD 718-470-3460 matlas@nshs.edu Contact: Derek R Hanson, MD 551-996-5437 DHanson@hackensackumc.org Principal Investigator: Mark P Atlas, MD Sub-Investigator: Derek R Hanson, MD Sub-Investigator: Arlene Redner, MD Sub-Investigator: Mohamad Badawi, MD Sub-Investigator: Avery Wright, DO Collapse <<
NCT00250211	Glioblastoma ... more >>Glioma Collapse <<	Phase 1 Phase 2	Completed	-	Canada, Alberta ... more >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Collapse <<
NCT02672241	Childhood Brain Stem Neoplasm	Phase 2	Recruiting	August 2019	China, Shanghai ... more >> he Department of Radiation Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200092 Contact: chuanying zhu, MD 862125076994 sdnanhai123@163.com Collapse <<
NCT02329795	-	-	Terminated(Slow accrual)	-	Denmark ... more >> Department of Oncology, Section for Radiotherapy, Rigshospitalet Copenhagen, Denmark, 2100 Collapse <<
NCT00539591	Malignant Melanoma	Phase 2	Completed	-	United States, California ... more >> Rady Children's Hospital San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas The Children's Cancer Hospital at UT M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02375334	-	-	Terminated(Support Staff Left ... more >>Institution) Collapse <<	-	United States, North Carolina ... more >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Collapse <<
NCT00539591	-	-	Completed	-	-
NCT02813135	Children, Adolescents and Youn... more >>g Adults With Refractory or Recurrent Malignancies Collapse <<	Phase 1 Phase 2	Recruiting	January 2022	France ... more >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Birgit Geoerger, MD 1 42 11 4661 ext +33 birgit.geoerger@gustaveroussy.fr Contact: Xavier Paoletti, MD 1 42 11 6564 ext +33 xavier.paoletti@gustaveroussy.fr Principal Investigator: Birgit Geoerger, MD Germany University Children's Hospitalermany Not yet recruiting Heidelberg, Germany Contact: Olaf Witt, MD 6221 56 4555 ext +49 O.Witt@Dkfz-Heidelberg.de Italy Fondazione IRCCS Istituto Nazionale dei Tumori Not yet recruiting Milan, Italy Contact: Michela Casanova, MD 02 23 90 25 94 ext +39 Michela.Casanova@istitutotumori.mi.it Netherlands Erasmus MC, Sophia Children's Hospital Not yet recruiting Rotterdam, Netherlands Contact: Michel Zwaan, MD 10 703 6691 ext +31 c.m.zwaan@erasmusmc.nl Spain Unidad de Oncología Pediátrica Hospital Niño Jesús Not yet recruiting Madrid, Spain, 28009 Contact: Francisco Bautista, MD 915 035 900 ext +43 franciscojose.bautista@salud.madrid.org United Kingdom Pediatric and Adolescent Oncology The Royal Marsden Hospital Not yet recruiting Sutton, United Kingdom Contact: Lynley Marshall, MD 208 661 3678 ext +44 Lynley.Marshall@icr.ac.uk Collapse <<
NCT02310451	Metastatic Melanoma	Not Applicable	Unknown	December 2016	France ... more >> CHU de Nice ^Hôpital de l'Archet Recruiting Nice, France, 06200 Contact: Vanina OLIVERI, CRA 0033 4 92 03 42 54 oliveri.v@chu-nice.fr Collapse <<
NCT02820857	Neuroendocrine Carcinomas	Phase 2	Recruiting	March 4, 2022	France ... more >> Service d'Hépato-Gastroenterologie et Oncologie Digestive, Hôpital Sud, CHU d'Amiens Recruiting Amiens, France, 80054 Contact: Vincent HAUTEFEUILLE, MD Principal Investigator: Vincent HAUTEFEUILLE, MD Service d'Hépatogastroentérologie, CHU d'Angers Recruiting Angers, France, 49933 Contact: Guillaume ROQUIN, MD Principal Investigator: Guillaume ROQUIN, MD Service de Gastroentérologie et Pancréatologie, Hôpital Beaujon, APHP Recruiting Clichy, France, 92118 Contact: Olivia HENTIC, MD Principal Investigator: Olivia HENTIC, MD Service d'Hépato-Gastroentérologie et Oncologie Digestive, CHU de Dijon Recruiting Dijon, France, 21000 Contact: Côme LEPAGE, MD Principal Investigator: Côme LEPAGE, MD Service d'Hépatogastroentéologie, Hôpital Michallon, CHU de Grenoble Recruiting Grenoble, France, 38043 Contact: Victoire GRANGER, MD Principal Investigator: Victoire GRANGER, MD Département de Cancérologie Urologique et Digestive, Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Farid EL HAJBI, MD Principal Investigator: Farid EL HAJBI, MD Service d'Oncologie Médicale - Hôpital Edouard Herriot - Hospices Civils de Lyon Recruiting Lyon, France, 69437 Contact: Thomas WALTER, MD 4 72 11 73 98 ext +33 thomas.walter@chu-lyon.fr Principal Investigator: Thomas WALTER, MD Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Hôpital de la Timone, APHM Recruiting Marseille, France, 13365 Contact: Laetitia DAHAN, MD Principal Investigator: Laetitia DAHAN, MD Service d'Oncologie Médicale, Hôpital Saint Eloi, CHU de Montpellier Recruiting Montpellier, France, 34298 Contact: Eric ASSENAT, MD Principal Investigator: Eric ASSENAT, MD Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Hôpital de la Salpêtrière, APHP Recruiting Paris, France, 75013 Contact: Olivier DUBREUIL, MD Principal Investigator: Olivier DUBREUIL, MD Service de Gastroentérologie, Hôpital Cochin, APHP Recruiting Paris, France, 75014 Contact: Romain CORIAT, MD Principal Investigator: Romain CORIAT, MD Service d'Hépato-Gastroenterologie et Oncologie Digestive, Hôpital Européen Georges Pompidou, APHP Recruiting Paris, France, 75015 Contact: Céline LEPERE, MD Principal Investigator: Céline LEPERE, MD Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Hôpital Haut Lévêque, CHU Bordeaux Recruiting Pessac, France, 33604 Contact: Denis SMITH, MD Principal Investigator: Denis SMITH, MD Pôle Régional de Cancérologie, CHU de Poitiers Recruiting Poitiers, France, 86021 Contact: Aurélie FERRU, MD Principal Investigator: Aurélie FERRU, MD Service d'Hépato-Gastroentérologie et Cancérologie, Hôpital Robert Debré, CHU de Reims Recruiting Reims, France, 51100 Contact: Guillaume CADIOT, MD Principal Investigator: Guillaume CADIOT, MD Service d'Hépatogastroentérologie, Hôpital Pontchaillou, CHU de Rennes Recruiting Rennes, France, 35000 Contact: Astrid LIEVRE, MD Principal Investigator: Astrid LIEVRE, MD Service de Gastroentérologie, CHU de Rouen Recruiting Rouen, France, 76031 Contact: Alice GANGLOFF, MD Principal Investigator: Alice GANGLOFF, MD Service de Gastro-Entérologie, Hôpital Nord, CHU de ST-Etienne Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Nadia BOUARIOUA, MD Principal Investigator: Nadia BOUARIOUA, MD Service d'Oncologie Médicale, Hôpital Civil, CHU de Strasbourg Recruiting Strasbourg, France, 67200 Contact: Jean-Emmanuel KURTZ, MD Principal Investigator: Jean-Emmanuel KURTZ, MD Service d'Oncologie Endocrinienne, Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Eric BAUDIN, MD Principal Investigator: Eric BAUDIN, MD Collapse <<
NCT00094653	Melanoma Meta... more >>stases Collapse <<	Phase 3	Completed	-	-
NCT02663271	Glioblastoma Multiforme ... more >> Glioblastoma Malignant Glioma GBM Collapse <<	Phase 2	Recruiting	March 2019	United States, Florida ... more >> University of Florida Recruiting Gainesville, Florida, United States, 32611 Contact: David Tran, MD, PhD 352-294-8137 david.tran@neurosurgery.ufl.edu Principal Investigator: David D Tran, MD, PhD United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Grayson Talcott, BS 314-273-0656 wu-grayson@wustl.edu Principal Investigator: George Ansstas, M.D. Collapse <<
NCT03631836	Glioblastoma	Phase 1	Not yet recruiting	January 1, 2022	France ... more >> Assistance Publique des Hôpitaux de Marseille Not yet recruiting Marseille, France, 13354 Contact: Olivier CHINOT, PU-PH 491385500 ext +33 olivier.chinot@ap-hm.fr Principal Investigator: Olivier CHINOT, PU-PH Collapse <<
NCT03632135	Recurrent Glioblastoma	Phase 3	Recruiting	January 31, 2022	United States, Mississippi ... more >> University of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 Contact: Mark D. Anderson, MD 601-984-5517 manderson4@umc.edu United States, Ohio University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Nicholas Marko, MD 513-558-3559 nicholas.marko@uc.edu Contact: , RN Toledo University Recruiting Toledo, Ohio, United States, 43614 Contact: Jason Schroeder, MD 419-383-4000 Jason.Schroeder5@UToledo.edu Contact: Stephanie Smiddy, RN 419-383-6962 stephanie.smiddy@UToledo.edu United States, Pennsylvania The Penn State Univeristy College of Medicine Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Dawit Aregawi, MD 717-531-3828 daregawi@PennStateHealth.psu.edu Allegheny Health Network Recruiting Pittsburgh, Pennsylvania, United States, 15212 Contact: Tulika Ranjan, MD 412-770-3039 Tulika.RANJAN@ahn.org United States, West Virginia Charleston Area Medical Center Recruiting Charleston, West Virginia, United States, 25326 Contact: Steven Jubelirer, MD 304-388-8380 steven.jubelirer@camc.org Contact: Tina Garten, RN 304-388-9995 Tina.Garten@camc.org Collapse <<
NCT03185780	Quality of Life ... more >> Chemotherapeutic Toxicity Radiation Toxicity Collapse <<	Not Applicable	Withdrawn(Unable to attain fun... more >>ding) Collapse <<	December 31, 2019	-
NCT01403285	Glioblastoma	Phase 1	Terminated(Due to poor accrual... more >>. This decision was taken without any safety reasons. Since beginning of the study (June 2011) only six patients were enrolled.) Collapse <<	-	United States, Maryland ... more >> Neuro-Oncology Branch of the National Cancer Institute, National Institutes of Health Bethesda, Maryland, United States, 20892 Collapse <<
NCT00094653	-	-	Completed	-	-
NCT03672721	Glioblastoma Multiforme ... more >> Relapse Collapse <<	Phase 1 Phase 2	Recruiting	July 10, 2021	Canada, Quebec ... more >> CHUS Recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: David Fortin, MD 819-346-1110 ext 13895 david.fortin@usherbrooke.ca Contact: marie-André Roy, nurse 819-346-1110 ext 13895 maroy.chus@ssss.gouv.qc.ca Collapse <<
NCT02466828	Glioblastoma ... more >>Hypoxia Collapse <<	Early Phase 1	Completed	-	Canada, Ontario ... more >> Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Collapse <<
NCT00800917	Glioblastoma Multiforme	Phase 2	Completed	-	Denmark ... more >> Rigshospitalet Copenhagen, Denmark Collapse <<
NCT02664363	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 1	Active, not recruiting	February 2024	United States, North Carolina ... more >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Collapse <<
NCT02062372	Glioblastoma	Not Applicable	Terminated(Expectation that wi... more >>thin the set time period insufficient patients will be included, so endpoints will not be achieved) Collapse <<	-	Netherlands ... more >> Maastricht Radiation Oncology (MAASTRO clinic) Maastricht, Limburg, Netherlands, 6229ET Collapse <<
NCT01308632	Glioblastoma	Phase 2 Phase 3	Unknown	June 2012	-
NCT02751138	-	-	Recruiting	September 1, 2019	Germany ... more >> Department of Neurosurgery Recruiting Ulm, Germany, 89081 Contact: Monika Deininger +4982219622504 monika.deininger@bkh-guenzburg.de Collapse <<
NCT02067156	Glioblastoma Multiforme	Phase 2	Completed	-	United States, California ... more >> University of California, San Diego Moores Cancer Center La Jolla, California, United States, 92093 Collapse <<
NCT03370926	-	-	Recruiting	October 31, 2019	France ... more >> CHRU de Brest Recruiting Brest, France, 29609 Contact: Ulrike SCHICK ulrike.schick@chu-brest.fr Collapse <<
NCT02876003	Glioblastoma	Phase 2	Withdrawn(This study has been ... more >>withdrawn prior to enrollment.) Collapse <<	October 2020	United States, California ... more >> John Wayne Cancer Institute Santa Monica, California, United States, 90404 Collapse <<
NCT01854099	Glioblastoma	Phase 1	Withdrawn(Investigator decided... more >> not to open study.) Collapse <<	-	-
NCT03607643	Cancer of Pancreas ... more >> Cancer of Liver Cancer of Rectum Cancer of Colon Cancer, Gall Bladder Myeloma Multiple Glioblastoma Multiforme Collapse <<	Phase 1 Phase 2	Not yet recruiting	December 15, 2020	United States, Florida ... more >> Southwest Cancer Center Not yet recruiting Orlando, Florida, United States, 32806 Contact: Sarah Katta, DO 407-426-8660 sarahfk1978@yahoo.com Contact: Philip Arlen, PhD 407-443-0656 parlen@leafvertical.com Collapse <<
NCT00111007	Melanoma	Phase 3	Completed	-	-
NCT03582514	Glioblastoma Multiforme	Phase 1 Phase 2	Not yet recruiting	July 1, 2022	Netherlands ... more >> The Netherlands Cancer Institute Not yet recruiting Amsterdam, Noord-Holland, Netherlands, 1066CX Contact: Gerben R Borst, MD,PhD Medisch Centrum Slotervaart Active, not recruiting Amsterdam, Noord-Holland, Netherlands, 1066EC Collapse <<
NCT03311542	-	-	-	-	Belarus ... more >> N.N. Alexandrov National Cancer Centre Minsk, Belarus, 223040 Hong Kong The Hong Kong Cancer Institute Hong Kong, Hong Kong, 518031 Tajikistan "Cancer Research Center" of the Ministry of Health of the Republic of Tajikistan Dushanbe, Tajikistan, 734026 Uzbekistan Republican Cancer Research Center of the Ministry of Health of the Republic of Uzbekistan (RENTC MH RUz) Tashkent, Uzbekistan, 100049 Collapse <<
NCT02986815	Glioma	Not Applicable	Recruiting	December 2021	United States, Texas ... more >> University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75063 Contact: Sarh McNeil, RN 214-645-8166 sarah.mcneil@utsouthwestern.edu Principal Investigator: Robert Bachoo, MD Collapse <<
NCT01827384	Advanced Malignant Solid Neopl... more >>asm Collapse <<	Not Applicable	Suspended(Scheduled Interim Mo... more >>nitoring) Collapse <<	-	United States, Colorado ... more >> University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Kentucky University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Maryland National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States, 20892 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT01737346	Recurrent Glioblastoma Multifo... more >>rme Collapse <<	Phase 2	Unknown	April 2014	Korea, Republic of ... more >> Ajou University Hospital Recruiting Wonchon-dong, Suwon, Korea, Republic of, 443-721 Contact: Se-Hyuk Kim, Doctor 82-31-219-5235 nsksh@ajou.ac.kr Principal Investigator: Se-Hyuk Kim, Doctor Collapse <<
NCT03616860	Glioblastoma	Not Applicable	Recruiting	December 2021	Canada, Ontario ... more >> Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Maheleth Contact 416-480-6100 ext 2476 maheleth.llinas@sunnybrook.ca Principal Investigator: Nir Lipsman, MD Collapse <<
NCT00392886	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 3	Unknown	-	-
NCT00111007	-	-	Completed	-	-
NCT03291314	Recurrent Glioblastoma (WHO-Gr... more >>ade IV Glioma) Collapse <<	Phase 2	Recruiting	September 30, 2018	Belgium ... more >> UZ Brussel Recruiting Brussel, Belgium, 1090 Contact: Bart Neyns, Phd,Md +32 2 477 ext 54 47 bart.neyns@uzbrussel.be Principal Investigator: Bart Neyns, Phd,Md Collapse <<
NCT00813566	-	-	Recruiting	July 2022	United States, Utah ... more >> Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Collapse <<
NCT03217097	Neuroendocrine Tumors	Phase 4	Not yet recruiting	October 2021	France ... more >> Hôpital Sud - CHU Amiens Not yet recruiting Amiens, France, 80054 Contact: Vincent HAUTEFEUILLE, MD Principal Investigator: Vincent HAUTEFEUILLE, MD CHU d'Angers Not yet recruiting Angers, France, 49933 Contact: Sandrine LABOUREAU, MD Principal Investigator: Sandrine LABOUREAU, MD Hôpital Beaujon - APHP Not yet recruiting Clichy, France, 92118 Contact: Olivia HENTIC, MD Principal Investigator: Olivia HENTIC, MD Hôpital François Mitterrand - CHU Dijon Bourgogne Not yet recruiting Dijon, France, 21000 Contact: Côme LEPAGE, MD Principal Investigator: Côme LEPAGE, MD Hôpital André Michalon - CHU Grenoble Alpes Not yet recruiting La Tronche, France, 38700 Contact: Victoire GRANGER, MD Principal Investigator: Victoire GRANGER, MD Centre Oscar Lambret Not yet recruiting Lille, France, 59020 Contact: Eric DANSIN, MD Principal Investigator: Eric DANSIN, MD Hôpital Claude Hurriet - CHRU Lille Not yet recruiting Lille, France, 59037 Contact: Christine DO CAO, MD Principal Investigator: Christine DO CAO, MD Hôpital Edouard Herriot - Hospices Civils de Lyon Not yet recruiting Lyon, France, 69003 Contact: Thomas WALTER, MD Principal Investigator: Catherine LOMBARD BOHAS, MD Sub-Investigator: Thomas WALTER, MD Hôpital Privé Jean Mermoz Not yet recruiting Lyon, France, 69008 Contact: Jérôme DESRAMES, MD Principal Investigator: Jérôme DESRAMES, MD Centre Léon Bérard Not yet recruiting Lyon, France, 69373 Contact: Matthieu SARABI, MD Principal Investigator: Matthieu SARABI, MD Institut Paoli Calmettes Not yet recruiting Marseille, France, 13009 Contact: Patricia NICCOLI, MD Principal Investigator: Patricia NICCOLI, MD Hôpital Saint Eloi - CHU Montpellier Not yet recruiting Montpellier, France, 34090 Contact: Eric ASSENAT, MD Principal Investigator: Eric ASSENAT, MD Hôpital Saint Louis - APHP Not yet recruiting Paris, France, 75010 Contact: Thomas APARICIO, MD Principal Investigator: Thomas APARICIO, MD Hôpital Cochin - APHP Not yet recruiting Paris, France, 75014 Contact: Romain CORIAT, MD Principal Investigator: Romain CORIAT, MD CH Annecy Genevois Not yet recruiting Pringy, France, 74374 Contact: Mathieu BACONNIER, MD Principal Investigator: Mathieu BACONNIER, MD Hôpital Robert Debré - CHU Reims Not yet recruiting Reims, France, 51092 Contact: Guillaume CADIOT, MD Principal Investigator: Guillaume CADIOT, MD Hôpital Nord - CHU Saint Etienne Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Nicolas WILLIET, MD Principal Investigator: Nicolas WILLIET, MD Institut de Cancérologie de la Loire Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Léa SABAN-ROCHE, MD Principal Investigator: Léa SABAN-ROCHE, MD Hôpital Rangueil - CHU Toulouse Not yet recruiting Toulouse, France, 31059 Contact: Rosine GUIMBAUD, MD Principal Investigator: Rosine GUIMBAUD, MD Hôpital Trousseau - CHU Tours Not yet recruiting Tours, France, 37044 Contact: Thierry LECOMTE, MD Principal Investigator: Thierry LECOMTE, MD Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Eric BAUDIN, MD Principal Investigator: Eric BAUDIN, MD Collapse <<
NCT00846430	Neurofibromatosis 1	Phase 2	Unknown	December 2017	United States, Michigan ... more >> Helen DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 Collapse <<
NCT00422682	Tumors	Phase 1	Completed	-	United States, Connecticut ... more >> Research Site New Haven, Connecticut, United States United States, Michigan Research Site Detroit, Michigan, United States United States, New York Research Site New York City, New York, United States United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States United States, Texas Research Site Houston, Texas, United States Research Site San Antonio, Texas, United States Collapse <<
NCT01666600	Glioblastoma Multiforme	Phase 1 Phase 2	Terminated(Interim Analysis fo... more >>r Feasibility) Collapse <<	-	Germany ... more >> University Hospital Heidelberg, Department of Neurooncology Heidelberg, Baden-Württemberg, Germany, 69120 University Hospital Heidelberg, Department of Pharmacology Heidelberg, Baden-Württemberg, Germany, 69120 Collapse <<
NCT02596828	Pineoblastoma	Phase 2	Recruiting	April 2020	Germany ... more >> University Hospital of Regensburg Recruiting Regensburg, Germany, 93053 Contact: Selim Corbacioglu, MD 0043 (0)941 944 ext 2101 kinderonkologie@ukr.de Contact: Susanne Ellinger 0043 (0)941 944 ext 2063 susanne.ellinger@ukr.de Collapse <<
NCT01861990	Pediatric Brain Tumor ... more >> Glioma Anaplastic Astrocytoma Medulloblastoma Glioblastoma Collapse <<	Phase 1	Withdrawn(Feasibility of the t... more >>rial was proven to be absent.) Collapse <<	-	United States, South Carolina ... more >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Collapse <<
NCT00084838	Central Nervous System Tumor, ... more >>Pediatric Collapse <<	Phase 2	Completed	-	United States, California ... more >> Stanford Cancer Center Stanford, California, United States, 94305-5826 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520-8028 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus Atlanta, Georgia, United States, 30342 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States, 55404 United States, Nevada Sunrise Hospital and Medical Center Las Vegas, Nevada, United States, 89109 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Collapse <<
NCT01933815	Glioblastoma Multiforme	Phase 1 Phase 2	Suspended(Temporarily suspende... more >>d for financial reasons) Collapse <<	March 2019	United States, Alabama ... more >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35249 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York The Long Island Brain Tumor Center at Neurological Surgery, P.C. Commack, New York, United States, 11725 The Long Island Brain Tumor Center at Neurological Surgery, P.C. Lake Success, New York, United States, 11042 University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43210 United States, Texas Memorial Hermann Hospital Houston, Texas, United States, 77030 United States, Washington Swedish Neuroscience Institute Seattle, Washington, United States, 98122 Collapse <<
NCT00084838	-	-	Completed	-	-
NCT01105988	Glioblastoma	Early Phase 1	Terminated(Funding ended)	-	United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Collapse <<
NCT00098774	Lymphoma	Phase 2	Completed	-	-
NCT00098774	-	-	Completed	-	-
NCT03047473	Glioblastoma Multiforme of Bra... more >>in Collapse <<	Phase 2	Recruiting	March 2020	Canada, Quebec ... more >> Clinique Neuro-Outaouais Recruiting Gatineau, Quebec, Canada, J9J 0A5 Contact: Victorine Sikati-Foko, RN Msc 819-777-2500 ext 3 victorine.sikatifoko@neuro-outaouais.ca Collapse <<
NCT00936156	Metastatic, Cerebral Primitive... more >> Neuroectodermal Tumors Collapse <<	Phase 2	Completed	-	France ... more >> Institut Gustave Roussy Villejuif, France, 94800 Collapse <<
NCT01856933	GBM Glioblast... more >>oma Multiforme Gliosarcoma Collapse <<	Phase 2	Completed	-	United States, Rhode Island ... more >> Rhode Island Hospital Providence, Rhode Island, United States, 02903 United States, Texas UT Southwestern Dallas, Texas, United States, 75235 Collapse <<
NCT02047214	Glioblastoma Multiforme	Phase 2	Terminated(Due to lack of clin... more >>ical benefit in the 17 subjects enrolled in the trial to date) Collapse <<	-	United States, Alabama ... more >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35249 United States, Florida H Lee Moffitt Cancer Center and Research Institute, Inc. Tampa, Florida, United States, 33612 United States, Illinois Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 United States, Missouri Washington University, School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43210 United States, Texas Memorial Hermann Hospital Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health System Charlottesville, Virginia, United States, 22908 United States, Washington Swedish Neuroscience Institute Seattle, Washington, United States, 98122 Collapse <<
NCT02727387	Ewing's Sarcoma (ES)	Phase 2	Recruiting	May 2020	Italy ... more >> Centro di Riferimento Oncologico - Unit of Medical Oncology Not yet recruiting Aviano, Pordenone, Italy, 33081 Contact: Maurizio Mascarin, MD +390434659 ext 536 mascarin@cro.it Principal Investigator: Maurizio Mascarin, MD I.R.C.C. - Unit of Medical Oncology Recruiting Candiolo, Torino, Italy, 10060 Contact: Massimo Aglietta, MD +39.011.9933 ext 628 massimo.aglietta@ircc.it Principal Investigator: Massimo Aglietta, MD Sub-Investigator: Giovanni Grignani, MD Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD +390516366199 ext 199 stefano.ferrari@ior.it Principal Investigator: Stefano Ferrari, MD Servizio di Oncoematologi Pediatrica Ospedale microcitemico ASL 8 Recruiting Cagliari, Italy, Rosamaria Contact: Rosamaria Mura, MD +39070504208 Principal Investigator: Rosamaria Mura, MD A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD +3905556 ext 621 a.tamburini@meyer.it Principal Investigator: Angela Tamburini, MD Istituto Giannina Gaslini Recruiting Genova, Italy Contact: Carla Manzitti, MD 0105636 2431 Principal Investigator: Carla Manzitti, MD Fondazione IRCCS INT Milano Recruiting Milano, Italy Contact: Rossella Bertulli, MD +390223903 ext 287 rossella.bertulli@istitutotumori.mi.it Principal Investigator: Rossella Bertulli, MD Fondazione IRCCS INT Milano Recruiting Milano, Italy Contact: Roberto Luksch, MD +390223903 Principal Investigator: Roberto Luksch, MD Ospedale Pediatrico Bambin Gesu' Recruiting Roma, Italy Contact: Raffaele Cozza, MD +39065266919 Principal Investigator: Raffaele Cozza, MD Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD +39.011.3135 ext 230 franca.fagioli@unito.it Principal Investigator: Franca Fagioli, MD Collapse <<
NCT01856933	-	-	Completed	-	-
NCT02015728	Recurrent Childhood Brain Tumo... more >>r Collapse <<	Not Applicable	Unknown	December 2017	United States, Washington ... more >> Seattle Children's Seattle, Washington, United States, 98105 Collapse <<
NCT01653834	Glioblastoma	Not Applicable	Completed	-	United States, Maryland ... more >> Johns Hopkins University Baltimore, Maryland, United States, 21287 Collapse <<
NCT02302235	Glioblastoma Multiforme of Bra... more >>in Collapse <<	Phase 2	Recruiting	December 2018	United States, Maryland ... more >> MidAtlantic Epilepsy and Sleep Center Recruiting Bethesda, Maryland, United States, 20817 Contact: Ivana Tyrlikova, MD 301-530-9744 tyrlikovai@epilepsydc.com Contact: Pavel Klein, MD 301-704-4925 kleinp@epilepsydc.com Principal Investigator: Pavel Klein, MD Collapse <<
NCT00753246	Adults With Glioblastoma Multi... more >>forma Collapse <<	Phase 3	Completed	-	Germany ... more >> Dep. Neurosurgery, Univ. Hamburg Hamburg, Germany, 20246 Collapse <<
NCT02854228	-	-	Recruiting	December 2020	France ... more >> Groupement Hospitalier Est, Lyon, France Recruiting Bron, France, 69500 Contact: Gerald Raverot, MD PhD (0)472119325 ext +33 gerald.raverot@chu-lyon.fr Contact: Emmanuel Jouanneau, MD PhD (0)472357411 ext +33 emmanuel.jouanneau@chu-lyon.fr Collapse <<
NCT00584883	Brain Tumor	Phase 1	Completed	-	United States, Alabama ... more >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Collapse <<
NCT00323115	-	-	Completed	-	-
NCT03334305	Malignant Glioma	Phase 1	Recruiting	May 2026	United States, Florida ... more >> UF Health Shands Children's Hospital Recruiting Gainesville, Florida, United States, 32608 Contact: Marcia Hodik, RN 352-273-6971 marcia.hodik@neurosurgery.ufl.edu Principal Investigator: Elias Sayour, MD, PhD Collapse <<
NCT00039000	Malignant Melanoma	Phase 3	Completed	-	-
NCT00323115	Glioblastoma Multiforme	Phase 2	Completed	-	United States, New Hampshire ... more >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Collapse <<
NCT01873469	-	-	Active, not recruiting	October 2018	Germany ... more >> Dresden University of Technology, University Hospital Carl Gustav Carus, Department of Radiation Oncology; and DKTK partner site Dresden Dresden, Saxony, Germany, 01307 Collapse <<
NCT02432417	Glioblastoma ... more >>Astrocytoma, Grade IV Collapse <<	Phase 2	Not yet recruiting	January 2024	-
NCT01805453	Newly-diagnosed Glioblastoma	Phase 3	Active, not recruiting	May 15, 2017	France ... more >> Neurology Department - Avicenne Hospital Bobigny, France, 93000 Collapse <<
NCT02501551	Melanoma	Phase 2	Recruiting	June 2019	Korea, Republic of ... more >> Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of, 120-752 Contact: Sang Joon Shin Collapse <<
NCT02678975	Glioma Gliobl... more >>astoma Collapse <<	Phase 2 Phase 3	Recruiting	September 2020	Norway ... more >> Cancer Clinic, St.Olavs University Hospital Recruiting Trondheim, Norway Contact: Tora S Solheim, MD, PhD Principal Investigator: Tora S Solheim, MD, PhD Sweden Dept. of Oncology, Sahlgrenska University Hospital Recruiting Gothenburg, Sweden Contact: Katja Werlenius, MD Principal Investigator: Katja Werlenius, MD Ryhov County Hospital Recruiting Jönköping, Sweden Contact: Michael Strandéus, MD Principal Investigator: Michael Strandéus, MD Linköping University Hospital Recruiting Linkoping, Sweden Contact: Munila Mudaisi, MD Principal Investigator: Munila Mudaisi, MD Lund University Hospital Recruiting Lund, Sweden Contact: Sara Kinhult, MD, PhD Principal Investigator: Sara Kinhult, MD, PhD Karolinska University Hospital Recruiting Stockholm, Sweden Contact: Sofia Hylin, MD Principal Investigator: Sofia Hylin, MD Uppsala University Hospital Recruiting Uppsala, Sweden Contact: Magnus Lindskog, MD, PhD Principal Investigator: Magnus Lindskog, MD, PHD Örebro University Hospital Recruiting Örebro, Sweden Contact: David Löfgren, MD Principal Investigator: David Löfgren, MD Collapse <<
NCT03526822	Brain Tumor	Not Applicable	Recruiting	May 1, 2022	France ... more >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13354 Contact: Emeline TABOURET, PH 491385500 ext +33 emeline.tabouret@ap-hm.fr Contact: Dominique FIGARELLA, PU-PH 413429011 ext +33 dominique.figarella-branger@ap-hm.fr Principal Investigator: Emeline TABOURET, PH Sub-Investigator: Olivier CHINOT, PU-PH Sub-Investigator: Philippe METELLUS, PU-PH Collapse <<
NCT00669669	Glioblastoma ... more >>Gliosarcoma Collapse <<	Phase 1 Phase 2	Active, not recruiting	December 31, 2027	United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Collapse <<
NCT01091792	Glioblastoma Multiforme	Early Phase 1	Completed	-	United States, New Hampshire ... more >> Dartmouth Hithcock Medcial Center Lebanon, New Hampshire, United States, 03756 Collapse <<
NCT02666066	-	-	Completed	-	Netherlands ... more >> Maastricht Radiation Oncology (MAASTRO clinic) Maastricht, Limburg, Netherlands, 6229ET Collapse <<
NCT00412542	Glioblastoma Multiforme ... more >> Glioma Collapse <<	Phase 2	Completed	-	United States, Texas ... more >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02843230	-	-	Recruiting	August 31, 2021	United States, Massachusetts ... more >> Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Eva-Maria Ratai, PhD 617-726-1744 eratai@mgh.harvard.edu Principal Investigator: Eva-Maria Ratai, PhD Collapse <<
NCT01868906	Malignant Glioma	Phase 2	Terminated(Isotope (FMISO) pro... more >>duction is no longer available in our country.) Collapse <<	-	Spain ... more >> Dr. Negrin University Hospital Las Palmas, Spain, 35010 Instituto Tecnologico Servicios Sanitarios, in MD Anderson Cancer Center, Madrid Madrid, Spain, 28.033 Collapse <<
NCT02619864	Glioblastoma Multiforme	Phase 1	Active, not recruiting	December 2019	Canada, Alberta ... more >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario University Health Network Toronto, Ontario, Canada, M5G 2M9 Collapse <<
NCT02366728	Glioblastoma ... more >>Astrocytoma, Grade IV Giant Cell Glioblastoma Glioblastoma Multiforme Collapse <<	Phase 2	Active, not recruiting	June 2020	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00412542	-	-	Completed	-	-
NCT01946529	Desmoplastic Small Round Cell ... more >>Tumor Ewing Sarcoma of Bone or Soft Tissue Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Collapse <<	Phase 2	Active, not recruiting	July 2026	United States, Tennessee ... more >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Collapse <<
NCT01946529	-	-	Active, not recruiting	-	-
NCT01181193	Glioblastoma Multiforme	Phase 1 Phase 2	Unknown	March 2014	Israel ... more >> Soroka University Medical Center Recruiting Beer Sheva, Israel, 84101 Contact: Konstantin Lavrenkov, MD, PhD +97286400537 constant@bgu.ac.il Contact: Olga Belochitski, MD +97286400537 olgab@clalit.org.il Sub-Investigator: Vladimir Gavrilov, MD, PhD Sub-Investigator: Olga Belochitski, MD Sub-Investigator: Vladimir Merkin, MD Collapse <<
NCT01639612	Grade IV Malignant Glioma	Phase 1	Completed	-	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT02394665	Glioblastoma	Phase 2	Terminated(Lack of Accrual/Enr... more >>ollment) Collapse <<	-	United States, Florida ... more >> University of Miami Miami, Florida, United States, 33136 Collapse <<
NCT03687957	Glioma	Phase 1 Phase 2	Not yet recruiting	October 31, 2022	United States, Missouri ... more >> Washington University School of Medicine Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Jian Campian, M.D., Ph.D. 314-747-4241 campian.jian@wustl.edu Principal Investigator: Jian Campian, M.D., Ph.D. Sub-Investigator: Milan Chheda, M.D. Sub-Investigator: George Ansstas, M.D. Sub-Investigator: Jiayi Huang, M.D. Sub-Investigator: Christina Tsien, M.D. Sub-Investigator: Dinesh Thotala, Ph.D. Sub-Investigator: Richard Hotchkiss, M.D. Sub-Investigator: John DiPersio, M.D., Ph.D. Collapse <<
NCT02394665	-	-	Terminated(Lack of Accrual/Enr... more >>ollment) Collapse <<	-	-
NCT03491683	Glioblastoma	Phase 1 Phase 2	Recruiting	January 18, 2021	United States, California ... more >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Site Care Coordinator Nurse Fatemeh Bidmeshk, BSN 626-218-4062 fbidmeshki@coh.org Principal Investigator: Dr. Jana Portnow Stanford University, School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Study Coordinator Hari Priya Yerraballa 650-724-9363 yhpriya@stanford.edu Principal Investigator: Seema Nagpal, MD University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Study Coordinator Karishma Kumar 415-514-5529 karishma.kumar@ucsf.edu Principal Investigator: Nancy Ann Oberheim Bush, MD United States, Florida University of Miami - Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Study Coordinator Alain Fernandez 305-243-9553 axf1187@med.miami.edu Principal Investigator: Antonio Omuro, MD United States, Michigan Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Study Coordinator John Gaggin, RN 313-916-3731 gaggin1@hfhs.org Principal Investigator: Tobias Walbert, MD United States, New Jersey Rutgers University - Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Study Coordinator Coordinator Sarah Nabeel, CCRP 732-235-8995 sn569@cinj.rutgers.edu Principal Investigator: Robert Aiken, MD United States, New York New York University Langone Medical Center; Perlmutter Cancer Center Recruiting New York, New York, United States, 10016 Contact: Study Coordinator Amie Patel, RN Amie.Patel@nyumc.org Principal Investigator: Andrew Chi, MD, PhD Columbia University Medical Center The Neurological Institute of New York Recruiting New York, New York, United States, 10032 Contact: Clinical Research Manager Natalie Busby 212-305-8487 Nb2718@cumc.columbia.edu Principal Investigator: Dr. Mary Welch United States, Oklahoma Stephenson Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Senior Oncology Research Nurse Team Lead Dena Suthers 405-271-8001 ext 2 Phase1ResearchNurses@ouhsc.edu Principal Investigator: Dr. James Battiste United States, Pennsylvania University of Pennsylvania Health System: Penn Medicine Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Department of Neurosurgery Penn Brain Tumor Center NCRD-BTC@uphs.upenn.edu Principal Investigator: Steven Brem, MD UPMC Cancer Center Neuro-Oncology; UPMC Cancer Pavilion Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Supervisor, Clinical Research Services Melinda Vargas-Jaffe, BSN RN CCRC 412-235-1320 vargasjaffema@upmc.edu Principal Investigator: Dr. Frank Lieberman United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Clinical Research Coordinator Matt Halverson 801-587-4756 Matt.Halverson@hci.utah.edu Principal Investigator: Howard Colman, MD PhD Collapse <<
NCT03224104	Astrocytoma, Grade III ... more >> Glioblastoma Collapse <<	Phase 1	Recruiting	August 2020	France ... more >> CHRU de Lille Recruiting Lille, France Contact: Emilie Le Rhun emilie.lerhun@chru-lille.fr Switzerland UniversitaetsSpital Zurich Recruiting Zürich, Switzerland, 8091 Principal Investigator: Michael Weller Collapse <<
NCT02414009	Metastatic Colorectal Cancer	Phase 2	Unknown	September 2017	Italy ... more >> Fondazione IRCCS Istituto Nazionale Tumori Recruiting Milan, Mi, Italy, 20133 Contact: Filippo Pietrantonio, MD 00390223903807 filippo.pietrantonio@istitutotumori.mi.it Contact trialcenter@istitutotumori.mi.it Principal Investigator: Filippo de Braud, MD Sub-Investigator: Filippo Pietrantonio, MD Collapse <<
NCT00756106	-	-	Terminated(Funding ended)	-	United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Collapse <<
NCT02772094	Glioblastoma Multiforme ... more >> Glioblastoma Collapse <<	Phase 2	Unknown	December 2016	Taiwan ... more >> China Medical University Hospital Taichung, Taiwan, 404 Collapse <<
NCT02864368	Glioblastoma ... more >>Glioblastoma Multiforme Collapse <<	Phase 1	Recruiting	October 2020	United States, North Carolina ... more >> The Preston Robert Tisch Brain Tumor Center at Duke Recruiting Durham, North Carolina, United States, 27710 Contact: Kristen Fisher 919-684-5301 Collapse <<
NCT03419403	Glioblastoma Multiforme	Phase 3	Recruiting	March 8, 2020	-
NCT00626015	Malignant Neoplasms of Brain	Phase 1	Completed	-	United States, North Carolina ... more >> Duke University Medical Center Durham, North Carolina, United States, 27710 Collapse <<
NCT00397072	Glioblastoma	Phase 2	Completed	-	Italy ... more >> Istituto Nazionale Neurologico Milan, Italy, 20133 Collapse <<
NCT00003567	Brain and Central Nervous Syst... more >>em Tumors Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Collapse <<	Phase 1	Terminated(slow accrual)	-	United States, Ohio ... more >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Collapse <<
NCT01704287	Malignant Melanoma	Phase 2	Active, not recruiting	January 31, 2019	-
NCT00960063	Neoplasms Sol... more >>id Tumors Bone Cancer Kidney Tumor Neuroblastoma Collapse <<	Phase 1	Terminated(Study was terminate... more >>d for business reasons.) Collapse <<	-	-
NCT00062933	Melanoma	Phase 2	Completed	-	United States, Maryland ... more >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Collapse <<
NCT00960063	-	-	Terminated(Study was terminate... more >>d for business reasons.) Collapse <<	-	-
NCT01704287	-	-	Active, not recruiting	-	-
NCT02659800	Lymphopenia M... more >>alignant Glioma Collapse <<	Phase 1	Recruiting	August 15, 2022	United States, Alabama ... more >> UAB Comprehensive Cancer Center Not yet recruiting Birmingham, Alabama, United States, 35294-3410 Contact: Thiru Pillay, RN 205-934-1842 thiru@uab.edu Principal Investigator: Burt Nabors, MD United States, California Jonsson Comprehensive Cancer Center at UCLA Not yet recruiting Los Angeles, California, United States, 90095 Contact: Timothy Cloughesy, MD 310-825-5321 TCloughesy@mednet.ucla.edu Principal Investigator: Timothy Cloughesy, MD UCSF Comprehensive Cancer Center Withdrawn San Francisco, California, United States, 94115 United States, Maryland Johns Hopkins Oncology Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Joy D Fisher, CCRP 410-955-8837 jfisher@jhmi.edu Principal Investigator: Stuart A Grossman, MD United States, Massachusetts Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Jennifer Barrs 617-632-6119 JenniferA_Barrs@DFCI.HARVARD.EDU Principal Investigator: Patrick Wen, MD United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Not yet recruiting Detroit, Michigan, United States, 48202 Contact: Amy Williamson, RN awillia12@hfhs.org Contact: Emily Krozek, MHSA Ekrozek1@hfhs.org Principal Investigator: Tobias Walbert, MD United States, Missouri Washington University Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Jian L Campian, MD 314-747-4241 Principal Investigator: Jian Campian, MD United States, New York Memorial Sloan-Kettering Cancer Center Not yet recruiting New York, New York, United States, 10021 Contact: Antonio Omuro, MD 212-639-7523 Principal Investigator: Antonio Omuro, MD United States, North Carolina Wake Forest University Comprehensive Cancer Center Not yet recruiting Winston-Salem, North Carolina, United States, 27157-1096 Contact: Clinical Trials Office - Wake Forest University CCC 336-713-6771 Principal Investigator: Glenn Lesser, MD United States, Ohio Cleveland Clinic Taussig Cancer Center Not yet recruiting Cleveland, Ohio, United States, 44195 Contact: Cancer Center-Cares 216-444-7923 Principal Investigator: David Peereboom, MD Sub-Investigator: Manmeet Ahluwalia, MD United States, Pennsylvania Abrams Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Clinical Trials Office-Abrams Cancer Center 800-474-9892 Principal Investigator: Arati Desai, MD Hillman Cancer Center at University of Pittsburgh Cancer Institute Not yet recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Rita Johnson, RN johnsonr1@msx.upmc.edu Principal Investigator: Frank Lieberman, MD Collapse <<
NCT03225963	-	-	Recruiting	July 31, 2018	Taiwan ... more >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 407 Contact: Weir Chiang You, M.D. PhD 886-4-23592525 ext 5602 bigjohnyou@vghtc.gov.tw Collapse <<
NCT00749723	Recurrent Brain Tumors ... more >> Supratentorial PNETs Medulloblastomas Ependymomas Collapse <<	Phase 2 Phase 3	Completed	-	-
NCT00727506	Glioma	Phase 2	Completed	-	-
NCT03554707	Childhood CNS Tumor	Early Phase 1	Not yet recruiting	March 2020	United States, District of Col... more >>umbia Children's National Medical Center Not yet recruiting Washington, District of Columbia, United States, 20010 Contact: Sabrina Malik 202-476-5115 SaMalik@childrensnational.org Principal Investigator: Eugene Hwang, MD Collapse <<
NCT02399189	Primary Central Nervous System... more >> Lymphoma Collapse <<	Phase 2	Recruiting	April 2019	China, Beijing ... more >> Lijuan Deng Recruiting Beijing, Beijing, China, 100142 Contact: Lijuan Deng, MD 1088196109 lijuan_deng@hotmail.com Contact: Yuqin Song, MD 1088196109 songyuqin622@sina.com Collapse <<
NCT00727506	-	-	Completed	-	-
NCT01165671	Primary Glioblastoma	Phase 2	Unknown	-	Germany ... more >> University Hospital of Heidelberg, Department of Radiation Oncology Recruiting Heidelberg, Germany, 69120 Sub-Investigator: Stephanie E Combs, MD Principal Investigator: Jürgen Debus, MD PhD Collapse <<
NCT01113463	Brain Cancer	Phase 2	Terminated(Low Accrual)	-	United States, Texas ... more >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT03576612	Glioma, Malignant	Phase 1	Active, not recruiting	January 5, 2022	United States, Alabama ... more >> Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham Birmingham, Alabama, United States, 35294 University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095 University of California San Francisco Medical Center San Francisco, California, United States, 94143 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abrams Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Collapse <<
NCT01113463	-	-	Terminated(Low Accrual)	-	-
NCT02014844	Glioblastoma	Phase 2	Completed	-	United States, California ... more >> City of Hope National Medical Center Duarte, California, United States, 91010 Sarcoma Oncology Center Santa Monica, California, United States, 90403 United States, Louisiana Ochsner Health System New Orleans, Louisiana, United States, 70115-6969 United States, Texas Texas Oncology-Austin Midtown Austin, Texas, United States, 78705 Collapse <<
NCT03522298	Glioblastoma, Adult	Phase 2	Recruiting	December 30, 2020	United States, California ... more >> University of California Los Angeles - Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Emese Filka efilka@mednet.ucla.edu Principal Investigator: Timothy Cloughesy, MD United States, Colorado University of Colorado Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Rachel Freedman Rachel.Freedman@ucdenver.edu Principal Investigator: Denise Damek, MD United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Swati Samtani Swati_Samtani@dfci.harvard.edu Principal Investigator: Patrick Wen, MD Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Edwin Nunez Enunez2@mgh.harvard.edu Principal Investigator: Elizabeth Gerstner, MD United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Lori Cappello 551-996-5098 Lori.Cappello@HackensackMeridian.org Principal Investigator: Samual A Goldlust, MD United States, Oklahoma University of Oklahoma Health Sciences Center (Stephenson Cancer Center) Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Julie Schreiner Contact Julie-Schreiner@ouhsc.edu Principal Investigator: James Battiste, MD United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Kathy Hunter 713-745-5769 kuhunter@mdanderson.org Principal Investigator: John de Groot, MD Collapse <<
NCT01284335	-	-	Terminated(Study was terminate... more >>d due to the termination of tasisulam development.) Collapse <<	-	-
NCT01284335	Advanced Solid Tumors	Phase 1	Terminated(Study was terminate... more >>d due to the termination of tasisulam development.) Collapse <<	-	United States, Alabama ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States, 35233 United States, Arkansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States, 72703 United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Denver, Colorado, United States, 80218 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States, 32806 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Park Ridge, Illinois, United States, 60068 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46219 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89169 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albany, New York, United States, 12206 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kettering, Ohio, United States, 45429 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97213 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, South Carolina, United States, 29605 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Austin, Texas, United States, 78731 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75246 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States, 77380 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tyler, Texas, United States, 75702 United States, Virginia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States, 23502 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Spokane, Washington, United States, 99218 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vancouver, Washington, United States, 98684 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yakima, Washington, United States, 98902 Collapse <<
NCT02149225	Glioblastoma	Phase 1	Completed	-	Denmark ... more >> Rigshospitalet, The Finsen Centre, Department of Oncology Copenhagen, Denmark, 2100 Germany Neurologische Klinik & Nationales Centrum für Tumorerkrankungen Heidelberg Heidelberg, Germany, 69120 Zentrum für Neurologie und Klinik für Neurochirurgie Tübingen, Germany, 72076 Netherlands Leiden University Medical Center, Department of Medical Oncology Leiden, Netherlands, 2333ZA Spain Vall d`Hebron University Hospital Barcelona, Spain, 08035 Switzerland Hôpitaux Universitaires de Genève Geneva 14, Switzerland, 1211 Collapse <<
NCT01089868	-	-	Completed	-	Germany ... more >> Department of Stereotactic Neurosurgery Freiburg, Baden Wuertemberg, Germany, 79095 University Hospital Munich, Department of Neurosurgery Munich, Bavaria, Germany, 81377 University Hospital Bonn, Department of Neurosurgery Bonn, North Rhine-Westphalia, Germany, 53127 Collapse <<
NCT00685750	Lung Cancer, Non-Small Cell	Not Applicable	Terminated(Slow enrolment over... more >> the last 2 years with none in the past 1 year. No increase in the number of completed subjects for 1 year and no more ongoing study subjects) Collapse <<	-	United States, California ... more >> GSK Investigational Site Los Angeles, California, United States, 90025 United States, Illinois GSK Investigational Site Park Ridge, Illinois, United States, 60068 United States, Missouri GSK Investigational Site St. Louis, Missouri, United States, 63110 United States, Utah GSK Investigational Site Murray, Utah, United States, 84107 France GSK Investigational Site Dijon, France, 21079 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Marseille, France, 13274 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Nantes, France, 44093 GSK Investigational Site Paris, France, 75012 Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69126 GSK Investigational Site Mannheim, Baden-Wuerttemberg, Germany, 68167 GSK Investigational Site Tuebingen, Baden-Wuerttemberg, Germany, 72076 GSK Investigational Site Regensburg, Bayern, Germany, 93049 GSK Investigational Site Wuerzburg, Bayern, Germany, 97080 GSK Investigational Site Greifswald, Mecklenburg-Vorpommern, Germany, 17487 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Ostercappeln, Niedersachsen, Germany, 49179 GSK Investigational Site Hemer, Nordrhein-Westfalen, Germany, 58675 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 51109 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Berlin, Germany, 12200 GSK Investigational Site Hamburg, Germany, 20246 Italy GSK Investigational Site Napoli, Campania, Italy, 80131 GSK Investigational Site Milano, Lombardia, Italy, 20141 GSK Investigational Site Siena, Toscana, Italy, 53100 GSK Investigational Site Padova, Veneto, Italy, 35128 Sweden GSK Investigational Site Göteborg, Sweden, SE-413 45 GSK Investigational Site Lund, Sweden, SE-221 85 GSK Investigational Site Stockholm, Sweden, SE-171 76 Collapse <<
NCT01743157	Metastatic Melanoma	Phase 1 Phase 2	Completed	-	United States, California ... more >> San Francisco Oncology Associates San Francisco, California, United States, 94115 Collapse <<
NCT01441388	Carcinoma, Renal Cell ... more >> Glioblastoma Carcinoma, Hepatocellular Collapse <<	Phase 1	Withdrawn(Business/Operational... more >> issues) Collapse <<	November 2013	-
NCT02833701	Glioblastoma ... more >>Glioma Collapse <<	Phase 1	Active, not recruiting	March 2019	United States, Nebraska ... more >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Collapse <<
NCT01567202	Glioma Gliobl... more >>astoma Multiforme Neoplasms Collapse <<	Phase 2	Unknown	December 2016	China, Shanghai ... more >> Huashan hospital, Fudan university Recruiting Shanghai, Shanghai, China, 200040 Contact: Liangfu Zhou, M.D. 86-21-52889999-7206 lfzhouc@126.com Contact: Wei Hua, M.D.,Ph.D. 15800589540 doctor.huawei@gmail.com Principal Investigator: Liangfu Zhou, M.D. Sub-Investigator: Yiwei Chu, M.D.,Ph.D. Sub-Investigator: Yu Yao, M.D.,Ph.D. Collapse <<
NCT01576692	Neuroblastoma	Phase 1	Completed	-	United States, Tennessee ... more >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Collapse <<
NCT00072358	Neuroblastoma	Phase 2	Active, not recruiting	December 2019	United States, New York ... more >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Collapse <<
NCT01678352	High Risk WHO Grade II Glioma ... more >> Recurrent/Post-Chemotherapy WHO Grade II Glioma Collapse <<	Early Phase 1	Active, not recruiting	December 2019	United States, Pennsylvania ... more >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Collapse <<
NCT02717962	Glioma Gliobl... more >>astoma Glioblastoma Multiforme GBM Brain Cancer Collapse <<	Phase 2	Recruiting	June 2021	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Kathy Hunter, R.N. 713-745-5769 kuhunter@mdanderson.org Contact: Stephanie Knight, B.S.N., R.N. 713-563-8746 SRKnight@mdanderson.org Principal Investigator: Barbara O'Brien, M.D. Sub-Investigator: Marta Penas-Prado, M.D. Sub-Investigator: Rivkah Cohen, M.D. Sub-Investigator: Carlos Kamiya-Matsuoka, M.D. Sub-Investigator: John DeGroot, M.D. Sub-Investigator: Monica Loghin, M.D. Sub-Investigator: Shiao-Pei Weathers, M.D. Sub-Investigator: W.K. Alfred Yung, M.D. Sub-Investigator: Greg Fuller, M.D. Sub-Investigator: Kenneth Hess, Ph.D. Collapse <<
NCT03739333	Glioblastoma	Not Applicable	Not yet recruiting	January 15, 2024	France ... more >> Hopices Civils de Lyon Not yet recruiting Bron, France, 69 677 Contact: DUCRAY François, MD 00 (33) 4 72 68 13 21 francois.ducray@chu-lyon.fr Contact: ISAL Sibel, MD 00 (33) 4 72 35 76 29 sibel.isal@chu-lyon.fr Collapse <<
NCT00811993	Neoplasms	Phase 1	Terminated	-	United States, Arizona ... more >> Tucson, Arizona, United States, 85724 United States, California San Francisco, California, United States, 94115 Santa Monica, California, United States, 90025 United States, District of Columbia Washington, District of Columbia, United States, 20007 United States, Illinois Chicago, Illinois, United States, 60637 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, North Carolina Chapel Hill, North Carolina, United States, 27514 United States, Texas Houston, Texas, United States, 77030 Collapse <<
NCT01089244	-	-	Unknown	December 2015	Germany ... more >> University Hospital Munich, Department of Neurosurgery Munich, Bavaria, Germany, 81377 University Hospital, Duesseldorf Duesseldorf, North Rhine-Westphalia, Germany, 40225 Collapse <<
NCT02747407	Astrocytoma G... more >>lioma Oligodendroglioma Collapse <<	Phase 2	Recruiting	January 2019	United States, North Carolina ... more >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Roy E. Strowd 336-716-3545 rstrowd@wakehealth.edu Principal Investigator: Roy E. Strowd Collapse <<
NCT03278249	Glioblastoma	Not Applicable	Recruiting	January 2021	United States, Ohio ... more >> UC Health Recruiting Cincinnati, Ohio, United States, 45219 Contact: University of Cincinnati Cancer Institute 513-584-7698 kastla@ucmail.uc.edu Collapse <<
NCT01587040	Neoplasm Malignant	Phase 1 Phase 2	Completed	-	-
NCT00045968	Glioblastoma Multiforme ... more >> Glioblastoma GBM Grade IV Astrocytoma Glioma Brain Cancer Brain Tumor Collapse <<	Phase 3	Unknown	-	-
NCT02997423	-	-	Active, not recruiting	November 2020	United States, Alabama ... more >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California UC Davis Sacramento, California, United States United States, Florida University of Miami Miami, Florida, United States United States, Illinois Northwestern University Chicago, Illinois, United States United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 64154 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States United States, Missouri Washington University Medical School Saint Louis, Missouri, United States, 63110 United States, New York Montefiore Medical Center Bronx, New York, United States Columbia University Medical Center New York, New York, United States University of Rodchester Medical Center Rochester, New York, United States SUNY Stony Brook Stony Brook, New York, United States United States, Ohio University of Cincinnati Cincinnati, Ohio, United States Ohio State University Columbus, Ohio, United States United States, Oregon Oregon Health & Science University Portland, Oregon, United States United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States United States, Tennessee Vanderbilt University Nashville, Tennessee, United States United States, Texas University of Texas Southwestern Dallas, Texas, United States United States, Utah University of Utah Salt Lake City, Utah, United States United States, Washington Swedish Neuroscience Institute Seattle, Washington, United States, 98122 Collapse <<
NCT01811992	Malignant Glioma ... more >> Glioblastoma Multiforme Collapse <<	Phase 1	Recruiting	December 2018	United States, Michigan ... more >> University of Michigan Health System Department of Neurosurgery Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Karen Frisch 734-232-4843 kfrisch@med.umich.edu Collapse <<
NCT03072134	Glioma Anapla... more >>stic Astrocytoma Anaplastic Oligodendroglioma Anaplastic Oligoastrocytoma Glioblastoma Multiforme Astrocytoma, Grade III Astrocytoma, Grade IV Brain Cancer Collapse <<	Phase 1	Recruiting	April 1, 2019	United States, Illinois ... more >> Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States, 60611 Contact: Christina Amidei, RN, PhD christina.amidei@northwestern.edu Contact: Maciej Lesniak, MD 3129261094 ext Lesniak maciej.lesniak@northwestern.edu Collapse <<
NCT03032484	Astrocytoma	Phase 2	Recruiting	April 10, 2021	United States, Texas ... more >> University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center Recruiting San Antonio, Texas, United States, 78229 Contact: Epp Goodwin CTRCReferral@uthscsa.edu Principal Investigator: Andew Brenner, MD Sub-Investigator: Adolfo E. Diaz-Duque, MD Collapse <<
NCT03011528	Ewing Sarcoma Family of Tumors	Phase 2	Recruiting	December 2022	France ... more >> Chr Felix Guyon Not yet recruiting La Réunion, Saint Denis, France, 97400 Principal Investigator: Yves REGUERRE, MD Bordeaux Chu Recruiting Bordeaux, France, 33076 Contact: Cécile VERITE-GOULARD, MD +33(0)556795430 cecile.verite@chu-bordeaux.fr CHU Grenoble Alpes Not yet recruiting Grenoble, France, 38043 Principal Investigator: Dominique PLANTAZ, P LILLE Centre Oscar Lambret Recruiting Lille, France, 59000 Contact: Cyril LERVAT, MD +33(0)320295935 c-lervat@o-lambret.fr LYON Centre Léon Bérard Recruiting Lyon, France, 69000 Contact: Nadège CORRADINI, MD +33(0)469166572 nadege.corradini@lyon-unicancer.fr Marseille Chu Not yet recruiting Marseille, France, 13000 Contact: Jean-Claude GENTET, MD +33(0)491386821 jcgentet@ap-hm.fr CHRU Montpellier - Hôpital A. de Villeneuve Recruiting Montpellier, France, 34295 Principal Investigator: Laure SAUMET, MD Nantes Chu Recruiting Nantes, France, 44000 Contact: Estelle THEBAUD, MD +33(0)240083810 estelle.thebaud@chu-nantes.fr PARIS Institut Curie Recruiting Paris, France, 75005 Contact: Valérie LAURENCE, MD +33(0)1 44 32 42 07 valerie.laurence@curie.fr PARIS Trousseau Recruiting Paris, France, 75012 Contact: Marie-Domnique TABONE, MD +33(0)144736062 marie-dominique.tabone@aphp.fr CHU Hôpital Sud Not yet recruiting Rennes, France, 35056 Principal Investigator: Sophie TAQUE, MD Strasbourg Chu Recruiting Strasbourg, France, 67098 Contact: Natacha ENTZ-WERLE, MD +33(0)388128072 natacha.entz-werle@chu-strasbourg.fr Toulouse Chu Recruiting Toulouse, France, 31059 Contact: Marie-Pierre CASTEX, MD +33(0)534558610 castex.mp@chu-toulouse.fr TOULOUSE Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Christine CHEVREAU, MD +33(0)531155151 chevreau.christine@iuct-oncopole.fr NANCY Institut de Cancérologie de Lorraine Not yet recruiting Vandoeuvre les Nancy, France, 54519 Contact: Maria RIOS, MD +33(0)383598358 m.rios@nancy.unicancer.fr Nancy Chu Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Ludovic MANSUY, MD +33(0)383154734 l.mansuy@chu-nancy.fr VILLEJUIF Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Nathalie GASPAR, MD +33(0)142114166 nathalie.gaspar@gustaveroussy.fr Collapse <<
NCT00766467	Malignant Glioma	Phase 2	Completed	-	United States, California ... more >> UCSD San Diego La Jolla, California, United States United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03766 Collapse <<
NCT00766467	-	-	Completed	-	-
NCT02443194	Depression	Phase 3	Terminated(principle investiga... more >>tor decision due to many adverse events in patients) Collapse <<	-	-
NCT01708174	Medulloblastoma	Phase 2	Completed	-	-
NCT03165292	Very High Risk Neuroblastoma	Phase 2	Not yet recruiting	June 2025	France ... more >> Gustave Roussy Not yet recruiting Villejuif, Val de Marne, France, 94805 Contact: Jonathan RUBINO 0142113891 ext +33 jonathan.rubino@gustaveroussy.fr Contact: Camille JANNIN 0142114884 ext +33 camille.jannin@gustaveroussy.fr Principal Investigator: Dominique VALTEAU COUANET, MD, PhD Collapse <<
NCT00003273	Brain and Central Nervous Syst... more >>em Tumors Neuroblastoma Retinoblastoma Sarcoma Collapse <<	Phase 2	Withdrawn	-	United States, Hawaii ... more >> Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 United States, Maine Maine Children's Cancer Program Scarborough, Maine, United States, 04074-9308 United States, Michigan Spectrum Health and DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 United States, Nebraska Children's Hospital of Omaha Omaha, Nebraska, United States, 68114 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 Winthrop University Hospital Mineola, New York, United States, 11501 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Beth Israel Hospital North New York, New York, United States, 10128 State University of New York Health Sciences Center - Stony Brook Stony Brook, New York, United States, 11790-7775 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio St. Vincent Mercy Medical Center Toledo, Ohio, United States, 43608 United States, Pennsylvania Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Argentina Children's Hospital Buenos Aires, Argentina, 1425 Canada, British Columbia British Columbia Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Collapse <<
NCT01596140	Advanced Cancer ... more >> Solid Tumor Collapse <<	Phase 1	Active, not recruiting	December 2020	United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse <<
NCT02465268	Glioblastoma Multiforme ... more >> Glioblastoma Malignant Glioma Astrocytoma, Grade IV GBM Collapse <<	Phase 2	Recruiting	June 2024	United States, Florida ... more >> University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Phuong Deleyrolle, RN 352-273-5529 phuong.deleyrolle@neurosurgery.ufl.edu Principal Investigator: Maryam Rahman, MD Orlando Health Recruiting Orlando, Florida, United States, 32806 Contact: Sherri Walton 321-841-1907 Sherri.Walton@orlandohealth.com Principal Investigator: Nicholas Avgeropoulos, M.D. United States, North Carolina Duke University Medical Center Active, not recruiting Durham, North Carolina, United States, 27710 Collapse <<
NCT03299309	Recurrent Medulloblastoma ... more >> Recurrent Brain Tumor, Childhood Malignant Glioma Collapse <<	Phase 1	Recruiting	June 2022	United States, North Carolina ... more >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Eric Thompson, MD 919-684-5013 pedsneuronc@duke.edu Contact: Charlene Flahiff, MS 919-684-5301 pedsneuronc@duke.edu Collapse <<
NCT01708174	-	-	Completed	-	-
NCT02567539	Recurrent High Grade Glioma	Not Applicable	Recruiting	April 2021	Italy ... more >> Istituto Clinico Humanitas Recruiting Rozzano, Milan, Italy, 20089 Contact: Piera Navarria, MD +390282247458 piera.navarria@cancercenter.humanitas.it Contact: Annamaria Ascolese, MD +390282247456 anna_maria@cancercenter.humanitas.it Principal Investigator: Piera Navarria, MD Principal Investigator: Federico Pessina, MD Sub-Investigator: Marta Scorsetti, MD Sub-Investigator: Lorenzo Bello, MD Sub-Investigator: Annamaria Ascolese, MD Collapse <<
NCT02598011	Newly Diagnosed High Grade Gli... more >>oma (HGG) Collapse <<	Phase 1	Not yet recruiting	-	-
NCT01478178	Glioma Gliobl... more >>astoma Glioblastoma Multiforme GBM Brain Cancer Collapse <<	Phase 1 Phase 2	Completed	-	United States, California ... more >> University of California, San Francisco, Division of Neuro-Oncology San Francisco, California, United States, 94143 United States, Colorado Sarah Cannon Research Institute Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Collapse <<
NCT03463265	High Grade Recurrent Glioma an... more >>d Newly Diagnosed Glioblastoma Collapse <<	Phase 2	Recruiting	June 2021	United States, California ... more >> John Wayne Cancer Institute Recruiting Santa Monica, California, United States, 90404 Contact: Najee Boucher 310-582-7460 najee.boucher@providence.org Collapse <<
NCT03055208	Glioblastoma	Phase 2	Recruiting	September 2020	Germany ... more >> Department of Radiotherapy University Hospital Mannheim Recruiting Mannheim, Germany, 68167 Contact: Frederik Wenz, MD +49 621 383 ext 4960 frederik.wenz@umm.de Collapse <<
NCT02613988	Adult Glioblastoma	Not Applicable	Unknown	-	Korea, Republic of ... more >> Asan Medical Center Recruiting Seoul, Korea, Republic of Collapse <<
NCT00293423	Brain and Central Nervous Syst... more >>em Tumors Collapse <<	Phase 1 Phase 2	Completed	-	United States, California ... more >> UCSF Department of Neurosurgery San Francisco, California, United States, 94143 United States, New York Columbia University New York, New York, United States, 10032 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Collapse <<
NCT00902577	Adult Giant Cell Glioblastoma ... more >> Adult Glioblastoma Adult Gliosarcoma Collapse <<	Phase 2	Active, not recruiting	-	United States, Alabama ... more >> University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States, 35233 United States, California USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Mount Sinai Hospital New York, New York, United States, 10029 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania American College of Radiology Imaging Network Philadelphia, Pennsylvania, United States, 19103 University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98195 Collapse <<
NCT01692496	Advanced and / or Metastatic L... more >>iposarcoma Collapse <<	Phase 2	Completed	-	Germany ... more >> HELIOS Klinikum Berlin-Buch (Sarkomzentrum Berlin-Brandenburg) Berlin, Germany, D-10707 Universitätsklinikum EssenInnere Klinik (Tumorforschung) Essen, Germany, D-45147 Medizinische Hochschule Hannover (Zentrum Innere Medizin) Hannover, Germany, D-30625 Universitätsmedizin Mannheim (Sarkomzentrum) Manheim, Germany, D-68169 Klinikum Großhadern der LMU Universität München (Med. Klinik und Poliklinik II) Munich, Germany, D-80336 Spain Hospital Central de Asturias Oviedo, Asturias, Spain, 33011 Hospital Universitario de Canarias La Laguna, Islas Canarias, Spain, 38320 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Complejo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain, 36204 Hospital Vall d'Hebrón Barcelona, Spain, 08035 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital Universitari Son Espases Palma de Mallorca, Spain, 07010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Instituto Valenciano de Oncología Valencia, Spain, 46009 Hospital Miguel Servet Zaragoza, Spain, 50009 Collapse <<
NCT03235934	-	-	Not yet recruiting	October 1, 2021	Canada, Ontario ... more >> Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Collapse <<
NCT01880008	-	-	Completed	-	United States, Missouri ... more >> Washington University School of Medicine/Barnes-Jewish Hospital St. Louis, Missouri, United States, 63110 Collapse <<
NCT02654041	Glioblastoma Multiforme (GBM)	Phase 2	Terminated(Drug manufacturer n... more >>o longer could supply for study) Collapse <<	-	Israel ... more >> Tel-Aviv Medical Center, Israel Tel-Aviv, Israel, 64239 Collapse <<
NCT02622620	-	-	Unknown	November 2018	-
NCT03403803	-	-	Recruiting	September 1, 2019	United States, Texas ... more >> Baylor Scott and White Medical Center Recruiting Temple, Texas, United States, 76508 Contact: Dedra Preece, BS 254-724-5939 Dedra.Preece@BSWHealth.org Contact: Vanessa Hoelscher, BS 254-724-6759 Vanessa.Hoelscher@BSWHealth.org Collapse <<
NCT00256230	Stage IV Melanoma	Phase 1 Phase 2	Completed	-	United States, California ... more >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Collapse <<
NCT01499823	-	-	Unknown	December 2013	Korea, Republic of ... more >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Collapse <<
NCT00541840	Soft Tissue Sarcoma	Phase 1 Phase 2	Unknown	April 2010	Spain ... more >> Grupo Geis Recruiting Madrid, Spain, 28001 Contact: Xavier Garcia del Muro, MD 915775281 info@grupogeis.org Principal Investigator: Xavier Garcia del Muro, MD Collapse <<
NCT01663012	Anaplastic Astrocytomas ... more >> Anaplastic Oligodendrogliomas Glioblastomas (GBM) Collapse <<	Phase 2	Completed	-	United States, California ... more >> Stanford University School of Medicine Palo Alto, California, United States, 94305 Collapse <<
NCT02848794	High-grade Glioma	Phase 1 Phase 2	Recruiting	July 2018	China, Jiangsu ... more >> The First's People Hospital of Lianyungang Recruiting Lianyungang, Jiangsu, China, 222000 Contact: Xiaodong Jiang, Doctor +86018961326201 jxdysy1970@163.com Contact: Tao Yang, Master +86018961327792 18961327792@163.com Collapse <<
NCT03642080	-	-	Not yet recruiting	December 31, 2023	United States, New York ... more >> New York Presbyterian - Brooklyn Methodist Hospital Not yet recruiting Brooklyn, New York, United States, 11215 Contact: Adel Guirguis, MD, MS 718-780-3677 adg9003@nyp.org Contact: Hani Ashamalla, MD 718-780-3677 hashamalla@gmail.com Principal Investigator: Theodore Yanagihara`, MD, PhD Collapse <<
NCT02129335	-	-	Terminated(insufficient enroll... more >>ment) Collapse <<	-	Switzerland ... more >> University Hospital Basel Basel, Switzerland, 4031 Kantonsspital Luzern Luzern, Switzerland, 6000 University Hospital Neurology Zürich, Switzerland, 8091 Collapse <<
NCT02283944	Glioblastoma	Phase 2	Suspended(Device for multi coi... more >>l TMS no longer supported) Collapse <<	January 2018	-
NCT00706810	Cancer Brain ... more >>Cancer Meningioma Collapse <<	Phase 2	Completed	-	United States, Utah ... more >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Collapse <<
NCT01663012	-	-	Completed	-	-
NCT00706810	-	-	Completed	-	-
NCT02104882	Glioblastoma Multiforme	Phase 1 Phase 2	Completed	-	Germany ... more >> Universitätsmedizin Mannheim, University of Heidelberg Mannheim, Germany, 68167 Collapse <<
NCT00088400	Glioblastoma	Phase 3	Completed	-	United States, Maryland ... more >> National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States, 20892 Collapse <<
NCT01867593	Glioblastoma	Early Phase 1	Completed	-	United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Collapse <<

替莫唑胺 Catalog No. CSN12046

靶点选择性

请登录您的专属账户

确认信息